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Stellingen 
1. De invloed van de interactie tussen het substraat en het reactieve ijzer-oxo 
deeltje op de orientatie van het substraat in het actieve centrum van 
cytochroom P450 tijdens de katalyse is van groter belang dan algemeen 
wordt aangenomen. 
Paulsen and Omstein, 1993, Protein Engineering 6,359-365. 
Dit Proefschrift 
2. Het feit dat in tegenstelling tot een fluor, broom en chloor atoom er geen 
cytochroom P450 gekatalyseerde jood NIH shift is waargenomen komt door 
het feit dat de aanval van het ijzer-oxo deeltje op de ring koolstof atomen 
naast het gesubstitueerde atoom wordt gehinderd door de grootte van het 
jood atoom. 
Dit proefschrift 
3. De rol van areen oxide intermediairen in de cytochroom P450 gekatalyseerde 
aromatische ring hydroxylering van gehalogeneerde benzenen wordt ten 
onrechte overschat. 
Korzekwa et al, 1989, Biochemistry 28, 9019-9027. 
Rietjens et at., 1993, Biochemistry 32,4801-4812. 
Rizk and Hanzlik, 1995, Xenobiotica 25,143-150. 
Dit proefschrift 
4. De invloed van de axiale ligand in heem-enzymen heeft minder invloed op 
het reactie mechanisme van het gevormde ijzer-oxo deeltje dan in de 
literatuur wordt gesuggereerd. 
Du and Loew, 1992, International Journal of Quantum Chemistry 44,251-261. 
Zakharieva et al, 1996, Journal of Biological Inorganic Chemistry 1,192-204. 
5. Ab initio moleculaire orbitaal berekeningen zijn per definitie niet beter voor 
de voorspelling van chemische reaches dan semi-empirische berekeningen. 
6. Bij het opstellen van QSAR's op basis van multivariatie technieken is het van 
belang om de variabelen in vergelijkbare eenheid weer te geven zodat uit de 
coefficienten de relatieve invloed van de verschillende parameters af te 
leiden is. 
Yin et al, 1995, Proceedings of the National Academy of Sciences USA 92,11076-11080. 
7. Het is soms onbegrijpelijk dat er geen QSAR lijkt te bestaan tussen de 
precisie waarmee het experiment wordt uitgevoerd en de netheid op het lab. 
8. Op grond van het feit dat de muis de meest gebruikte diersoort is voor 
onderzoek zou de uitdrukking 'Proefkonijn' beter vervangen kunnen worden 
door 'Proefmuis'. 
9. Voor de financiele administratie van de LUW geldt hetzelfde als voor 
wetenschappelijk onderzoek: op het moment dat je denkt te weten hoe het 
ongeveer werkt is het toch net even anders. 
10. Door de toename van de bevolking en diens activiteit worden de winters in 
Nederland mogelijk weer kouder ('Heinrich events'). Ondanks deze 
klimaatsverandering blijkt helaas toch dat door de omvang van deze 
populatie een officiele Elfstedentocht in het water valt. 
11. Aan de houding van een violist(e) kan men zien of er de eerste viool 
gespeeld wordt. 
12. De emancipatie van de vrouw is nabij als in de wasmiddelen-reclame een 
man, net zoals een vrouw nu, het 'belang' van een witte en schone was kan 
overdrijven. 
13. Het feit dat liefdadigheidsacties vaak veel meer succes hebben wanneer deze 
gekoppeld zijn aan een loterij toont meer eigenliefde van de deelnemer dan 
liefde voor zijn medemens. 
14. De enige geboden die de mens niet belemmeren maar uiteindelijk tot zijn 
bevrijding zullen leiden zijn De Tien Geboden. 
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Chapter 1 
Introduction to the biotransformation of xenobiotics 
The progress in prosperity and welfare in modern industrial society can be 
partially ascribed to the enormous amount of chemical products which have been 
synthesized and used, and an even further increase in the development of new 
compounds is foreseen. These non-natural occurring xenobiotics (foreign to 
organisms) comprise chemical products such as agrochemicals, pharmaceutical 
products, industrial chemicals and food additives. The extensive use of these 
xenobiotics exposes organisms to a large number of these agents under widely 
varying conditions. Exposure results from industrial application of these chemicals 
and also from the presence of these chemicals as environmental pollutants. 
Organisms, like humans and animals, have an enzymatic system to protect 
themselves against these xenobiotics. In mammals small xenobiotics can principally 
become inactivated by enzymatic conversion. The biotransformation enzymes 
involved catalyse the modification of these xenobiotics to compounds which can be 
more easily excreted from the body. Although most of these biotransformation 
reactions result in detoxification of the chemical, some of these reactions appear to 
result in metabolites provoking toxic and/or mutagenic/carcinogenic effects in the 
organism (bioactivation). Therefore, a better insight in the mechanisms of 
biotransformation of (hazardous) xenobiotics would improve possibilities for the 
assessment of the risks of xenobiotics for organisms. For example, understanding of 
the biotransformation reactions of xenobiotics is a prerequisite for the development 
and registration of new industrial chemicals and drugs, as biotransformation 
reactions might have consequences for their bioavailability and/or the balance 
between their elimination or their conversion to metabolites that might bring about 
unintentional (toxic) side-effects. 
The rate of development of new xenobiotics is such fast that it becomes more 
and more unfeasible to test the biotransformation patterns and toxic and /o r 
mutagenic/carcinogenic effects of all newly developed chemical compounds 
individually. One way to reduce this problem is the development of QSARs 
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(Quantitative Structure-Activity Relationships). A QSAR describes a model in which 
structural characteristics of a chemical are linked to its biological activity. On the 
basis of these QSARs, predictions can be made for the biotransformation and /or 
biological activity of newly developed chemicals. This could help to set priorities in 
toxicological studies resulting in a decreased use of experimental animals. 
Furthermore, QSARs often give more insight in the mechanism of the 
biotransformation enzymes and/or the biological activity of xenobiotics. This 
knowledge can contribute to the development of chemicals which better fulfil their 
industrial, medical and/or agricultural requirements and are safer in use. 
In this chapter the general principles of the biotransformation of xenobiotics 
and the development of QSARs in biotransformation research will be described in 
greater detail. 
1 General principles of the biotransformation of xenobiotics 
1.1 Phase I: General aspects of cytochromes P450 
A. The mechanism of oxygen activation 
B. The function and regulation of cytochrome P450 enzyme patterns 
C. Factors controlling cytochrome P450 catalysis 
D. Proposed mechanisms for cytochrome P450-catalysed oxidations 
1.2 Phase II 
2 Quantitative Structure-Activity Relationships in biotransformation 
studies 
A. Frontier Orbital Theory 
B. Review of frontier orbital based MO-QSARs for biotransforma-
tion of xenobiotics. 
1 General principles of the biotransformation of xenobiotics 
Since most xenobiotics are hydrophobic, they can readily be absorbed by 
human beings and animals through the skin, lungs and the gastro-intestinal tract. 
Also dependent on their physical characteristics compounds absorbed will be 
divided over the various tissues of the body. Organisms defend themselves against 
accumulation of the xenobiotics by enzymatic conversion of these chemicals to more 
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hydrophilic (water-soluble) products facilitating excretion in the urine or, through 
bile, in the faeces. The enzymes responsible for the biotransformation of xenobiotics 
are present in nearly all organs, but the liver appears to contain the highest amount 
of biotransformation enzymes. This is a logic consequence of the function of the 
liver: i.e. its capacity to extract substances readily from the blood which are absorbed 
from the gastro-intestinal tract and to store or distribute them after chemical 
modification. 
The biotransformation reactions are roughly divided into two types, i.e. the 
Phase I (transformation or modification) and Phase II (conjugation) reactions. In 
Phase I reactions a functional group (e.g. -OH, -SH, -NH2, -COOH) is introduced by 
oxidation, reduction or hydrolysis of the parent compound, generally increasing the 
hydrophilicity of the compound and making it more susceptible for Phase II 
reactions. In the Phase II reactions the parent compound or the Phase I-derivative is 
covalently linked to an endogenous agent (e.g. glucuronic acid, sulphate, 
glutathione, H2O) thereby often further enhancing the hydrophilicity and making it 
possible to excrete the chemical by urinary and biliary faecal routes. There are also 
xenobiotics which are so hydrophilic that they can be excreted in their unmodified 
form. Figure 1 shows the process of Phase I and II biotransformation of xenobiotics 
and the main enzymes involved in these conversions. 
1.1 Phase I 
General aspects of cytochromes P450 
The cytochrome P450 monooxygenases are important Phase I enzymes. It is 
an enzyme complex which in humans and animals consists of various cytochrome 
P450 enzymes, NADPH-cytochrome P450 reductase, NADH-cytochrome P450 
reductase and cytochrome b5, which are all embedded in the phospholipid matrix of 
mainly the endoplasmatic reticulum. The phospholipids are thought to facilitate the 
interaction between the various components of the enzyme system and/or to play a 
role in concentrating the hydrophobic substrates in the neighbourhood of this Phase 
I enzyme system [1]. The cytochromes P450 have a molecular weight of about 50 kDa 
and contain an iron (Ill)-protoporphyrin IX (heme) as the prosthetic group, the iron 
of which is coordinated by a cysteine-thiolate residue from the apoprotein (Figure 2). 
The cytochromes P450 owe their name to the fact that reduced cytochrome P450 
(Fe2+) liganded with carbon monoxide has an absorption spectrum with a maximum 
near 450 nm, a characteristic attributable to the ligation of the heme by the cysteine-
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Figure 1 The process of Phase I and II biotransformation of xenobiotics and the main 
enzymes involved, 
thiolate [2,3]. Absorption at 420 ran indicates inactivated cytochrome P450 due to a 
larger distance between the iron and the axial thiolate or replacement of the thiolate 
by another ligand (e.g. imidazole) [4,5]. 
The NADH- and NADPH-cytochrome P450 reductases are flavin containing 
enzymes (molecular weight about 78 kDa) and they catalyse the electron transport 
from NADH and NADPH respectively to the cytochromes P450. NADPH-
cytochrome P450 reductase can directly donate the electrons to cytochrome P450 or 
via cytochrome bs while NADH-cytochrome P450 reductase transfers the electrons 
to cytochrome b5. Cytochrome b5 (molecular weight about 17 kDa) is a hemeprotein 
and has been suggested that in some cases it can transfer electrons from NADH- and 
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NADPH-cytochrome P450 reductase to cytochrome P450 [6]. 
The cytochrome P450 enzyme system is widespread in nature and many 
different enzymes have been observed in animals, plants and microorganisms. In 
humans and animals the enzyme system has been found in every type of cell with 
the exception of red blood cells and skeletal muscle cells. The liver appears to have 
the highest amount of cytochromes P450 [6]. 
H,C-4 II Scvsl >CH=CH2 
H,CH\ X />CH: 
Figure 2 A schematic picture of the prosthetic group of cytochrome P450. 
A. The mechanism of oxygen activation 
The cytochrome P450 enzyme system is a monooxygenase. It catalyses 
dioxygen activation using two electrons (from NAD(P)H) and two protons, 
ultimately resulting in the insertion of one oxygen atom from O2 into a substrate (S) 
and incorporation of the other oxygen atom in a water molecule (Equation 1): 
S + 0 2 + 2e" + 2H+ > SO + H 2 0 (1) 
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The mechanism proposed for oxygen activation and substrate conversion in a 
cytochrome P450 reaction cycle is depicted in the overall scheme in Figure 3 [7]. The 
individual steps in this cycle are discussed below. 
Step 1. The oxidized state (ferric iron (III)) of cytochrome P450 exists in two forms 
which are in equilibrium: a hexacoordinated low-spin (S=l/2) or a pentacoordinated 
high-spin (S=5/2) complex. The hexacoordinated low-spin iron (III) complex has two 
axial ligands perpendicular to the plane of the porphyrin ring system; a proximal 
cysteine-thiolate residue of the apoprotein and the distal ligand, presumably an OH-
containing residue (H2O or a tyrosine). The pentacoordinated high-spin complex has 
only the cysteine-thiolate ligand which results in displacement of the Fe3+ out of the 
plane of the porphyrin ring system [8]. Binding of substrates in the active sites of 
cytochromes P450 induces a shift in the spin state of the heme resulting in a 
characteristic spectral change. Type I substrates preferentially bind to the high-spin 
form resulting in a shift of the absorption maximum of the free cytochrome P450 to 
lower wavelengths (± 390 nm (high-spin band)), while Type II substrates 
preferentially bind to the low-spin form resulting in a shift of the absorption 
maximum to higher wavelengths (425-435 nm (low-spin band)) [9]. So far, it is 
thought that Type I substrates bind at or near the catalytic site of cytochrome P450 
while Type II substrates, especially nitrogen containing compounds, are suggested to 
coordinate directly to the heme iron occupying the sixth axial ligand position [10-12]. 
Step 2. The binding of substrate to the enzyme results in a conformational change in 
the apoprotein triggering an one-electron transfer via NADPH-cytochrome P450 
reductase to reduce ferric iron-heme to Fe2+. For some cytochromes P450 it has been 
observed that Type II substrates increase while Type I substrates decrease the redox-
potential resulting in an increased and decreased rate of reduction of the ferric heme 
respectively [8]. However, this spin-redox coupling is not observed for all 
cytochromes P450 and the spin state is not correlated to catalytic activity [13]. 
Step 2a. Although the cytochromes P450 are classified as monooxygenases it is noteworthy that 
cytochromes P450 in the ferrous state are able to catalyse the reduction of some easily reducible 
compounds, especially under low oxygen pressure conditions. These reductions, which are 
considerably less important than monooxygenation reactions, have been reported for substrates like 
halogenated alkanes, azodyes, nitro compounds, benzoquinoneimines and quinones [14]. 
12 
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'XOOF 
Figure 3 General proposed mechanism of oxygen activation. The different numbers are 
explained in the text (S=substrate). 
Step 3. The reduction of the ferric cytochrome P450-substrate complex to the ferrous 
state initiates step 3, which represents the binding of molecular oxygen. 
Step 3a. The cytochrome P450 oxygen cycle can be short circuited when an electron of the Fe2 + is 
transferred to O2 producing O2"* that dissociates. This phenomenon is called uncoupling or futile 
13 
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cycling of the cytochrome P450 oxygen cycle and is probably due to steric interference between water 
molecules and dioxygen as well as access of dioxygen to solvent protons [15]. Hydrogen peroxide 
may be formed by disproportionation of two superoxide anion molecules as follows: 
C>2"* + 02"* > O2 + H2Q2 
Hydroxyl radicals can be produced from the hydrogen peroxide in a Fe2+ catalysed Fenton reaction 
[9,17]: 
Fe2"1- + H2Q2 > Fe3+ + OH" + OH* 
Step 4. The ferrous cytochrome P450-substrate-oxygen complex receives another 
electron from NADPH via NADPH-cytochrome P450 reductase or, in some cases, 
from NADH via NADH-cytochrome reductase and cytochrome bs [5]. The structure 
of this intermediate depicted in Figure 3 is a hypothetical representation as its 
structure has not been established yet for example on the basis of model-compound 
analogues [16]. 
Step 4a. Uncoupling of the oxygen cycle at this stage can occur in some bacterial and mammalian 
cytochromes P450, i.e. hydrogen peroxide is released, which is possibly due to the presence of 
disorderd water molecules [18-20]. In a Fe'+ catalysed Fenton reaction hydroxyl radicals might be 
formed (see step 3a) [9,17]. 
Step 5. In a series of reactions, which is not fully proved so far but which is thought 
to be facilitated by the thiolate ligand [21-23], heterolytic cleavage of the oxygen 
bond takes place and two electrons are transferred to the molecular oxygen atom, 
which is then reduced to water. The other oxygen is bound to the heme iron 
resulting in a high-valent iron-oxo porphyrin radical cation species (FeO)3+ which is 
thought to have a structure similar to that of horseradish peroxidase (HRP) 
Compound I [8,24,25]. 
Step 5a. The high-valent iron-oxo species can be reduced by two electrons to form a second water 
molecule. Formation of excess water is in competition with substrate oxidation [26,27]. This 
uncoupling pathway might prevent oxidation of active site amino acids and heme when the catalytic 
oxygen cycle is initiated but the substrate leaves the active site before catalysis. This phenomenon is 
seen with substrates of low reactivity for oxidation or pseudo substrates like perfluorinated 
hydrocarbons. 
Step 6. The resulting high-valent iron-oxo species, whatever its exact electronic 
structure, is highly reactive and able to insert its oxygen into the substrate. The 
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mechanism of oxygen incorporation in the substrate is dependent on the atom or 
molecule to be oxidized [28] (see paragraph 1.1 D). The oxygenated substrate 
dissociates thereby regenerating the oxidized form of cytochrome P450 which is then 
available for the next cycle of oxygen activation. 
Step 7. This reaction step depicted in Figure 3 involves the direct creation of the 
high-valent iron-oxo species of cytochrome P450 from its Fe3+ form using alternative 
oxygen donors such as iodosobenzene, cumene hydroperoxide, t-butyl 
hydroperoxide, and is called the "peroxidase shunt". Cytochrome P450-catalysed 
oxygenations by oxygen and peroxycompounds are thought to result in the same 
high-valent iron-oxo intermediate (Compound I). The rate of catalysis of a 
peroxidase supported cytochrome P450 conversion is generally faster than the 
normal NADPH/O2 driven reaction because the reduction steps in the normal 
cytochrome P450 cycle are often the rate limiting steps in overall catalysis [24,29]. 
B. The function and regulation of cytochrome P450 enzyme patterns 
Besides metabolizing endogenous compounds like signalling molecules 
(prostaglandins, thromboxanes, leukotrienes, NO*), steroids (e.g. pregnenolone and 
progesterone), alkaloids (morphine, codeine), bile acids and the fat soluble vitamins 
A and D, cytochromes P450 are able to modify a large range of structurally diverse 
xenobiotics. The number of known chemical substrates for cytochromes P450 
extends to about 250,000 now. As it would be impractical for the body to produce 
elaborate and specific enzyme systems to deal with every new molecule that might 
enter the body, the cytochromes P450 comprise a superfamily of enzymes with a 
generally broad substrate specificity. All cytochrome P450 enzymes are thought to 
use a common heme perferryl (FeO)3+ intermediate, and therefore the chemistry of 
cytochromes P450 oxidation reactions is proposed to be essentially identical among 
the different enzymes [30]. However, the cytochrome P450 enzymes differ in the 
three dimensional structure of their apoprotein due to differences in amino acid 
sequences. Based on the similarities in their amino acid sequences they have been 
classified into families and subfamilies [31]. Those complementary DNA sequences 
with at least 40% identity are grouped into families (1,2,3...). Sequences within a 
family that are at least 55% identical are grouped into subfamilies (A,B,C,...). The 
individual genes within a subfamily are denoted with an Arabic numeral (1,2,3...). 
The corresponding genes are given the prefix CYP (cyp for mouse). So far 221 
cytochrome P450 genes have been characterized [31]. The known human and animal 
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cytochromes P450 comprise 12 gene families, which can be subdivided into two 
groups. One group contains the cytochromes P4501, 2, 3 and 4, which are mainly 
concerned with the oxidation of xenobiotics (Table 1) [32], and the other group 
consists of cytochrome P450 families 5, 7,11,17,19,21,24 and 27 which are involved 
in hydroxylation of endogenous compounds. The latter group of enzymes is fairly 
restrictive in their substrate specificity while the former has a wide and overlapping 
substrate specificity. The cytochromes P4501, 2, 3 and 4 are proposed to have been 
evolved and diverged in animals due to their exposure to plant poisons over the last 
one billion years. 
As organisms are not continuously exposed to the whole array of xenobiotics 
there is a cellular control mechanism to respond to certain substances (inducers) 
resulting in the increased biosynthesis and/or stabilization of specific cytochrome 
P450 enzymes. The induction of cytochromes P450 is accomplished by certain 
hormones and chemicals which increase the biosynthesis of cytochrome P450 
apoproteins (Table 1). The enhancement of biosynthesis of apoproteins is initiated by 
elevation of the specific mRNA coding for the protein through either increased DNA 
transcription and /o r mRNA stabilization [33]. The exact mechanisms of the 
increased rate of transcription are unknown. Most is known about the transcription 
of cytochrome P4501A1 which is regulated by a cytosolic (steroid like) receptor: the 
Ah receptor, which binds some carcinogens and other planar molecules. This 
complex is transported into the nucleus where it binds to a specific region of the 
P4501A1 gene inducing production of mRNA, which is the template for synthesis of 
the cytochrome P4501A1 enzyme [34,35]. Inducers of cytochrome P4501A1 are all 
potential substrates for this isoform, therefore the optimum spatial conformation of 
the active site of cytochrome P4501A1 and the binding site of the Ah receptor have 
been suggested to be similar [36,37]. The regulation of some other cytochromes P450 
is known to proceed by a post-transcriptional mechanism, which includes the 
stabilization of mRNA and/or protein. This mechanism of induction is suggested for 
cytochromes P4502E, which are protected against degradation by the substrates 
acetone and imidazole [38,39]. Post-transcriptional regulation can also be 
accomplished by regulation of the pool of the necessary heme prosthetic cofactor 
[29]. Generally, it appears that, somewhat in contrast to the situation described 
above for P4501A1, there is little structural similarity between the cytochrome P450 
inducer of a specific enzyme and the substrates for this enzyme. 
Apart from cytochrome P450 induction, it is also known that cytochromes 
P450 can be inhibited by various chemical compounds. The most common type of 
inhibition is the competitive or non-competitive binding of substrates to the 
16 
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Table 1 
involved 
The nomenclature of the main cytochrome P450 enzymes, and their typical inducing agents, 
in the oxygenation of xenobiotics in humans and some experimental animals [31,52]. 
Subfamily individual gene 
1A 
1A 
2A 
2B 
2C 
2D 
2E 
3A 
4A 
1 
2 
1,2,3 
4,5 
6,7 
10,11 
1,2,3,8,14 
4,5 
6 
9,10,13 
1-5,14-16 
6,7,11-13,22-24 
8,9,18,19 
1-5 
6 
9-13 
1 
2 
1,2,9 
3,4,5,7 
6 
11,13 
1-3,8 
4-7 
9,11 
10,12 
species 
rat, human 
rabbit, mouse 
rat, human 
rabbit, mouse 
rat 
mouse 
human 
rabbit 
rat 
rabbit 
human 
mouse 
rabbit 
rat 
human 
rat 
human 
mouse 
rat 
human 
rabbit 
mouse 
rabbit 
rat 
human 
rabbit 
mouse 
rat 
rabbit 
human 
mouse 
typical inducers 
3-MC, P-NF 
isosafrole 
3-MC, P-NF 
phenobarbital 
phenobarbital 
non inducible 
ethanol, isoniazid, acetone 
PCN, dexamethasone 
clofibrate 
Unfortunately, there is some ambiguity in the system concerning the last number when referring to 
different species-in some cases the last number is specific to the animal species, but in other instances 
the same nomenclature applies to all species. 
3-MC= 3 -methylcholanthrene, p-NF= p-naphtoflavone, PCN= pregnenolone 16a-carbonitrile 
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substrate binding site. In addition, irreversible inhibition may result from activation 
of a chemical upon its conversion by cytochrome P450, whereby reactive metabolites 
bind covalently to the pyrole nitrogens of heme, resulting in the destruction of the 
heme and loss of cytochrome P450 activity [40]. Cytochrome P450 inhibitors are 
often used in studies on the physiological role of cytochromes P450. 
The cytochromes P450 which are involved in the metabolism of endogenous 
compounds are often constitutively expressed and sexually determined by neonatal 
imprinting and hormones. This means that the activity of these cytochromes P450 
may vary in female and male species and in their activity during certain stages of the 
life cycle [33,41]. 
Finally, there might be cytochrome P450 differences between organisms due 
to polymorphism, i.e. some individuals might lack certain isozymes. Well-known 
examples of this phenomenon is cytochrome P4502D6 and P4502C19 which convert 
the drugs debrisoquine and S-mephenytoin respectively [42,43]. 
The regulation of cytochromes P450 is very important as especially the 
cytochromes P4501,2,3 and 4 are concerned with the detoxification of xenobiotics to 
more-polar, biologically-inactive, readily-excretable metabolites. However, the same 
microsomal enzymes can also catalyse the oxidative formation of reactive 
intermediates which might ultimately lead to carcinogens (epoxides, arene oxides, 
free (oxygen) radicals and N-hydroxy derivatives) through covalent binding to 
protein or DNA resulting in malignancy and other pathologic processes [37,44,45,46]. 
Especially the cytochrome P4501A family and to a lesser extent the cytochrome 
P4502E family of enzymes is concerned with the bioactivation of chemicals and 
carcinogens to reactive intermediates [32,37,47]. For example, the cytochrome 
P4501A subfamily selectively accepts planar molecules and oxygenates them in 
conformationally hindered positions, thus forming highly reactive arene oxides, 
which are not easily detoxified by other enzymes (Phase II) however [48]. The 
nitrosamines and other small molecules are mainly activated by cytochrome P4502E 
[32,49,50]. Furthermore, the cytochromes P4502E are also known to produce reactive 
oxygen species resulting in oxidative stress [47,51]. 
This catalysis of opposing pathways of detoxification and bioactivation of chemicals 
by the same group of enzymes has become of increasing importance with regard to 
biological consequences of biotransformation. Thus, the intensity and length of 
induction or inhibition of cytochromes P450 can have dramatic consequences for the 
detoxification or bioactivation of chemicals, but also for the availability of the 
compound. For example, co-administration of cytochrome P450 inhibitors with other 
drugs can prevent rapid drug metabolism. 
18 
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C. Factors controlling cytochrome P450 catalysis 
In the first part of this chapter the general proposed catalytic reaction cycle 
of cytochrome P450-catalysed oxygen activation resulting in a perferryl (FeO)3+ 
intermediate was described. This catalytic active conformation relevant for the 
monooxygenation reactions catalysed by the enzymes is suggested to be similar for 
all cytochrome P450 enzymes [30]. However, this does not imply that all cytochrome 
P450 substrates are converted by all enzymes to the same extent or result in similar 
metabolic patterns. Although many cytochrome P450 enzymes have an overlapping 
substrate specificity, the extent and regio-/stereoselectivity of the cytochrome P450-
catalysed conversion of chemicals might differ widely due to differences in the three-
dimensional structure of cytochrome P450 enzymes. The chemical characteristics of 
the various substrates might also influence the cytochrome P450 catalysis. The 
apoprotein and substrate characteristics which control the cytochrome P450-
catalysed biotransformation reactions have been investigated using various 
approaches. As more computing power has become available the development of 
many techniques accelerated enormously. Many attempts have been made to model 
the interactions between the substrate and the catalytic active site of cytochromes 
P450 through docking experiments, pharmacophore-3D representations, pattern 
recognitions or chemical and theoretical model systems. The influence of the 
chemical reactivity of the substrate on its cytochrome P450-catalysed conversion has 
been described by QSARs (see paragraph 2). In this session several factors 
controlling the cytochrome P450 catalysis of substrates are discussed in some more 
detail. 
1. Accessibility of the active site for the substrate 
Since the eukaryotic cytochromes P450 are embedded in a phospholipid 
matrix, the substrates might have to be dissolved in the membrane before they can 
enter the access channel which leads to the active site of the enzyme. Especially 
hydrophobic compounds will be able to dissolve in the lipophilic membrane, 
increasing their effective concentration in the neighbourhood of the enzyme and 
apparently increased affinity of the enzyme for the substrate [53]. 
For several bacterial cytochromes it has been shown that the hydrophobic 
substrates are recognized on the surface of the protein by a hydrophobic patch of 
amino acids adjacent to the substrate channel [54-56]. The substrates will partition 
down via the access chancel into the active site as a result of hydrophobic 
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interactions. This access route appears to be flexible, i.e. it has a large open/close 
motion [57-60]. This flexibility of the entrance channel is probably important in 
controlling substrate access to the active site and hence it is expected to exhibit wide 
variations between cytochromes P450, that have different substrate specificity 
[60,61]. 
2. Binding of the substrate in the active site 
Cytochrome P450 substrates reach the active site by the entrance channel and 
will be bound in the catalytic cavity before catalysis. The binding affinity and 
orientation of the substrate in the active site is dependent on both the 
physicochemical properties of the active site as well as those of the substrate. 
Together, these factors will influence the extent and regio-/stereoselectivity of 
cytochrome P450 catalysis. 
Much research so far has been centred on solving the three-dimensional 
structure of the active site of both bacterial as well as mammalian cytochromes P450. 
One of the best ways to resolve the three-dimensional structure of a protein is by X-
ray analysis of its crystal structure. With the aid of computers these data are used to 
identify other molecules which fit into the same active site (docking) [62-64]. 
However, so far X-ray crystallographic analysis has only been successful for the 
cytosolic bacterial cytochromes P450, i.e. P450cam/ P450terp, and P450BM3 [18,54,55], 
mainly because technical difficulties are inherent to the crystallographic analysis of 
membrane-bound proteins due to the high hydrophobicity of these enzymes. Many 
attempts have been made to use the bacterial cytochromes P450 as a model for the 
mammalian systems like for example the elucidation of the substrate recognition 
regions in the cytochrome P4502C family based on amino acid sequence alignment 
with cytochrome P450cam [56]. However, this is a risky endeavour as the bacterial 
cytochromes P450 are not membrane bound, have low sequence homology with the 
mammalian cytochromes P450 and generally receive their electrons from a FAD 
reductase via a putidaredoxin instead of through the NAD(P)H cytochrome 
reductases [65,66]. In this respect, the tertiary structure of the bacterial cytochrome 
P450BM3 from Bacillus megaterium which, similar to mammalian cytochromes P450, 
receives its electrons directly from NADPH-reductase and furthermore has a higher 
amino acid sequence homology to the mammalian bound enzymes is likely to 
provide better information as a standard template for three-dimensional models [54]. 
NMR analysis is also a good tool in solving protein structures. Unfortunately, 
elucidation of the tertiary structure of the cytochromes P450 by NMR analysis has 
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not been possible so far as the enzymes are relatively large for NMR analysis. 
Therefore, up till now other techniques have been applied to obtain some 
insight in the three-dimensional structure of the active site of mammalian 
cytochromes P450. The topology and dynamics of the active sites of P4501A1,1A2, 
2B1, 2B2, 2E1 [67-71] and of the bacterial cytochromes P450cam, P450terp and 
P450BM3 [69,72] have been investigated by preparation of a-bonded iron-aryl 
complexes of the heme-proteins. Exposure of these iron-aryl complexes to an 
oxidizing agent results in a covalent coupling of the aryl group to the porphyrin 
nitrogens in the original active site. The ratio of the four possible regioisomers gives 
information on the regions above the heme group that are (or are not) occupied by 
protein residues and thus are (not) accessible for substrates. The results obtained 
with this method for cytochromes P450cam and P450terp agreed with the resolved 
crystal structures of these enzymes showing the reliability of the approach. 
Additional results obtained showed that the topology of the bacterial and 
mammalian cytochromes P450 differs. For the mammalian cytochromes P450 the 
regions above the pyrole rings of the heme-cofactor are not accessible to a similar 
extent, i.e. two pyrole rings were found to be relatively exposed while the two others 
were occluded by protein residues, with subtle differences between the various 
cytochrome P450 enzymes. Thus, despite a gross difference in substrate specificity, 
the active sites of these cytochromes have a common architecture with respect to the 
accessibility of the pyrole rings of the heme, except for cytochrome P4501A2 for 
which the active site is open above all four rings [70]. The results of the iron-aryl 
complex studies have also been connected to results from previous studies on the 
proposed topology of the active site of cytochrome P4501A1 based on the molecular 
geometries of specific substrates for cytochrome P4501A1 [73] and the regio- and 
stereospecificity of P450 catalysis [74]. The conclusion was that the active site of 
P4501A1 is a relatively large but shallow region parallel to the heme plane and has a 
high area-to-depth ratio. In addition, it can be derived that if the aromatic 
hydrocarbon binding site is roughly parallel to the heme face, the data obtained with 
the iron-aryl complexes require that the bulk of the binding-site extends over two 
pyrole rings. This proposal is in accordance with the observation that the regions 
over the two other pyrole rings are masked by the protein. 
Based on the homology between molecular geometries of other (cytochrome 
P450) substrates, it was concluded that the active sites of cytochromes P4502E are 
relatively small [75] and the active sites of phenobarbital induced cytochromes P450 
accommodate bulky substrates with a relatively low area-to-depth ratio [37,76]. For 
acetanilide and acetaminophen it was shown, based on ^H NMR Ti relaxation 
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measurements, that the substrates were oriented differently with respect to the heme 
iron in two cytochrome P450 isozymes [77-80]. Acetaminophen was suggested to be 
oriented with its phenol group to the heme iron in cytochrome P4501A1, while in 
cytochrome P4502B1 it was oriented with its acetylamino to the heme iron [80]. 
Surprisingly, another study showed the opposite situation [79]. 
Altogether, the presently available data indicate that substrates might be differently 
bound in various cytochrome P450 enzymes. 
Furthermore specific interactions between substrates and active site 
characteristics can be distinguished. By replacing specific amino acid residues 
through recombinant DNA technology (mutagenic changes at specific sites on the 
genes) it is possible to identify specific regions in the amino acid sequence which 
bind the substrate [81-84]. Interaction between the amino acids at the substrate 
binding site (distal region) and the bound substrate can be of ionic [85-89], hydrogen 
bonding [18,57,64,76] or hydrophobic [64,86,90] character and often result in a 
stereoselective orientation of the substrate in the active site. For example, based on 
pharmacophore space filling models, the human liver cytochrome P4502D6 binds 
compounds which have a positive charge on the nitrogen atom which is supposed to 
interact with a negatively charged carboxylate group of an amino acid [85,87,88,89]. 
Hydrogen bonding interactions are reported for the binding of camphor to 
cytochrome P450Cam- This substrate is bound through a hydrogen bond between its 
carbonyl group and a tyrosine residue [91]. 
Secondly, there are also possibilities of interactions with the Fe3+-heme-cofactor in 
its resting state. The type II substrates, like arylamines [12], are known to bind near 
the heme-iron and act as a ligand to the heme-iron through their nitrogen atom; i.e. 
the sp2 or sp3 non-bonded electrons of the nitrogen are coordinating to the heme-
iron [92]. Nearly all studies on substrate orientation in the active site reported so far 
neglect the possibility of interaction of the substrate with the catalytic active high-
valent iron-oxo species, which is the ultimate reaction intermediate for cytochrome 
P450 catalysis. That this interaction can be important is shown for thiocamphor-
bound to cytochrome P450c a m . The preferred substrate orientation was very 
different in the presence of the ferryl oxygen than in the absence of that oxygen and 
the orientation of thiocamphor in the presence of the oxygen was in agreement with 
the product profile found [64,93]. 
Although properties of the active site might impose a stereoselective 
orientation of the substrate there are also examples where binding of the substrate is 
aspecific with possibilities of high substrate mobility [18]. This means that a broad 
regioselectivity of catalysis might occur. 
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Altogether, the three-dimensional structure of the active site of cytochromes 
P450 and the specific interactions between properties of this active site and the 
substrate might result in the fact that specific substrates are better bound than others 
and that a stereoselective orientation of the substrate in the active site is induced. 
These binding characteristics influence the cytochrome P450-catalysed extent and 
regio-/stereoselectivity of substrate oxidation. The sometimes observed broad 
regioselectivity of substrate oxidation is consistent with multiple substrate 
orientations due to non-specific binding. In those cases the regioselectivity of the 
cytochrome P450-catalysed substrate conversion can be predominantly determined 
by intrinsic chemical reactivity characteristics of the substrate 
3. Intrinsic chemical reactivity of the substrate 
The intrinsic chemical reactivity of the substrate is particularly important for 
substrates which have a relatively large freedom of motion in the catalytic cavity, 
such as small non-polar hydrophobic xenobiotics which are substrates for the 
cytochromes P4501-4 family. This means that interactions between the substrate and 
the active site resulting in a stereoselective orientation of the chemical are not 
important factors in controlling the regioselectivity of catalysis. Thus, for these 
substrates the oxidation reaction catalysed by cytochromes P450 is predominantly 
determined by the properties of the substrate and the catalytic active iron-oxo 
species, i.e. the electronic characteristics of the reactants in the oxidation reaction. 
That this situation can indeed be relevant for cytochrome P450 catalysis is in 
accordance with the observations that i) most P450 oxidations are thought to involve 
radical reactions, and therefore charge stabilisation by the apoprotein may not be an 
important factor during the reaction and ii) the often broad regioselectivity suggests 
that the oxidation of the substrate is indeed 'chemical-like' and does not require 
specific substrate interactions with the apoprotein [66]. A clear example of this 
second phenomenon is the cytochrome P450-catalysed regioselectivity of aromatic 
ring hydroxy la tion of a series of fluorinated benzene and aniline derivatives [94,95]. 
In these studies it was demonstrated that the regioselectivity of aromatic ring 
hydroxylation was independent of the cytochrome P450 isozyme and could be 
correlated with the relative reactivity of the ring carbon atoms for an electrophilic 
attack by the cytochrome P450 high-valent iron-oxo species, ultimately resulting in 
the formation of the phenol derivative. 
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D. Proposed mechanisms for cytochrome P450-catalysed oxidations 
There are various reactions known which are performed by cytochromes 
P450. Figure 4 shows a survey of the various known reactions and the mechanism by 
which these reactions are proposed to proceed. The following monooxygenation 
reactions are depicted: aliphatic hydroxylation [28,96-100], N-hydroxylation 
[100,101], heteroatom dealkylation [98,102-106], aromatic hydroxylation with or 
without an NIH shift [94,107-113], aromatic oxidative dehalogenation [114-116] and 
heteroatom oxidation [28,117]. 
Aliphatic hydroxylation 
R R 
[FeO] 3+ 
R 
[FeOH] 3+ 
R •R R -C •R 
H 
N-hydroxylation 
[FeOl3+ 
[FeOH] 3+ 
[FeOH] 3+ 
*~ R NH 
[FeOH]d 
R NH2 
[FeO]3+ 
[FeO] 
[FeO] 2+ 
[Fe; |3+ 
[FeOH] 3+ 
+ • 
R NH2 
2+ 
^V. » R" C R 
[Fe] 3 + I 
OH 
OH 
R NH 
Figure 4 The mechanism of cytochrome P450-catalysed monooxygenation reactions: 
aliphatic hydroxylation, N-hydroxylation, heteroatom dealkylation, aromatic hydroxylation with or 
without an NIH shift, aromatic oxidative dehalogenation and heteroatom oxidation. 
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2) o-addition mechanism (X=H or halogen) 
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Figure 4 -continued-
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1.2. Phase II 
Contrary to the overwhelming knowledge about (cytochrome P450) Phase I 
reactions, less attention has been paid to Phase II reactions with perhaps the 
exception of the reactions catalysed by GSH S-transferases which have been 
extensively studied. The Phase II biotransformation reactions are conjugation 
reactions, i.e. the substrate is generally enzymatically linked to an endogenous agent. 
Phase II reactions are generally biosynthetic and often require energy which is 
obtained by activation of the cofactor or the substrate by ATP. This means that the 
chance that for some Phase II reactions a substrate undergoes a Phase II reaction 
depends on the availability of ATP and the cofactor. Often the Phase II reaction is 
preceded by a Phase I metabolic reaction to provide a metabolite with a group which 
is the reaction centre for conjugation. Phase II reactions can be subdivided in 
reactions with nucleophilic substrates, catalysed by UDP-glucuronyl-, sulfo-, acetyl-, 
methyl- and amino acid transferases and with electrophilic substrates catalysed by 
GSH S-transferases and epoxide hydrolases (see Table 2). 
The enormous amount of different chemicals which can undergo a Phase II 
reaction is due to the presence of multiple forms of the various Phase II enzymes, 
which have overlapping and broad substrate specificity. They exist in soluble and 
microsomal cell fractions of different tissues, the liver generally being the organ with 
the highest amount of Phase II enzymes. However, as with Phase I enzymes the 
enzyme pattern present can differ widely from one organ to another, with age, 
between species or sexes, and with genotype. A well-known example of genetic 
polymorphism is the occurrence of so-called fast and slow acetylators, reflected in a 
different ability to acetylate isoniazid. It appears that 50% of the Caucasian 
population can be classified as slow acetylators due to a genetically dependent 
deficiency in a specific fast N-acetyl transferase [118]. As acetyl conjugation reactions 
are often detoxification reactions and thus important for organisms to defend 
themselves against toxic and mutagenic chemicals, slow acetylators are more 
susceptible for the toxic effects of chemicals such as arylamines [119]. 
As said earlier, the function of the Phase II enzymes in xenobiotic 
metabolism is detoxification of the chemical and facilitating its excretion. Well-
known examples of these detoxification reactions are the detoxification of arene 
oxide metabolites from benzo(a)pyrene by epoxide hydrolases [120,121], the 
glutathione conjugation of epoxides and of halogenated benzenes such as 
bromobenzene 3,4-arene oxide [122] and the O-methylation of the glucuronide of 4-
bromo-catechol [123]. As transport systems have evolved for the conjugated 
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2 Quantitative Structure-Activity Relationships in biotransformation 
studies 
In order to predict and explain biotransformation reactions QSAR models 
(Quantitative Structure-Activity Relationships) have been developed. In these 
QSARs a correlation is described between parameters characterizing the structural 
electronic and /o r reactivity properties of a series of chemicals and their 
biotransformation [95,126-128]. Based on these QSARs predictions for the 
biotransformation of non-tested related compounds can be made. Furthermore, these 
QSARs often give more insight in the mechanism of biotransformation reactions. In 
addition to QSARs for biotransformation reactions there are also examples of QSARs 
predicting the mutagenicity or carcinogenicity or other toxic characteristics of 
chemicals [37,129,130]. 
One of the main founders of the QSAR concept is Corwin Hansch, who 
extended models on linear energy relationships based on Hammett parameters 
(electronic effects) and Taft parameters (steric effects) by a hydrophobic parameter re, 
based on the logarithm of the experimental octanol/water partition coefficients 
[131]. This hydrophobic parameter turned out to be an important factor in the 
biological activity of chemicals. This can be rationalized as a mechanism in which a 
chemical is transported through cell membranes and across other biological barriers 
to reach its target. The work of Hansch has been extended and more than 200 
parameters have been proposed to describe biological processes [132]. Due to the 
large amount of chemical and physical factors (physicochemical 
properties /parameters), other regression methods than the multiple linear 
regression methods were developed as these parameters might be collinear and not 
be important to a similar extent for a specific process. Along with the advent of high 
speed computers, multivariate statistical analyse techniques were developed, like 
Principal Components Analysis [133] and Partial Least Squares (PLS) to reduce the 
number of parameters [134] and to make it possible to test diverse type of groups of 
chemicals. 
Most important for the reliability of QSARs is the choice of the right chemical 
parameters to describe the process and the right statistical method. The drawback of 
these methods is that there is the real risk of meaningless correlations, because the 
more parameters one selects to fit the biological process, the greater is the chance of a 
correlation arising [135]. Another problem arising is the fact that the more 
parameters used in a QSAR the more difficult it is to understand which chemical 
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property predominantly determines the process under investigation and thus the 
mechanism of the biological activity. In restricting the QSAR to the rate-limiting 
step, more insight can be obtained in the mechanism of the most important step of 
the whole biological process, because the rate-limiting step can be often described by 
only a few physicochemical parameters. 
In addition to all experimental parameters, the availability of powerful and 
fast computers has accelerated the development of chemical parameters which are 
based on electronic and molecular structural properties obtained from quantum-
chemical calculations [98,136-140]. Sometimes physicochemical parameters in QSARs 
are more easily obtained by quantum-chemical calculations than by experiments as 
determination of these experimental parameters require highly specific equipment, a 
lot of time and can be less accurate. 
The quantum-chemical calculations are based on MO (Molecular Orbital) 
computer methods in which an approximate solution of the Schrodinger equation is 
obtained [141]: 
HY=EY (2) 
H Hamiltonian operator 
Y Electron wave function 
E Energy of the molecular orbital 
As this equation can be solved exactly for a hydrogen atom only, various 
approximations are used to solve this equation for other molecules than hydrogen. 
There are roughly two methods to solve this equation, i.e. ab initio and semi-
empirical methods, of which the latter use several approximations. Due to the 
additional approximations in semi-empirical calculations, the main difference 
between the ab initio and semi-empirical methods is that the semi-empirical methods 
require less computer time and space providing the advantage that they can also 
calculate some very large molecules. Although it seems that ab initio calculations are 
far more accurate as they are based on less approximations, this is not by definition 
the case. It appears that the choice of the most suitable MO method depends very 
much on the particular problem under consideration [142]. 
MO methods have given good results for (relative) prediction of 
experimental data such as molecular geometries, ionization energies, redox 
potentials, heat of formation and electron densities. However, as most of the MO 
calculation methods are applied to hypothetical motionless molecules in vacuo, this 
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means that the real biological situation under investigation is not taken into account 
as solvent or other characteristics of the surrounding are neglected. These differences 
involve effects such as entropy, the population of vibrational energy levels, 
solvation, and aggregation, of which each one is able to determine the selectivity of 
the reaction. Therefore, these calculations are most appropriate used to compare and 
study relative effects in series of closely related compounds or when relative 
differences in chemical properties in one molecule are investigated. Due to the 
developments in computer technology it is foreseen that in the future more 
complicated systems can be handled. For example, already commercial programs 
exist which can take into account solvation fields around the molecule. 
A. Frontier Orbital Theory 
In QSARs for chemical reactions the activation energy might be an important 
parameter. This activation energy can be approximated in two ways. When in a 
chemical reaction two molecules collide an activated complex (transition-state 
complex) of relatively high energy is formed. This transition-state complex 
decomposes into the product(s) (Figure 5). Enzymes are able to lower the activation 
energy, i.e. the energy difference between the starting situation and the transition 
state complex, thereby enhancing the reaction rate according to the equation of 
Arhenius: 
k c a t = Ae-AEac./RT (3) 
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However, it is difficult to assess or calculate the energy of the transition state since 
for many reactions a clear description of the transition state is unavailable. A 
possible way to overcome this problem is to investigate whether there exists a 
Bronsted relationship, i.e. a linear correlation between the activation energy (AHt) 
and the heat of the reaction (AHR). The Bronsted relationship has been described for 
series of corresponding reactions for which the effects that stabilize or destabilize the 
reactants, the products and/or the transition state are similar [143]. In such a 
situation the AHR which is the energy difference between reactants and products can 
be used as a relative approximation of the activation energy. 
Another approach to assess the activation energy of a reaction is treating the 
interaction of two molecules as a pertubation which can be characterized by similar 
bonding and antibonding interactions as described by the valence bond theory. 
However, there are some limitations to this approach as finally the interaction is not 
merely a perturbation of two molecules on each other when they form the transition-
state complex. Nevertheless, the Hammond postulate [144] says that the transition 
states for exothermic reactions are reactant-like, so a steeper slope is likely to lead to 
a higher-energy transition-state (Figure 5). Thus, it is possible to assess the relative 
activation energy by determining the slope of an early part of the path along the 
reaction coordinate. 
Based on many approximations and assumptions, Klopman and Salem 
[145,146] derived an expression for the energy (AE) gain and loss when the orbitals 
of two reactants overlap: 
AE = - Qnucl'Qelec/(eT) + 2(celec,CnucrP)2/(EHOMO-ELUMO) (4) 
Qnucl/ Qelec a r e t r i e total charges on the reaction centre in the nucleophile or 
electrophile, respectively 
e is the local dielectric constant 
r is the distance between the nucleophilic and electrophilic reaction centre 
c
^nucl/ c^elec orbital density of the HOMO or LUMO on the reaction centre of the 
nucleophile or electrophile, respectively 
P is the resonance overlap integral 
EHOMO is the energy of the Highest Occupied Molecular Orbital of the 
nucleophile 
E L U M O is the energy of the Lowest Unoccupied Molecular Orbital of the 
electrophile 
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This expression (equation 4) contains two terms, the Coulombic (first term) and the 
frontier orbital term (second term). The frontier orbital theory states that the 
interaction between molecules depends mainly on the electrons in the outer shell 
orbitals, i.e. the HOMO (Highest Occupied Molecular Orbital) and LUMO (Lowest 
Unoccupied Molecular Orbital). From Figure 6 it can be seen that an energy gain 
results from orbital interactions when the first reactant has a filled interacting 
frontier orbital (HOMO) and the other atom has an empty or partly filled interacting 
frontier orbital (LUMO or SOMO (Singly Occupied Molecular Orbital)). Two orbitals 
can combine to a bonding orbital and an antibonding orbital which are lower and 
higher in energy respectively. The energy needed to put two electrons into a 
bonding orbital costs more energy than in an antibonding orbital. 
A B 
I , 
/T~h 
HOMO 
•LUMO 
• i i HOMO-f-H---fc / i , 
"H' ^L H *H i. 
Hi 
^ H n H 
AE = 2E2 - 2Ej > 0 AE = - 2Ej < 0 
Figure 6 (A) Interaction of the HOMO orbitals of two molecules and (B) interaction of the 
HOMO orbital of one molecule with the LUMO orbital of another molecule. 
The frontier orbital term in equation 4 is only valid when EHOMO^ELUMO- I n case 
EHOMO-ELUMO the interaction is better described in charge-transfer terms. It is 
obvious from equation 4 that a HOMO (nucleophile) and LUMO (electrophile) make 
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the largest contribution to the AE, especially to the frontier orbital term in AE when 
the value of E H O M O E L U M O is smallest. 
The frontier orbital density on the reaction centre (c2) is also important in 
this term (equation 4). This frontier orbital density (c2) can be calculated by an 
empirical derived equation from Fukui [147]. 
c2 = 2 (C2HOMO + C2HOMO-I e"3AE) / (1+ e-3AE) (5) 
Fukui et al. experimentally determined that not only the HOMO but also the 
HOMO-1 (Molecular orbital below the HOMO) can contribute to the frontier orbital 
density. The extent of the contribution of the HOMO-1 to the frontier orbital density 
depends on the energy difference between the HOMO and the HOMO-1 (AE). This 
equation 5 is also valid for calculating the LUMO/LUMO+1 density on a reaction 
centre. 
Nucleophiles and electrophiles are divided into hard and soft ones. Hard 
nucleophiles and electrophiles have relatively high-energy LUMOs and low energy 
HOMOs respectively. When they interact the energy difference between the HOMO 
and LUMO is large, so that the frontier orbital term can be neglected and the 
interaction can best described by charge interaction (Coulombic term). This situation 
is important for example for the reactions between ions and polar reactants. 
However, most reactants in enzymatic reactions are thought to be soft, i.e. they have 
low energy LUMOs and high energy HOMOs and are relatively uncharged. Thus for 
these reactants the frontier orbital term is most important. This also includes radicals 
which are soft as most are uncharged. Their frontier orbital is a SOMO [148]. 
The frontier orbital term of the high-valent iron-oxo species of cytochrome 
P450, which is involved in the catalysis of many xenobiotics, is supposed to be a 
SOMO as this species has been proposed to have radical character. This species 
might thus react with the HOMO of a substrate since the cytochrome P450(FeO)3+ is 
considered to be an electrophilic species. 
B. Review of frontier orbital based MO-QSARs for biotransformation of 
xenobiotics 
In Table 3 a survey is presented of known frontier orbital based MO-QSARs/ 
or QSMRs (Quantitative Structure-Metabolism Relationships) for Phase I and II 
biotransformation reactions. 
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Chapter 1 
Aim of the present study 
The starting point for this study is a MO-QSAR for the cytochrome P450-
catalysed regioselectivity of aromatic ring hydroxylation of a series 
(poly)fluorobenzenes [94]. This MO-QSAR was obtained for benzene derivatives 
with fluorine substituents which are inert but also relatively small, so that steric 
effects due to these substituents or interactions between the substrate and the active 
site by these substituents are not expected. In the present study it is investigated 
whether this QSAR could also be applied to benzene derivatives with substituents 
which are more complicated and/or larger than a fluorine atom (Chapters 2 and 3). 
Additional experiments are performed when deviations between the predicted and 
observed regioselectivity of aromatic ring hydroxylation are observed. The possible 
influence of interactions between the substrate and properties of the active site on 
the regioselectivity of aromatic ring hydroxylation are investigated in Chapters 4 and 
5. In Chapter 4 the orientation of a series fluoromethylanilines in cytochromes P450 
1A1 and 2B1 is investigated. The mechanism of aromatic ring hydroxylation by the 
mini-heme enzyme microperoxidase-8 (MP-8) is studied in order to determine 
whether this enzyme might be used as a model system for cytochrome P450-
catalysed aromatic hydroxylation (Chapter 5). This mini-heme enzyme, containing 
only eight amino acids, lacks an active site, and, thus, can be used to determine the 
influence of the active site on the regioselectivity of aromatic ring hydroxylation 
assuming that it acts by a similar mechanism of aromatic hydroxylation as 
cytochrome P450. 
In contrast to literature data about the extensive NIH shift upon cytochrome 
P450-catalysed aromatic ring hydroxylation of bromine and chlorine substituted 
benzenes, absence of such NIH shifted metabolites in the mainly fluorinated benzene 
derivatives in the previous chapters is observed. In Chapter 6 the discrepancy in the 
occurrence of NIH shifted metabolites between chlorine and fluorinated benzenes is 
investigated. 
Finally, in addition to all studies on model benzene derivatives, in Chapter 7 
the biotransformation of the insecticide Teflubenzuron is investigated. This study is 
performed to determine whether outcomes of studies on model benzene derivatives 
can be used to obtain more insight in the biotransformation of other benzene 
derivatives. 
The summary and conclusions are presented in Chapter 8. 
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Influence of substituents in fluorobenzene derivatives on the 
cytochrome P450-catalysed hydroxylation at the adjacent ortho 
aromatic carbon centre 
J. Koerts, M.M.C. Velraeds, A.E.M.F. Soffers, J. Vervoort and I. M.C.M. Rietjens 
Chemical Research in Toxicology, accepted for publication. 
Abstract 
In a previous study the in vivo cytochrome P450-catalysed regioselectivity of 
aromatic ring hydroxylation for a series of (poly)fluorobenzenes could be 
quantitatively predicted by the calculated frontier orbital density distribution in the 
aromatic ring [Rietjens et al. (1993), Biochemistry 32, 4801-4812]. However, the 
relative small fluorine, its size almost comparable to a hydrogen, is not expected to 
influence the regioselectivity of aromatic hydroxylation due to steric hindrance. The 
aim of the present study was to investigate the influence of larger substituents than a 
hydrogen or fluorine on the possibilities for hydroxylation at the adjacent carbon 
centre. First, the in vivo regioselectivity of aromatic ring hydroxylation of a series of 
C4-substituted fluorobenzenes was investigated. The results obtained demonstrate 
that a chlorine and cyano C4 substituent do not hamper hydroxylation at the 
positions ortho to the C4 carbon atom. For 4-chloro- and 4-cyanofluorobenzene the 
observed regioselectivity of aromatic hydroxylation correlated with the 
regioselectivity predicted on the basis of the frontier orbital density distribution. In 
contrast, a bromine and iodine substituent affected the hydroxylation at the adjacent 
ortho carbon centres reducing it to respectively 40% and 6% of the calculated intrinsic 
reactivity of the carbon centres. Additional experiments were performed to 
investigate whether the regioselectivity of the aromatic hydroxylation of the C4-
substituted fluorobenzene model compounds was influenced by changes in the 
cytochrome P450 enzyme pattern. Results obtained demonstrate that for these 
relatively small substrates the regioselectivity of their hydroxylation was not 
significantly influenced by several cytochrome P450 inducers. This suggests that the 
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active sites of the cytochromes P450 catalyzing the aromatic hydroxylation, do not 
impose a stereoselective orientation of the aromatic rings with respect to the iron-oxo 
porphyrin reaction centre. Thus, the working hypothesis for additional experiments 
was that the deviations for the regioselectivity of aromatic hydroxylation observed 
for 4-bromo- and 4-iodofluorobenzene may be ascribed to steric hindrance by the 
bromine and iodine substituents hampering the attack of the cytochrome P450 iron-
oxo species on the adjacent carbon centres in the benzene derivative. This working 
hypothesis was further tested by investigating whether useful steric correction 
factors could be derived from the results obtained with the series C4-substituted 
fluorobenzenes. These correction factors should make it possible to correct calculated 
relative reactivities of carbon sites for steric hindrance by substituents positioned 
ortho with respect to the carbon to be hydroxylated. This will make it possible to 
better explain and predict the regioselectivities for other chlorine, bromine, iodine 
and cyano containing fluorobenzenes. The in vivo regioselectivity of aromatic ring 
hydroxylation of a series of five chlorine, bromine, iodine or cyano containing 
fluorobenzenes did not correlate with the non-corrected calculated reactivities 
(r=0.49). However, upon correction of the calculated reactivity values by using the 
steric correction factors, a correlation between the observed and calculated 
regioselectivity for the substrates of the present study was obtained (r=0.91). 
Together these results strongly indicate that for the fluorobenzenes studied main 
factors directing the regioselectivity of their aromatic hydroxylation are i) the 
nucleophilic chemical reactivity of the site to be hydroxylated and ii) steric influence 
of the substituent ortho with respect to the site of hydroxylation. This latter effect 
appears to be negligible for a fluorine, chlorine, and cyano substituent but significant 
for a bromine and iodine substituent. 
Introduction 
The regioselectivity and extent of the cytochrome P450-catalysed 
monooxygenation of benzene derivatives is an important factor influencing their 
conversion in either bioactivation or elimination pathways. The pathways leading to 
various ring hydroxylated metabolites of a single benzene derivative may differ in 
the type of toxic intermediates formed. For bromobenzene the pathway leading to 2-
bromophenol appeared to be not as toxic as the metabolic pathway leading to 
formation of 4-bromophenol [1,2]. In addition, the formation of the various aromatic 
ring hydroxylated products might be dependent on the cytochrome P450 enzyme 
48 
Chapter 2 
pattern present [3-6]. For example, upon treatment of rats with 3-
methylcholanthrene the biotransformation pattern of bromobenzene shifted in 
favour of the 2-bromophenol metabolic route [3,4]. 
In a previous study on the cytochrome P450-catalysed regioselectivity of 
aromatic ring hydroxylation of a series of (poly)fluorobenzenes the extent of 
aromatic ring hydroxylation on a non-substituted carbon centre correlated (r=0.96) 
with the calculated frontier orbital density on the respective carbon atom [7]. This 
observation is consistent with a reaction mechanism that proceeds by an initial 
electrophilic attack of the high-valent iron-oxo intermediate of cytochrome P450 on 
the reactive Jt-electrons of the aromatic ring. This means that formation of phenolic 
metabolites resulting from epoxide intermediates is not a main biotransformation 
route, as upon formation of epoxides the site of attack of the iron-oxo species does 
not need to be the site of hydroxylation [8-10]. Furthermore, for the tested series 
fluorobenzenes, containing the relatively small fluorine, it could be demonstrated 
that a change in the cytochrome P450 enzyme pattern did not significantly influence 
the regioselectivity of aromatic hydroxylation [7]. However, the cytochrome P450-
catalysed regioselectivity of aromatic hydroxylation of benzene derivatives with 
larger substituents than a hydrogen or fluorine, for example a chlorine, bromine or 
iodine, might be influenced by factors originating from steric hindrance. This could 
be either i) steric hindrance in the active sites of the cytochromes P450 imposing a 
specific orientation of the substrate with respect to the activated heme cofactor 
and/or ii) steric hindrance of the substituent hampering the attack of the cytochrome 
P450 iron-oxo species on the carbon centres ortho with respect to the substituted 
carbon atom. 
The aim of the present study was to investigate to what extent substituents, 
which are larger than a hydrogen or fluorine, influence possibilities for the 
cytochrome P450-catalysed aromatic hydroxylation of carbon atoms ortho with 
respect to the substituent. This was performed by studying the in vivo 
regioselectivity of aromatic hydroxylation of a series of fluorobenzenes, containing a 
chlorine, bromine, iodine or cyano substituent at the C4 position. Comparison of the 
observed regioselectivity of aromatic ring hydroxylation of the C4-substituted 
fluorobenzenes to the regioselectivity predicted on the basis of the frontier orbital 
calculations, will provide information on the actual influence of the various C4 
substituents on possibilities for hydroxylation at the ortho aromatic carbon centres. 
Furthermore, possible deviations between the predicted and observed 
regioselectivities can result in steric correction factors for the extent of hydroxylation 
at a carbon atom adjacent to a substituent in a benzene derivative. Experiments 
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described in the present paper indicate to what extent such steric correction factors 
may actually affect and improve predictions for the cytochrome P450-catalysed 
regioselectivity of aromatic hydroxylation of benzene derivatives. 
Materials and Methods 
Chemicals 
Fluorobenzene was purchased from Aldrich Chemie (Steinheim, Germany). 
4-Cyanofluorobenzene was obtained from Fluka (Buchs, Switzerland). 4-
Bromofluorobenzene, 4-chlorofluorobenzene, 2-bromo-4-fluorophenol, 2-bromo-5-
fluorophenol, 4-bromo-2-fluorophenol, 2-chloro-4-fluorophenol, 2-chloro-5-
fluorophenol, 4-chloro-2-fluorophenol, 4-chloro-l,2-difluorobenzene, 4-bromo-l,2-
difluorobenzene, 4-cyano-l,2-difluorobenzene, 4-iodo-l,2-difluorobenzene and 2-
chloro-5-bromofluorobenzene were all purchased from Fluorochem (Derbyshire, 
United Kingdom). 4-Iodofluorobenzene, 2-fluorophenol, 3-fluorophenol and 4-
fluorophenol were obtained from Acros Chimica (Beerse, Belgium). 
In vivo exposure of rats 
Male Wistar rats (± 350 g) either untreated or pretreated with cytochrome 
P450 inducers, were exposed to 500 umol/kg body weight of fluorobenzene, 4-
chlorofluorobenzene, 4-bromofluorobenzene, 4-iodofluorobenzene, 4-cyanofluoro-
benzene, 4-chloro-l,2-difluorobenzene, 4-bromo-l,2-difluorobenzene, 4-iodo-l,2-
difluorobenzene, 4-cyano-l,2-difluorobenzene or 2-chloro-5-bromo-fluorobenzene, 
administered in olive oil by oral injection. After dosing, 0-24 h urine samples were 
collected. 
Pretreatment of rats with different cytochrome P450 inducers was carried out 
essentially as described before [11]: acetone (Merck, Darmstadt, Germany) (1.5 ml, 
using a stock solution of 30% in H2O, p.o. 1 day), fi-naphtoflavone (Sigma, St. Louis, 
MO, USA) (30 mg/kg body weight, using a stock solution of 10 mg/ml in olive oil, 
i.p. daily for 3 days) or phenobarbital (Brocacef, Maarssen, The Netherlands) (0.1% in 
drinking water for 7 days). The benzene derivatives were administered 24 h after 
administration of the final inducer injection. 
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Preparation of microsomes 
Microsomes were prepared from the perfused livers of male Wistar rats (300-
400 g) as described before [12]. 
Cytochrome P450 content of the microsomes was measured as described by Omura 
and Sato [13]. 
Microsomal incubations 
Cytochrome P450 dependent conversion was studied in vitro in microsomal 
incubations containing (final concentrations) 0.1 M potassium phosphate pH 7.6, 2 
mM microsomal cytochrome P450,1 mM of the benzene added as 1% (v/v) of a 0.1 
M cold stock solution in acetone, 1 mM ascorbic acid to prevent autoxidation of the 
hydroxylated reaction products and 1.0 mM NADPH. The reaction was started by 
the addition of the benzene and NADPH. The total reaction volume was 20 ml and 
the reaction was carried out at 37 °C for 10 min in a closed reaction vessel to prevent 
evaporation of the substrate. The reaction was terminated by the addition of 1 ml 12 
N HC1 and 5 ml ethyl acetate. Upon mixing and centrifugation (10 min 3000 rpm) the 
ethyl acetate layer was collected and 1.6 ml of the ethyl acetate extract was analysed 
by 19p NMR as described hereafter. 
Analysis of urine samples 
Urine samples were diluted once in 0.2 M potassium phosphate buffer pH 
7.6 for analysis by ^ F NMR. Phenolic metabolites, excreted in the urine in a 
sulphated or glucuronidated form, were converted to their non-conjugated forms by 
treatment of the urine with arylsulphatase/p-glucuronidase (from Helix pomatia 
(Boehringer, Mannheim, Germany) carried out essentially as described before [11]. 
Purification and identification of aromatic ring hydroxylated metabolites 
The 0-24 h urine of rats exposed to 4-chloro-l,2-difluorobenzene, 4-bromo-
1,2-difluorobenzene, 4-iodo-l,2-difluorobenzene, 4-cyano-l,2-difluorobenzene and 2-
chloro-5-bromofluorobenzene was freeze-dried and resolved in 2 ml H2O. 1.5 Ml of 
this fraction was applied on a Bio-Gel P2 column (Bio-Rad, Richmond, USA) (V=150 
ml; d=1.5 cm) and eluted with 10 mM sodium acetate buffer pH 5.2 [14]. Fractions of 
1.5 ml were collected and pooled based on 19p NMR analysis. The pooled fractions 
were freeze-dried and resolved in 1 ml H2O. The presence of phenolic products in 
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these fractions was proved by arylsulphatase/p-glucuronidase treatment of the 
fractions as previously described [11] and on the basis of the observation of 
characteristic shifts in the 19p NMR ppm values of the phenolic metabolites 
compared to the 19p NMR chemical shifts of other fluorobenzene substrates 
[7,15,16]. Unequivocal characterisation of the various conjugated ring hydroxylated 
metabolites in the pooled fractions was performed by analysing the proton-coupled 
and proton-decoupled 19p NMR spectra of these samples (see Table 5 and results 
section for details). 
^F and ^HNMR measurements 
l^F NMR measurements of the urine samples were performed on a Bruker 
AMX 300 NMR spectrometer at 280 K. Spectra were recorded using 5 us pulses and 
proton-decoupling was achieved with the Waltz-16 pulse sequence at -20dB from 
50W. Samples contained 100 ul ^H20 for locking the magnetic field and 10 JJ.1 8.4 
mM 4-fluorobenzoic acid added as an internal standard. The total sample volume 
was 1.71 ml. Enzyme treated urine samples were made anaerobic by evacuating and 
filling with argon four times before analysis. This was done to prevent autoxidation 
of the phenolic metabolites. About 1500 scans were recorded. Chemical shifts are 
reported relative to CFCI3. Quantification of the different metabolites was achieved 
by comparison of the integral of the l^p NMR resonance of the added internal 
standard 4-fluorobenzoic acid to the integrals of the 19p NMR peaks of the 
metabolites. 
Proton-coupled 19p NMR measurements of the Bio-Gel P2 column fractions 
were performed on a Bruker AMX 500 NMR spectrometer at 303 K. Spectra were 
recorded using 3 (is pulses. Samples contained 50 ul ^H20 for locking the magnetic 
field. The total sample volume was 0.5 ml. About 3000 scans were recorded. 
l^F NMR HOMO-decoupling of these samples was performed on a Bruker 
DPX 400 NMR spectrometer at 303 K. Spectra were recorded using 5 us pulses. 
About 200 scans were recorded for each spectrum. 
Molecular orbital calculations 
Semi-empirical molecular orbital calculations were performed on a Silicon 
Graphics Iris 4D/85 computer with the AMI (Austin Method 1) Hamiltonian from 
the AMP AC program (Quantum Chemistry Program Exchange, program no. 506, 
Indiana University, Bloomington, IN, USA). The AMI Hamiltonian was used since it 
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was reported to provide improved results for molecules containing heteroatoms 
compared to the MINDO/3 and MNDO methods [17]. Calculations were carried out 
with PRECISE criteria and self-consistent field was achieved for all calculations. 
Geometries were optimised for all bond lengths, bond angles and torsion angles 
using the Fletcher-Powell criteria. 
Frontier electron densities for electrophilic attack on the 7t-electrons of the 
aromatic ring were calculated according to the equation of Fukui et al. [18]. In this 
equation the contribution of the HOMO (highest occupied molecular orbital) and the 
HOMO-1 (highest occupied molecular orbital below the HOMO) are both taken into 
account. The calculated electronic parameters are compared with the results from the 
in vivo biotransformation of the substrates upon their binding to the active sites of 
the cytochromes P450. Upon binding of the substrates to the active sites of the 
cytochromes P450, the intrinsic properties of the compounds might be changed due 
to solvation effects and a different dielectric constant. Because a series of closely 
related compounds is being compared and because the active sites of the 
mammalian cytochromes P450 are rather large aspecific hydrophobic pockets, it can 
be assumed that the relative differences calculated between the related compounds 
as well as between various sites in one molecule will not be influenced by binding of 
the substrates to the active sites of the cytochromes P450. 
From the calculated HOMO/HOMO-1 density distributions the predicted 
regioselectivity of aromatic ring hydroxylation of the benzene derivatives was 
calculated by summation of frontier orbital densities of non-substituted aromatic 
ring carbon atoms and normalization of the sum of the values to 1.0. The predicted 
percentage of hydroxylation of an aromatic centre was calculated as the fraction of 
this normalized total frontier orbital density present on the respective non-
substituted aromatic centre. 
Results 
In vivo regioselectivity of aromatic hydroxylation of the C4-substituted 
fluorobenzene derivatives 
Figure 1 presents the 19p NMR spectra of the arylsulphatase/|3-
glucuronidase treated 0-24 h urine samples of rats exposed to a series of C4-
substituted fluorobenzenes (C4=H, CI, Br, I and CN in Figures 1 a, b, c, d and e 
respectively). 1,4-Difluorobenzene was not included since the four non-substituted 
carbon positions in this substrate are identical. Metabolites were identified on the 
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Figure 1 ^ p NMR spectra of the arylsulphatase/P-glucuronidase treated 0-24 h urine 
samples of rats exposed to (a) fluorobenzene, (b) 4-chlorofluorobenzene, (c) 4-bromofluorobenzene, 
(d) 4 iodofluorobenzene and (e) 4-cyanofluorobenzene. The arrows indicate the resonance positions of 
NIH shifted phenolic metabolites. The resonance marked "IS" is from the internal standard 4-
fluorobenzoic acid. The resonances labelled with an asterisk in Figures b and c possibly belong to 
dihydroxylated products. 
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Table 1 Chemical shifts of 1 9 F NMR resonances of identified aromatic ring hydroxylated 
products of the tested C4-substituted fluorobenzene derivatives (measured in 0.1 M potassium 
phosphate pH 7.6). "F NMR resonances are presented relative to CFCI3. Predicted ppm values were 
calculated on the basis of the characteristic 
of a hydroxyl moiety ortho (-23.1 + 0.6 (n= 
ppm shifts observed in previous studies upon introduction 
=7)), meta (+1.8 + 1 
respect to a fluorine substituent (see text for further details). 
substrate 
metabolite 
fluorobenzene 
2-fluorophenol 
3-fluorophenol 
4-fluorophenol 
3-fluoro-2-hydroxyphenol 
4-fluoro-2-hydroxyphenol 
2-fluoro-4-hydroxyphenol 
4-chlorofluorobenzene 
2-chloro-5-fluorophenol 
5-chloro-2-fluorophenol 
4-chloro-2-fluorophenol 
2-chloro-4-fluorophenol 
6-chloro-3-fluoro-2-hydroxyphenol 
5-chloro-2-fluoro-4-hydroxyphenol 
4-bromofluorobenzene 
2-bromo-5-fluorophenol 
5-bromo-2-fluorophenol 
4-bromo-2-fluorophenol 
2-bromo-4-fluorophenol 
6-bromo-3-fluoro-2-hydroxyphenol 
5-bromo-2-fluoro-4-hydroxyphenol 
.2 (n=ll)) or para (-11.0 ± 1.7 (n=6)) with 
l^F NMR ppm value (in 0.1 M potassium phosphate) 
predicted 
-141.9 ± 0.6 
-116.5 ± 1.2 
-129.1 ±1.7 
-139.9 +1.2 
-127.4 + 1.7 
-139.9 ± 1.2 
-118.9+1.2 
-143.8 + 0.6 
-138.8 ±0.6 
-126.7 ±1.7 
-141.8 ±1.2 
-141.8 ± 1.2 
-118.4 ±1.2 
-143.3 ±0.6 
-138.5 ± 0.6 
-126.4 ±1.7 
-141.3 ±1.2 
-141.3 ± 1.2 
reference 
compound 
-141.9 
-116.5 
-129.1 
-140.4" 
-126.7" 
-138.7" 
-118.6 
-
-138.5 
-127.3 
-
-
-117.8 
-
-138.3 
-127.4 
-
-
metabolite 
peak 
observed in 
0-24 h urine 
-141.9 
-116.5 
-129.1 
-140.4 
-126.7 
no b 
-118.6 
-144.0 
no 6 
nofc 
-140.0C 
-140.0C 
-117.8 
-143.3 
no*> 
no b 
-139.1e 
-139.1c 
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Table 1 -continued-
substrate 
metabolite 
4-iodofluorobenzene 
2-iodo-5-fluorophenol 
5-iodo-2-fluorophenol 
4-iodo-2-fluorophenol 
2-iodo-4-fluorophenol 
6-iodo-3-fluoro-2-hydroxyphenol 
5-iodo-2-fluoro-4-hydroxyphenol 
4-cvanofluorobenzene 
2-cyano-5-fluorophenol 
5-cyano-2-fluorophenol 
4-cyano-2-fluorophenol 
2-cyano-4-fluorophenol 
6-cyano-3-fluoro-2-hydroxyphenol 
5-cyano-2-fluoro-4-hydroxyphenol 
a
 Taken from Rietjens et al. [7]. 
" Not observed. 
c
 One of the two dihydroxylated products is 
19F NMR ppm value (in 0.1 M 
predicted 
-117.5 ± 1.2 
-142.4 + 0.6 
-138.6 ±0.6 
-126.5 + 1.7 
-140.6 ±1.2 
-140.6 +1.2 
-105.2 + 1.2 
-130.1 ±0.6 
-138.2 ±0.6 
-126.1 +1.7 
-130.5 ± 1.2 
-130.5 ± 1.2 
> possibly observed. 
reference 
compound 
-
-
-
-
-
-
-
-
-
-
-
potassium phosphate) 
metabolite 
peak 
observed in 
0-24 h urine 
-117.4 
-142.6 
no6 
nob 
no6 
no6 
-108.1 
-131.7 
no6 
nob 
no6 
no6 
basis of added reference compounds, and/or on the basis of the consideration that 
the incorporation of a hydroxyl moiety in the benzene derivative results in a 
characteristic change in the 19p NMR chemical shift of the fluorine at CI. Based on 
previous results with fluorinated anilines and benzenes converted to their phenolic 
metabolites [7,15,16] it can be calculated that the chemical shift of an aromatic 
fluorine substituent changes upon incorporation of a hydroxyl group at a position 
ortho, meta or para with respect to the fluorine by a value of -23.1 ± 0.6 (n=7), + 1.8 ± 
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1.2 (n=ll) and -11.0 ± 1.7 ppm (n=6) respectively. On the basis of these results the 
l^F NMR chemical shift values of the various phenolic metabolites could be 
predicted (Table 1). Table 1 also shows the values actually observed for phenolic 
derivatives that were commercially available. Comparison of the observed and 
predicted values indicates that the approach provides reliable results. 
The arrows in Figure 1 indicate the resonance position of phenolic 
metabolites that would have resulted from hydroxylation accompanied by an NIH 
shift of either the fluorine or the C4 substituent [8,9]. Clearly, phenolic metabolites 
resulting from such an NIH shift were not observed. The unidentified peaks in 
Figure 1 do not belong to phenolic metabolites but might be ascribed to mercapturic 
acid metabolites or other sulphur containing metabolites because i) their resonance 
positions did not change upon enzyme treatment of the urine samples and ii) these 
type of metabolites were also observed for the in vivo metabolism of other 
halogenated benzenes [2,19-21]. Because the aim of the present study was the 
investigation of the influence of various substituents on the regioselectivity of 
aromatic ring hydroxylation at non-substituted positions, the resonances of non-
phenolic metabolites were not identified at this stage. Since such mercapturic acid 
metabolites might arise from glutathione conjugation of epoxide intermediates their 
identification as such might even be an argument in favour of performing the 
predictive regioselectivity experiments in vivo and not in in vitro cytochrome P450 
systems. This because in vitro, perhaps, phenolic metabolic profiles might to some 
extent become influenced by (partial) involvement of epoxide intermediate 
pathways. The latter would result in the situation where the site of the high-valent 
iron-oxo attack on the aromatic ring would be no longer necessarily the site of 
hydroxylation, eliminating possibilities for correlations between calculated reactivity 
parameters of the aromatic substrate and the regioselectivity of aromatic 
hydroxylation. 
Based on the 19p NMR results presented in Figure 1 the ratio of C2/6 : C3/5 : 
C4 or C2/6 : C3/5 hydroxylation of the C4-substituted fluorobenzenes could be 
calculated. The results (Table 2) show that the regioselectivity of aromatic ring 
hydroxylation varies with the type of the C4 substituent. One could argue that the 
observed urinary phenolic metabolic profiles might not reflect the actual outcome of 
the cytochrome P450-catalysed enzymatic conversion in the liver due to additional 
metabolic reactions of the phenols formed and/or their excretion through bile 
instead of urine. However, the urinary metabolic patterns of rats orally exposed to 
various substituted fluorophenols show that the fluorophenols were always 
efficiently excreted in the urine as their glucuronidated or sulphated conjugates at a 
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0-24 h recovery of nearly 100% [7,22]. Furthermore, results from in vivo experiments 
in part published in Rietjens et al. [16] with the cytochrome P450 inducer isosafrole 
showed that this compound effectively inhibits cytochrome P450-dependent 
metabolism, but that isosafrole is not able to inhibit other enzymes like the Phase II 
ones. When halogenated benzenes were orally dosed to rats pretreated with 
isosafrole, no urinary phenolic metabolites could be detected, showing that, indeed, 
cytochrome P450 Phase I catalysis is necessary for excretion of the halogenated 
benzenes. Clearly, this excludes biliary excretion and alternative biotransformation 
pathways of phenol derivatives formed. Further support for the assumption that the 
in vivo aromatic hydroxylation profile of the benzene derivatives is a proper 
reflection of the cytochrome P450-catalysed dependent formation of these 
metabolites comes from comparison between in vitro and in vivo regioselectivities 
which have been demonstrated to be similar for many benzene derivatives in 
previous studies reported in the literature [7,15,23]. In addition, this was 
experimentally checked and confirmed for two of the model benzenes of the present 
study. The C2/6 : C3/5 regioselectivity of aromatic hydroxylation of 4-chloro- and 4-
bromofluorobenzene in incubations with microsomes from control rat livers 
amounted to 52 : 48 and 64 : 36 respectively which resembles the values observed in 
vivo with the generally observed margin of 10% [7,15,23]. 
From the l^F NMR spectra presented in Figure 1 and the volumes of the 
respective 0-24 h urine samples the recovery of the various model C4-substituted 
fluorobenzenes was determined (Table 2). Table 2 also presents the percentage of the 
urine metabolites that could be ascribed to mono-phenolic metabolites. These results 
show that the total 0-24 h recovery is about 45-83% and that aromatic ring 
hydroxylation is a main pathway for urine excretion since 61-77% of the total 
amount of excreted metabolites are phenolic products. 
Influence of the cytochrome P450 enzyme pattern on the regioselectivity of aromatic 
hydroxylation of the C4-substituted fluorobenzenes 
Rats pretreated with specific cytochrome P450 enzyme inducers were also 
dosed with the C4-substituted fluorobenzenes. This was done to investigate the 
extent to which a variation in the cytochrome P450 enzyme pattern would influence 
the regioselectivity of aromatic hydroxylation of the various C4-substituted 
fluorobenzenes. The observation that ethoxyresorufin O-dealkylating, 
pentoxyresorufin O-dealkylating and aniline para-hydroxylation activity were 
increased 30, 60 [7], and 2 fold in the liver microsomes from rats receiving 
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pretreatments with P-naphtoflavone, phenobarbital and acetone respectively (data 
not shown) confirms a proper cytochrome P450 induction in the animals used. The 
regioselectivity of aromatic hydroxylation was determined from the 19p NMR 
spectra of the arylsulphatase ^ -glucuronidase treated urine samples. The results 
obtained are presented in Table 3 and clearly demonstrate that a variation in the 
cytochrome P450 enzyme pattern hardly influences the regioselectivity of the 
aromatic hydroxylation. The observed regioselectivities for a specific C4-substituted 
benzene, dosed to differently pretreated rats, vary by at most a few percent. 
Table 2 
metabolic pattern 
The 0-24 h urine recovery, the percentage phenolic metabolites in the urinary 
and the regioselectivity of the in vivo aromatic ring hydroxylation of a series C4-
substituted fluorobenzene derivatives. Ratios were calculated from the enzyme 
samples of exposed rats (n 
benzene 
fluorobenzene 
4-chlorofluoro-
4-bromofluoro-
4-iodofluoro-
4-cyanofluoro-
=2). The fluorine atom is positioned 
0-24 h 
recovery 
(% of doses) 
83 
65 
67 
64 
45 
phenolic 
metabolites 
(% of total 
metabolites) 
61 
77 
75 
75 
69 
at carbon atom CI. 
ring carbon 
atom 
C2/6:C3/5:C4 
C 2 / 6 : C3/5 
C 2 / 6 : C3/5 
C 2 / 6 : C3/5 
C 2 / 6 : C3/5 
treated 0-24 h urine 
regioselectivity 
of aromatic ring 
hydroxylation 
33 : 20 :47 
46:54 
74:26 
96 :4 
64:36 
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Table 3 The regioselectivity of th« 
substituted fluorobenzene derivatives in rats 
calculated from the enzyme treated 0-24 h 
positioned at carbon atom CI. 
benzene 
fluorobenzene 
4-chlorofluoro-
4-bromofluoro-
4-iodofluoro-
4-cyanofluoro-
inducer 
none 
p-naphtoflavone 
phenobarbital 
acetone 
none 
P-naphtoflavone 
phenobarbital 
acetone 
none 
p-naphtoflavone 
phenobarbital 
acetone 
none 
P-naphtoflavone 
phenobarbital 
acetone 
none 
P-naphtoflavone 
phenobarbital 
acetone 
> in vivo aromatic ring hydroxylation of a series C4-
pretreated with cytochrome P450 inducers. Ratios were 
urine samples of exposed rats. 
ring carbon atom 
C2/6 : C3/5 : C4 
C 2 / 6 : C3/5 
C 2 / 6 : C3/5 
C 2 / 6 : C3/5 
C 2 / 6 : C3/5 
The fluorine atom is 
regioselectivity 
of aromatic ring 
hydroxylation 
3 3 : 20 :47 
34 :15 : 51 
3 4 : 1 9 : 47 
32: 21 :47 
46:54 
47 :53 
47 :53 
49 :51 
74:26 
73:27 
74:26 
76:24 
9 6 : 4 
88:12 
9 5 : 5 
9 7 : 3 
64:36 
60:40 
59:41 
61:39 
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Calculated reactivity of the carbon centres of the C4-substituted fluorobenzenes for 
an electrophilic attack by the cytochrome P450 iron-oxo species 
In a previous study it was demonstrated that the cytochrome P450-catalysed 
regioselectivity of aromatic hydroxylation of a series of (poly)fluorobenzenes 
correlated (r=0.96) with the calculated reactivity of the various non-substituted 
carbon centres in the aromatic ring for an electrophilic attack by the cytochrome 
P450 high-valent iron-oxo intermediate [7]. 
This reactivity can be calculated on the basis of the frontier electron density 
distribution, which is the distribution of the reactive 7t-electrons in the aromatic ring. 
Table 4 presents the regioselectivity of aromatic hydroxylation for the C4-substituted 
fluorobenzenes expected on the basis of the calculated reactivity of the aromatic 
centres. Comparison of the calculated regioselectivities to the regioselectivities 
observed demonstrates that for the fluorobenzenes with a chlorine or cyano C4 
substituent, the expected values match the values actually observed within a few 
percent (Tables 2 and 4). However, for 4-bromofluorobenzene hydroxylation at the 
positions ortho to the bromine is only 40% of the calculated intrinsic reactivity of the 
sites for an electrophilic attack. For 4-iodofluorobenzene hydroxylation at C3/5 
amounts to an even lower percentage (6%) of what would be expected on the basis of 
the calculated chemical reactivity (Tables 2 and 4). From these results steric 
correction factors of 1.0,1.0,0.4,0.06 and 1.0 for hydroxylation at positions ortho with 
respect to a fluorine, chlorine, bromine, iodine and cyano respectively were derived. 
The in vivo regioselectivity of aromatic hydroxylation of other substituted 
fluorobenzene derivatives 
Additional experiments were performed in order to investigate whether the 
steric correction factors thus obtained would also improve the prediction of the 
regioselectivity of the aromatic hydroxylation of other substituted fluorobenzenes. 
Figure 2 presents the 19p NMR spectra of the arylsulphatase/p-glucuronidase 
treated 0-24 h urine samples of five substituted fluorobenzenes. The 19p NMR ppm 
values of the various aromatic ring hydroxylated products resulting from 
hydroxylation of non-substituted carbon centres were identified on the basis of the 
consideration that the incorporation of the hydroxyl moiety results in a characteristic 
change in the chemical shift of the fluorines [7,15,16] and on the proton-coupled and 
proton-decoupled l^F NMR spectra of the pooled Bio-Gel P2 column fractions of the 
0-24 h urine (Table 5). Phenolic metabolites resulting from hydroxylation 
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accompanied by an NIH shift were again not observed. The unidentified peaks in 
Figure 2 might be ascribed to mercapturic acid metabolites or other sulphur 
containing metabolites as outlined above for the C4-substituted fluorobenzenes. 
From the 19p NMR spectra of the arylsulphatase/p-glucuronidase treated urine 
samples in Figure 2 the regioselectivity of aromatic ring hydroxylation could be 
calculated and the results are presented in Table 6. From the 19p NMR spectra in 
Figure 2 and the volumes of the 0-24 h urine samples the recovery of the tested 
substituted fluorobenzenes and the percentage of mono-phenolic metabolites was 
calculated. About 63-72% of the benzene derivative is excreted in the urine within 24 
h after dosage, except for 4-cyano-l,2-difluorobenzene and 2-chloro-5-
bromofluorobenzene for which only 21% and 28% was excreted respectively. 
Aromatic ring hydroxylation was a main biotransformation route as 46-78% of the 
total amount of excreted metabolites were phenolic products. 
Table 4 
fluorobenzenes. 
The calculated HOMO/HOMO-1 density 
From the HOMO/HOMO-1 density 
centres the calculated regioselectivity of aromatic ring 
is positioned at carbon atom CI. 
benzene 
fluorobenzene 
4-chlorofluoro-
4-bromofluoro-
4-iodofluoro-
4-cyanofluoro-
HOMO/HOMO-1 density 
CI 
0.45 
0.43 
0.39 
0.37 
0.42 
C2 
0.27 
0.18 
0.18 
0.19 
0.23 
C3 
0.19 
0.17 
0.17 
0.15 
0.16 
distribution in 
distribution at hydrogen 
the C4-substituted 
substituted carbon 
hydroxylation was derived. The fluorine atom 
on carbon atom 
C4 
0.48 
0.47 
0.47 
0.44 
0.50 
C5 
0.19 
0.17 
0.17 
0.15 
0.16 
C6 
0.27 
0.18 
0.18 
0.19 
0.23 
calculated 
regioselectivity 
C2/6:C3/5:C4 or 
C2/6:C3/5 
39 : 27: 34 
51:49 
53 :47 
56:44 
59:41 
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Figure 2 *^p NMR spectra of the arylsulphatase/fJ-glucuronidase treated 0-24 h urine 
samples of rats exposed to (a) 4-chloro-l,2-difluorobenzene, (b) 4-bromo-l,2-difluorobenzene, (c) 4-
iodo-l,2-difluorobenzene, (d) 4-cyano-l/2-difluorobenzene and (e) 2-chloro-5-bromofluorobenzene. 
The resonance marked "IS" is from the internal standard 4-fluorobenzoic acid. 
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Table 5 *9 F NMR resonances and J F F and J H F coupling constants of identified aromatic 
ring hydroxylated products of five substituted fluorobenzene derivatives (measured in 0.1 M 
potassium phosphate pH 7.6). "F 
substrate 
metabolite 
4-chloro-l .2-difluorobenzene 
6-chloro-2,3-difluorophenol 
6-chloro-3,4-difluorophenol 
5-chloro-2,3-difluorophenol 
4-bromo-l .2-difluorobenzene 
6-bromo-2,3-difluorophenol 
6-bromo-3,4-difluorophenol 
5-bromo-2,3-difluorophenol 
4-iodo-l .2-difluorobenzene 
6-iodo-2,3-difluorophenol 
6-iodo-3,4-difluorophenol 
5-iodo-2/3-difluorophenol 
4-cvano-l .2-difluorobenzene 
6-cyano-2/3-difluorophenol 
6-cyano-3/4-difluorophenol 
5-cyano-2,3-difluorophenol 
2-chloro-5-bromofluorobenzene 
2-bromo-5-chloro-6-fluorophenol 
2-bromo-4-fluoro-5-chlorophenol 
2-chloro-3-fluoro-5-bromophenol 
MMR resonances are presented relative to CFCI3. 
1 9 F N M R p p m 
-164.1 (F2) 
-144.9 (F3) 
-142.4 (F3) 
-153.7 (F4) 
-169.3 (F2) 
-142.1 (F3) 
-163.5 (F2) 
-144.4 (F3) 
-141.6 (F3) 
-153.9 (F4) 
-168.9 (F2) 
-142.1 (F3) 
no" 
-140.7 (F3) 
-154.2 (F4) 
-168.2 (F2) 
-142.4 (F3) 
-166.8 (F2) 
-135.6 (F3) 
-131.5 (F3) 
-158.3 (F4) 
-158.8 (F2) 
-141.5 (F3) 
-139.7 (F6) 
-132.1 (F4) 
-118.2 (F3) 
value (J values) 
[Hz] 
(3jFF= 20.4,4jHF= 7.5) 
(3JFF= 20.4,3jHF= 9.5,4JHF= 5.0) 
(3jFF= 21.7,3jHF= 11.3,4JHF= 8.0) 
(3jFF= 21.7,3jHF= 10.4,4JH F= 7.6) 
(3jFF= 20.6,4jHF= 6.2,4JHF= 6.2) 
(3jFF= 20.6,3jH F= 10.7) 
(3jFF= 20.0,4JHF= 5.9) 
( 3 j F F = 20.0, 3 J H F = 9.4, 4 J H F = 4.7) 
(3jFF= 21.6,3jH F= 11.0,4jH F= 8.3) 
(3jFF= 21.6,3jHF= 9.8,4 j Hp= 7.4) 
(3jFF= 20.0,4JHF= 5.9,4JHF= 5.9) 
( 3 J F F = 20.0,3jHF= 9.4) 
(3jFF= 21.1,3jH F= 11.2, 4 J H F = 8.9) 
(3JFF= 21.1,3jH F= 9.7,4JH F= 7.3) 
(3JFF= 19.6,4JHF= 6.5) 
(3jFF= 19.6,3jHF= 8.7) 
(3jFF= 21.0,4JHF= 7.2) 
(3jFF= 21.0,3jH F= 9.6,4JHF= 5.0) 
(3jFF= 21.8,3jH F= 10.7,4JHF= 8.3) 
(3jFF= 21.8,3jH F= 9.6,4JH F= 6.9) 
(3jFF= 20.7,4JHF= 6.5) 
(3JFF= 20.7,3jH F= 9.8) 
(4JHF= 7.0) 
( 3 J H F = 8 . 6 , 4 J H F = 7 . 0 ) 
(3jH F=8.6) 
a
 Not observed. 
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The calculated reactivity for aromatic ring hydroxylation of five substituted 
fluorobenzenes 
Like for the C4-substituted fluorobenzenes, the HOMO/HOMO-1 density on 
the non-substituted aromatic ring carbon atoms of the five fluorobenzenes was 
calculated and from these results the expected regioselectivity of aromatic ring 
hydroxylation was derived. This calculated regioselectivity was further adjusted by 
taking into account the steric correction factors derived from the experiments with 
the C4-substituted fluorobenzenes. Thus, the expected extent of hydroxylation of 
carbon atoms ortho with respect to a hydrogen, fluorine, chlorine or cyano were not 
corrected (correction factor=1.0), whereas expected values obtained for carbon 
centres ortho with respect to a bromine or iodine were multiplied by a factor of 0.4 
and 0.06 respectively, followed by normalization of the values then obtained. Thus 
for non-corrected positions the calculated relative reactivity increases due to their 
normalization. The corrected values for the regioselectivity of aromatic ring 
hydroxylation are also presented in Table 6. 
Comparison of the non-corrected calculated frontier orbital density 
distribution with the observed regioselectivity of aromatic ring hydroxylation of the 
five substituted fluorobenzenes shows no correlation (r=0.49) (Figure 3A). However, 
Table 6 Calculated and observed regioselectivity of in vivo aromatic hydroxylation of five 
substituted fluorobenzenes. The corrected values for the regioselectivity of aromatic hydroxylation 
were calculated using the steric correction factors derived from the results obtained with the C4-
substituted fluorobenzenes (see Results section). 
benzene regioselectivity of aromatic ring hydroxylation 
at carbon calculated corrected 
centres from 
HOMO/HOMO-1 
density 
observed 
in vivo 
4-chloro-l,2-difluoro-
4-bromo-l,2-diftuoro-
4-iodo-l,2-difluoro-
4-cyano-l,2-difluoro-
2-chloro-5-bromofluoro-
C3 
C3 
C3 
C3 
C3 
C5 
C5 
C5 
C5 
C4 
C6 
C6 
C6 
C6 
C6 
20 
21 
22 
21 
20 
60 
58 
57 
57 
55 
20 
21 
21 
22 
25 
20 : 60 : 20 
16 : 44 : 40 
5 : 13 : 82 
21 : 57: 22 
39 : 42 : 19 
12 : 71 :17 
4 : 6 3 : 33 
0 : 24 : 76 
18 : 50 : 32 
53 :42 :5 
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Figure 3 Plots of regioselectivity for aromatic hydroxylation observed in in vivo experiments 
and (A) predicted for the substituted fluorobenzenes of the present study without further correction 
(B) predicted for the substituted fluorobenzenes of the present study taking into account the steric 
correction factors of the present study and (C) predicted for all fluorobenzenes tested in this study 
and in a previous study [7] taking into account the steric correction factors of the present study. The 
correlation coefficients are A) 0.49, B) 0.91 and C) 0.95 respectively. In Figures 3A and B: O 4-chloro-
1,2-difluorobenzene; A 4-bromo-l,2-difluorobenzene; • 4-iodo-l/2-difluorobenzene; x 4-cyano-l,2-
difluorobenzene; 0 2-chloro-5-bromofluorobenzene. 
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taking into account the steric correction factors, the expected and observed 
regioselectivity of aromatic hydroxylation correlate well (r=0.91) (Figure 3B). 
Further, without taking into account the steric correction factors for prediction of the 
regioselectivity of aromatic ring hydroxylation of the bromine and iodine substituted 
fluorobenzenes, the absolute mean deviation between the predicted and observed 
regioselectivity of the five substituted fluorobenzenes was 16.8 ± 14.2%. However, 
upon correction of the predicted values for the regioselectivity of aromatic ring 
hydroxylation, the absolute mean deviation decreased to 8.7 ± 5.0%. 
Discussion 
In the present study the in vivo cytochrome P450-catalysed regioselectivity of 
aromatic ring hydroxylation of a series substituted fluorobenzenes with other than 
only fluorine substituents (i.e. CI, Br, I and CN) was investigated. Special attention 
was focused on the possible steric hindrance of substituents on the possibilities for 
aromatic ring hydroxylation of the adjacent aromatic carbon atoms. First, the in vivo 
regioselectivity of aromatic ring hydroxylation of a series C4-substituted 
fluorobenzenes was investigated and compared with the predicted regioselectivity 
based on the frontier orbital density distribution. For the fluorobenzene derivatives 
substituted with a chlorine or cyano moiety, the observed in vivo regioselectivity of 
aromatic ring hydroxylation correlated well with the calculated reactivity of the 
carbon sites. However, for the bromine and iodine substituted fluorobenzenes the 
expected and observed regioselectivity of aromatic ring hydroxylation deviated 
significantly. For 4-bromofluorobenzene hydroxylation at C3/5 was 40% of the value 
expected on the basis of the calculated reactivity while for 4-iodofluorobenzene this 
was only 6%. These results suggest that bromine and iodine substituents hamper the 
attack of the iron-oxo species on the adjacent carbon atoms due to factors originating 
from steric hindrance. This could be either i) steric hindrance in the active sites of 
cytochromes P450 imposing a stereoselective orientation of the substrate with 
respect to the activated heme cofactor and/or ii) steric hindrance of the substituent 
hampering the attack of the iron-oxo species on the adjacent ring carbon atoms. 
Results of the in vivo regioselectivity of aromatic ring hydroxylation of the tested 
substrates in rats pretreated with different cytochrome P450 inducers showed that 
the regioselectivity of aromatic ring hydroxylation was not significantly influenced 
by the cytochrome P450 inducers. Altogether, the data of the present study indicate 
that the observed deviations between the predicted and observed 
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regioselectivity for 4-bromo- and 4-iodofluorobenzene should not be ascribed to a 
stereoselective positioning of the substrate in the cytochrome P450 active site, but 
might rather be ascribed to steric hindrance by the substituents hampering the attack 
of the cytochrome P450 iron-oxo species on the adjacent carbon atoms. The larger 
deviation between the predicted and observed regioselectivity of aromatic 
hydroxylation for the iodine than the bromine substituted fluorobenzene is in 
accordance with the fact that the Van der Waals radius of a iodine (2.15 A) is larger 
than a bromine (1.95 A), and thus a iodine substituent might be expected to cause 
greater steric hindrance than a bromine for attack of the cytochrome P450 iron-oxo 
species on the adjacent aromatic carbon atoms. The results obtained for 4-
chlorofluorobenzene show that a chlorine, which is smaller (Van der Waals radius is 
1.8 A) than a bromine and iodine substituent, did not cause steric hindrance for 
attack of the iron-oxo species on the adjacent ring carbon atoms. The results obtained 
for 4-cyanofluorobenzene are interesting because the cyano group, consisting of a 
carbon and nitrogen atom with a Van der Waals radius of 1.85 and 1.5 A 
respectively, might overall be larger than a bromine atom. However, in contrast to 
the observed significant steric hindrance by the bromine atom for aromatic ring 
hydroxylation of the adjacent carbon atoms, this was not observed for the cyano 
group. A possible explanation for these results is that the shape of the cyano group is 
such that only the steric hindrance by the carbon atom has to be taken into account. 
As the Van der Waals radius of a carbon atom is similar to that of a chlorine and 
smaller than a bromine and iodine, significant steric hindrance by the carbon 
substituent for attack of the cytochrome P450 iron-oxo species on the adjacent 
aromatic ring carbon atoms is not expected. 
Altogether, comparison between the in vivo regioselectivity of aromatic 
hydroxylation of a series C4-substituted fluorobenzenes and their calculated 
reactivity for aromatic hydroxylation resulted in the hypothesis that a bromine or 
iodine, but not a fluorine, chlorine or cyano, cause steric hindrance for attack of the 
cytochrome P450 iron-oxo species on the adjacent aromatic carbon atom. Based on 
these results steric correction factors can be derived for prediction of the extent of 
aromatic carbon hydroxylation adjacent to a substituent, i.e. 1.0 for a fluorine, 
chlorine and cyano and 0.4 and 0.06 for a bromine and iodine substituent 
respectively. These results were further checked by investigating if and to what 
extent application of the steric correction factors would improve the prediction of the 
regioselectivity of aromatic ring hydroxylation of five other substituted 
fluorobenzenes. The observed regioselectivity of aromatic ring hydroxylation for 
these five substituted fluorobenzenes did not correlate with the calculated reactivity 
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(r=0.49). However, taking into account the correction factors as obtained for the C4-
substituted fluorobenzenes, a correlation between the observed and predicted 
regioselectivity of aromatic hydroxylation (r=0.91) was observed. It is of importance 
to stress that the approach of the present study excludes epoxides as obligatory 
intermediates in the formation of phenolic metabolites. To do so is supported by the 
correlations obtained demonstrating that the site of attack is the site of hydroxylation 
which would not be the case when epoxide intermediates are involved. Furthermore 
other literature data support this view. First, Korzekwa et al. [24] also concluded, 
based on the results obtained from a study on the hydroxylation of deuterated 
chlorobenzenes, that the epoxide mechanism for hydroxylation of the chorobenzenes 
to phenols might be untenable. Second, in a study from Rizk and Hanzlik [25] the 
absence of any deuterium loss upon conversion of deuterated [3,5-^H2]-4-
iodoanisole to 2-methoxy-5-iodophenol also suggested that this aromatic 
hydroxylation must occur almost entirely by direct aromatic hydroxylation instead 
of proceeding by an epoxide mechanism. Furthermore, it is known that NIH shifted 
phenolic metabolites can be formed from epoxide metabolites [8,9]. However, upon 
the in vivo aromatic hydroxylation of the substituted fluorobenzenes of the previous 
[7] and the present study, NIH shifted phenolic metabolites were not observed. 
Figure 3C presents the correlation between the predicted and observed 
regioselectivity of aromatic ring hydroxylation of all the fluorobenzene derivatives 
now studied in the present and a previous study [7] taking into account the steric 
correction factors of the present study. The results in Figure 3C show that a good 
correlation (r=0.95) was obtained between the predicted and observed 
regioselectivity. These results show that for the tested fluorobenzenes (Figure 3C) the 
main factors directing the regioselectivity of their aromatic hydroxylation must be i) 
nucleophilic chemical reactivity of the site to be hydroxylated and ii) steric influence 
of the substituent ortho with respect to the site of hydroxylation. The latter was 
observed for a bromine and iodine substituent but not for a fluorine, chlorine or 
cyano substituent. The small deviations between the predicted and observed 
regioselectivities may be systematic and due to an interaction between the substrate 
and the cytochrome P450(FeO)3+ species resulting in a stereoselective orientation of 
the substrate before the attack of the high-valent iron-oxo species [23,26] and/or to 
small contributions of epoxide intermediates. 
Finally, one might address the toxicological significance of the predictions of 
regioselectivity of aromatic hydroxylation reported in the present study for the 
various congeners. This requires the identification of the ultimate reactive metabolite 
inducing the toxic effect. For halobenzenes the reactive metabolites involved could 
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be either epoxide intermediates or benzoquinone-type reactive metabolites formed 
upon oxidation of secondary diol metabolites [27,28]. Epoxide intermediates, as well 
as benzoquinone derivatives are known to be reactive and to bind to protein and 
DNA thereby possibly resulting in toxicologic and ultimately mutagenic/ 
carcinogenic responses [1,2]. Since the present study only relates to the primary 
phenolic metabolite profiles, the possible toxicological significance of the present 
results to the formation of benzoquinone-type reactive metabolites, has to await 
studies on prediction of regioselectivity of phenol hydroxylation, i.e. the secondary 
cytochrome P450-catalysed conversion of the benzenes. Furthermore, since the 
results of the present study argue against an important role for epoxide 
intermediates in the route leading to phenolic metabolites, the predictions presented 
can neither predict the type of reactive epoxide intermediates to be expected. 
Clearly, this absence for an intermediate role of toxic epoxide intermediates in the 
route leading to phenolic metabolites is to some extent opposite to what has been 
widely assumed. However, previous studies already reported additional evidence 
against an obligatory role for epoxides in aromatic hydroxylation. Based on studies 
of the hydroxylation of deuterated bromobenzenes [29], deuterated chlorobenzenes 
[24] and fluorobenzenes [7] it was also concluded that epoxides were not obligatory 
intermediates in the route leading to phenolic metabolites. This latter aspect seems to 
be a matter not yet well appreciated in biochemical toxicological studies on aromatic 
hydroxylation pathways. 
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Interaction between the substrate and the high-valent iron-oxo 
porphyrin cofactor as a possible factor influencing the regioselectivity 
of cytochrome P450-catalysed aromatic ring hydroxylation of 3-
fluoro(methyl)anilines 
J. Koerts, S. Boeren, J. Vervoort, R. Weiss, C. Veeger and I.M.C.M. Rietjens 
Chemico-Biological Interactions 99,1996,129-146. 
Abstract 
In the present study the in vitro and in vivo aromatic ring hydroxylation of a 
series of amino and/or methyl containing fluorobenzenes, i.e. 3-fluoro(methyl)-
anilines, was investigated and compared to the calculated density distribution of the 
reactive frontier Jt-electrons of the aromatic substrate. This was done i) to study to 
what extent the regioselectivity of the aromatic ring hydroxylation of the 3-
fluoro(methyl)anilines could be predicted on the basis of the calculated chemical 
reactivity, as was previously observed for a series of fluorinated benzenes and 
monofluoroanilines, and ii) to investigate which factors contribute to possible 
deviations from the predictions on the basis of the calculated chemical reactivity. 
Results obtained show that the in vitro and in vivo aromatic ring hydroxylation of the 
series 3-fluoro(methyl)anilines correlate qualitatively with the calculated frontier 
orbital density distribution for electrophilic attack by the cytochrome P450(FeO)3+ 
species. These results indicate that the HOMO/HOMO-1 frontier orbital densities, 
i.e. the chemical reactivity of the carbon centres for an electrophilic attack, predict 
the preferential as well as the non-reactive sites for cytochrome P450-catalysed 
aromatic ring hydroxylation of the tested model compounds. The absolute values, 
however, deviated in a systematic way; C4 para hydroxylation being observed to a 
higher extent than expected on the basis of chemical reactivity and C2/C6 ortho 
hydroxylation being observed to a lower extent than expected. Additional 
experiments were performed using different microsomal preparations and 
microperoxidase-8. The latter is a mini heme protein of eight amino 
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acids without a substrate binding site. In incubations of the model compounds with 
different types of microsomal preparations, as well as with MP-8 and purified 
reconstituted cytochrome P450 2B1, similar systematic deviations between the 
predicted and observed regioselectivity of aromatic hydroxylation were observed. 
These results show that the regioselectivity of aromatic ring hydroxylation of the 3-
fluoro(methyl)anilines cannot be predominantly ascribed to an interaction between 
the substrate and the substrate binding site of the cytochromes P450 dictating a 
specific stereoselective positioning of the substrate in the active site. More likely, the 
systematic deviations between the observed and predicted regioselectivity of 
hydroxylation of the tested model substrates should be ascribed to an (orienting) 
interaction between the substrate and the activated cytochrome P450(FeO)3+ 
cofactor. 
Introduction 
In previous studies on the regioselectivity of the cytochrome P450-catalysed 
hydroxylation of monofluoroanilines [1] and a series of fluorinated benzenes [2] a 
qualitative and even a quantitative correlation was observed between the 
regioselectivity of the aromatic ring hydroxylation and the calculated density 
distribution of the reactive frontier 7C-electrons of the aromatic substrate. These 
results support a mechanism of hydroxylation of fluorinated benzene derivatives 
that proceeds through an initial electrophilic attack of the cytochrome P450(FeO)3+ 
intermediate on the frontier Jt-electrons of the benzene derivative without an 
important role for epoxide intermediates [2]. The objective of the present study was 
to investigate to what extent this MO-QSAR (molecular orbital based quantitative 
structure activity relationship) would be applicable to fluorinated benzene 
derivatives containing additional methyl and /or amino substituents. Thus, 
fluorinated (methyl)anilines were used as model substrates. Insight into factors 
which determine the bioconversion of (methyl)aniline derivatives is of importance, 
because they are frequently used in the manufacture of agrochemicals, chemical dyes 
and drugs. In spite of the well-recognized implications of metabolic profiles of the 
methylanilines for their ultimate possibilities for excretion or bioactivation [3-14], 
only a limited number of studies are available on the metabolic pattern of these 
compounds [15-20]. 
In the present paper the biotransformation characteristics of 3-
fluoromethylanilines were determined in vitro in incubations with microsomal 
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cytochromes P450 and in vivo on the basis of analysis of urine samples from exposed 
rats by l^F NMR. A main objective of the present study was to investigate the 
influence of the cytochrome P450 substrate binding site, of activated cofactor-
substrate interaction and of the chemical substrate reactivity on the regioselectivity 
of the aromatic ring hydroxylation. Thus, the outcomes of the biotransformation 
studies were compared to the calculated chemical reactivity parameters and 
additional studies were performed in which the conversion of the model compounds 
was studied in incubations with microperoxidase-8 (MP-8). MP-8 is a water soluble 
heme compound obtained by proteolytic digestion of horse heart cytochrome c, 
which consists of iron-protoporphyrin IX covalently bound to only eight residual 
cytochrome c amino acids [21]. Literature data report on the cytochrome P450 like 
catalytic properties of this MP-8 in a H2O2 but also in a NADPH/O2/ 
NADPHxytochrome reductase driven system [22,23]. The axial histidine in MP-8 
instead of a cysteine in cytochromes P450 is not expected to be crucial for the 
reaction chemistry that can be catalysed, also because the calculations of Du and 
Loew [24] reported similar electronic and spin properties in a cysteyl and histidyl 
coordinated high-valent iron-oxo porphyrin cofactor. Because the MP-8 model 
provides the activated porphyrin cofactor but has no substrate binding site, it was 
used in our study as a model to discriminate between the influences of the substrate 
binding site and of the cofactor-substrate interaction on the regioselectivity of the 
cytochrome P450-catalysed aromatic ring hydroxylation. 
Materials and Methods 
Chemicals 
The substrates 3-fluoro-2-methylaniline, 3-fluoro-4-methylaniline and 3-
fluoro-6-methylaniline were all purchased from Aldrich (Steinheim, Germany). 2-
Amino-4-fluoro-5-methylphenylsulphate, 2-amino-6-fluoro-5-rnethylphenylsulphate 
and 2-amino-6-fluoro-3-methylphenylsulphate were synthesized according to a 
method described by Boyland et al. [25]. In short, 0.05 g of the corresponding 3-
fluoromethylaniline and 0.25 ml (2 M) KOH were dissolved in 5 ml water under 
stirring. To this mixture 0.25 ml 0.2 M potassium persulphate was added over a 
period of 2 hours. The reaction mixture was analysed by 19p NMR in 0.2 M 
potassium phosphate pH 7.6. For 3-fluoro-2-methylaniline the mixture appeared to 
contain the two possible fluorinated ortho phenylsulphate metabolites with the 
following 19p NMR spectral characteristics; 2-amino-4-fluoro-5-methylphenyl-
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sulphate 8 = -123.8 ppm (3JHF=9.7 H Z , 4JHF=89 H Z ) and 2-amino-6-fluoro-5-
methylphenylsulphate 8 = -137.1 ppm (4jHF=8-5 HZ) . For 3-fluoro-6-methylaniline 
formation of the ortho phenylsulphate metabolite 2-amino-6-fluoro-3-methylphenyl-
sulphate at 5 = -136.3 ppm (3JHF= H-9 HZ, 4JHF= 8.8 Hz) was observed. 
3-Fluoro-2-hydroxy-4-methylaniline, 3-fluoro-6-hydroxy-4-methylanilineand 
3-fluoro-2-hydroxy-6-methylaniline were obtained by acid hydrolysis (30 min 1 N 
HC1 100°C) of 2-amino-6-fluoro-5-methylphenylsulphate, 2-amino-4-fluoro-5-
methylphenylsulphate and 2-amino-6-fluoro-3-methylphenylsulphate, respectively. 
The 19p NMR spectral characteristics in 0.2 M potassium phosphate pH 7.6 were: 3-
fluoro-2-hydroxy-4-methylaniline 8 = -144.9 ppm (4JHF=8.5 HZ) , 3-fluoro-6-hydroxy-
4-methylaniline 8 = -131.6 ppm (3JHF=9.6 HZ, 4JHF=7.3 HZ) and 3-fluoro-2-hydroxy-
6-methylaniline 8 = -143.7 ppm (3jHF=H-2 HZ, 4JHF=5.6 HZ) . 
In vivo exposure to the 3-fluoromethylanilines 
Male Wistar rats (± 400 g) were exposed to 50 mg of the respective 3-
fluoromethylaniline per kg body weight, administered in olive oil by oral injection. 
After oral dosing, 24 h urine samples were collected for two days. For 19p NMR 
measurement, urine samples were diluted once in 0.2 M potassium phosphate pH 
7.6. 
Enzyme and acid hydrolysis of urine samples 
In order to identify phenolic 3-fluoromethylaniline metabolites excreted in 
the urine in their glucuronidated, sulphated or N-acetylated form, urine samples 
were treated with acid, with p-glucuronidase (from Escherichia coli K12 (Boehringer, 
Mannheim, Germany)) or with arylsulphatase/P-glucuronidase (from Helix pomatia 
(Boehringer, Mannheim, Germany)). Enzyme treatments were carried out essentially 
as described before [26]. For acid hydrolysis of the urine samples 1.0 ml urine sample 
was incubated with 0.1 ml 37% (12 N) HC1 for 1 hour in a boiling water bath. After 
acid hydrolysis the mixture was neutralised with 6 N NaOH and the sample was 
diluted 2 times in 0.2 M potassium phosphate pH 7.6 for analysis by 19p NMR. 
For l H NMR measurements on urinary metabolites the arylsulphatase/p-
glucuronidase treated urine samples were extracted three times with an equal 
volume of ethyl acetate. The ethyl acetate phase was evaporated and the residue was 
dissolved in CDCI3. 
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Chemical assay for the detection of 4-hydroxylated derivatives 
4-Aminophenol derivatives present in the urine of 3-fluoromethylaniline 
exposed rats were determined using the method of Brodie and Axelrod [27]. Before 
chemical analysis, 4-aminophenol derivatives were extracted from the urine as 
follows; 400 ul urine of a methylaniline exposed rat was treated with 
arylsulphatase/p-glucuronidase as described above and extracted 2 times with 400 
ul ethyl acetate. To 40 ul of the collected ethyl acetate extract 760 ul demi water and 
240 ul trichloroacetic acid (20% w/v) were added. To 800 ul of this mixture 80 ul 
phenol reagent (5% w / v phenol in 2.5 M NaOH) and 160 ul 2.5 M Na2C03 were 
added. The absorbance at 630 nm was measured after 45 min. 
Microsomal preparations 
Preparation of microsomes was carried out essentially as described 
previously [26]. Microsomes were obtained from perfused livers of male Wistar rats 
(300-400 g) which were untreated or pretreated with the following cytochrome P450 
inducers: acetone (Merck, Darmstadt, Germany) (1.5 ml, 30% in water, orally dosed 
24 h before liver perfusion), isosafrole (Janssen Chimica, Beerse, Belgium) (150 
mg/kg body weight, using a stock solution of 100 mg/ml in olive oil, injected i.p. 
daily for 3 days), p-naphtoflavone (Sigma, St. Louis, MO, USA) (30 mg/kg body 
weight, using a stock solution of 12 mg/ml in olive oil, injected i.p. daily for 3 days) 
or phenobarbital (Brocacef, Maarssen, The Netherlands) (0.1% in drinking water for 
7 days). The amount of cytochrome P450 in the microsomes was measured according 
to the method described by Omura and Sato [28]. 
Purification of microperoxidase-8 (MP-8) 
MP-8 was purified after proteolytic digestion of horse heart cytochrome c 
(Sigma, St. Louis, MO USA) essentially as described in the literature [21]. The sample 
was over 96% pure based on HPLC analysis [21]. The HPLC analysis was performed 
on a Waters M600 HPLC with a Bakerbond WP-C4 column (25 cm x 4.6 mm). A 
linear gradient from 0 to 50% 0.1% trifluoroacetonitril in water and 50% 0.1% 
trifluoroacetic acid in acetonitril was applied in 50 min. Detection at 214 nm was 
performed on an ISCO V^ absorbance detector and detection at 395 nm was 
performed on an Applied Biosystems 757 absorbance detector. 
The heme content was determined essentially as described previously [29]. 
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In vitro incubations 
Microsomal P450 
The incubation mixture contained (final concentrations) 0.1 M potassium 
phosphate pH 7.6, 3 mM substrate, added from a 0.3 M stock solution in dimethyl 
sulfoxide, 2.0 uM microsomal cytochrome P450, 1 mM ascorbic acid (Janssen 
Chimica, Beerse, Belgium) to prevent autoxidation of the ring-hydroxylated 
metabolites, added from a freshly prepared 20 mM stock solution in 0.1 M potassium 
phosphate pH 7.6. 
The incubations were preincubated at 37 °C for 2 min and the reaction was 
started by the addition of NADPH (2 mM final concentration). The total sample 
volume was 2 ml. After 10 min the reaction was terminated by freezing the samples 
in liquid nitrogen. Blanks contained distilled water instead of NADPH or instead of 
microsomes. 
The reaction rate was linear in time up to at least 10 min and with the 
amount of microsomal cytochrome P450 up to at least 2 uM. The regioselectivity of 
aromatic ring hydroxylation appeared to be unaffected by an increase in the 
cytochrome P450 concentration up to at least 2 uM (data not shown). 
Microperoxidase-8 (MP-8) 
The incubation mixture contained (final concentrations) 0.1 M potassium 
phosphate pH 7.6, 3 mM substrate, added from a 0.3 M stock solution in dimethyl 
sulfoxide, 7.5 uM MP-8, 2 mM ascorbic acid, added from a freshly prepared 20 mM 
stock solution in 0.1 M potassium phosphate pH 7.6. The incubations were 
preincubated at 37 °C for 1 min and the reaction was started by the addition of 
hydrogen peroxide (2.5 mM final concentration). The total sample volume was 2 ml. 
After 1 min the reaction was terminated by adding 6500 U catalase (Boehringer, 
Mannheim, Germany) and freezing the samples in liquid nitrogen. Blanks contained 
distilled water instead of hydrogen peroxide or instead of MP-8. 
Cytochrome P4502B1 
Cytochrome P4502B1 was purified and reconstituted as previously described 
[36]. 
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19FNMR and iHNMR measurements 
l^F NMR measurements were performed on a Bruker AMX 300 NMR 
spectrometer at 280 K. Proton-decoupling was achieved with the Waltz-16 pulse 
sequence at -20dB from 50W. 
Samples contained 100 fxl ^H20 for locking the magnetic field and 10 (il 8.4 
mM 4-fluorobenzoic acid added as an internal standard. The total sample volume 
was 1.71 ml. Enzyme treated urine samples and samples from in vitro incubations 
were made anaerobic by evacuating and filling with argon four times before 
analysis. This was done to prevent autoxidation of the phenolic metabolites. About 
1500 scans for in vivo urine samples and 60 000 scans for the microsomal incubations 
samples were recorded. Chemical shifts are reported relative to CFCI3. 
Quantification of the different metabolites was done by comparison of the integral of 
the 19p NMR resonance of the added internal standard 4-fluorobenzoic acid to the 
integrals of the 19p NMR peaks of the metabolites. 
l H NMR measurements were carried out on a Bruker AMX 500 NMR 
spectrometer at 296 K. Spectra were recorded using 30° pulses (3 |is), a 10 kHz 
spectral width, a repetition time of 1.9 s, quadrature phase detection and quadrature 
phase cycling (CYCLOPS). Samples contained CDCI3 for locking the magnetic field. 
The total sample volume was 0.5 ml. About 2000 scans were recorded. 
Molecular orbital calculations 
Semi-empirical molecular orbital calculations were performed on a Silicon 
Graphics Iris 4D/85 computer with the AMI (Austin Method 1) Hamiltonian from 
the AMP AC program (Quantum Chemistry Program Exchange, program no. 506, 
Indiana University, Bloomington, IN, USA). The AMI Hamiltonian was used since it 
was reported to provide improved results for molecules containing heteroatoms 
compared to the MINDO/3 and MNDO methods [30]. Calculations were carried out 
with PRECISE criteria and self-consistent field was achieved for all calculations. 
Geometries were optimised for all bond lengths, bond angles and torsion angles 
using the Fletcher-Powell criteria. 
Frontier electron densities of the substrates for electrophilic attack on the n-
electrons of the aromatic ring were calculated according to the equation of Fukui et 
al. [31]. In this equation the contribution of the HOMO (highest occupied molecular 
orbital) and HOMO-1 (highest occupied molecular orbital below the HOMO) are 
both taken into account. 
The calculated electronic parameters are compared with the results from the 
81 
Chapter 3 
in vivo and in vitro biotransformation of the substrates to aromatic ring hydroxylated 
products by cytochromes P450. Upon binding of the substrates to the active site of 
the cytochromes P450, the intrinsic properties of the compounds might be changed 
due to solvation effects and a different dielectric constant. Because a series of closely 
related compounds is being compared and because the active sites of the 
mammalian cytochromes P450 are rather large aspecific hydrophobic pockets, it can 
be assumed that the relative differences calculated between the related compounds 
as well as between various sites in one molecule will not be influenced by binding of 
the substrates to the active site of the cytochromes P450. 
From the calculated HOMO/HOMO-1 density distributions the 
regioselectivity of aromatic ring hydroxylation of the 3-fluoro(methyl)anilines was 
calculated by summation of the frontier orbital densities of non-substituted aromatic 
ring carbon atoms and normalization of the sum of the values to 1.0. The predicted 
percentage of hydroxylation of an aromatic centre was calculated as the fraction of 
this normalized total frontier orbital density present on the respective non-
substituted aromatic centre. 
Statistical analysis of data 
Values are presented as the mean ± S.D. (standard deviation). 
Results 
Identification of aromatic ring hydroxylated metabolites 
Identification of the 19p NMR resonances of the various hydroxylated 
metabolites of the 3-fluoromethylaniline model compounds was carried out on the 
basis of the following strategy. The effect of introduction of a hydroxyl moiety at an 
ortho, meta or para position with respect to the aromatic fluorine substituent can be 
expected to result in a relatively characteristic change in its 1'F NMR chemical shift 
[32]. The actual values for the change in a l^F-chemical shift value as a result of 
introduction of a hydroxyl moiety at a position ortho, meta or para with respect to a 
specific fluorine substituent can be derived from the chemical shift values observed 
in previous studies with fluorinated anilines [1] and benzenes [2] converted to their 
hydroxylated derivatives. The mean value of these changes for introduction of a 
hydroxyl moiety at respectively the ortho, meta and para position with respect to the 
fluorine substituent amounts to -23.1 ± 0.6 (n=7), +1.8 ± 1.2 (n=ll) and -11.0 ± 1.7 
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(n=6) ppm [33]. On the basis of these results the expected 19p NMR chemical shifts 
of the various possible hydroxylated metabolites of the 3-fluoromethylanilines were 
calculated. The ppm values thus obtained are presented in Table 1. For example, 
introduction of a hydroxyl moiety ortho with respect to the fluorinated C3 in 3-
fluoro-2-methylaniline can be expected to result in a shift of the 19p NMR resonance 
by -23.1 ± 0.6 ppm from -121.9 to approximately -145.0 + 0.6 ppm. 
In order to check that this way of identification of ring hydroxylated 
metabolites was justified some of the hydroxylated 3-fluoromethylaniline 
metabolites were synthesized, i.e. 3-fluoro-2-hydroxy-4-methylaniline, 3-fluoro-6-
hydroxy-4-methylaniline and 3-fluoro-2-hydroxy-6-methylaniline. The 19p NMR 
ppm values of these synthesized reference compounds are -144.9, -131.6 and -143.7 
ppm respectively, i.e. similar to the predicted values presented in Table 1. In one 
case, an ortho C2 and para C4 ring hydroxylated derivative were predicted to have 
similar ppm values, i.e. the ortho C2 and para C4 hydroxylated derivative of 3-fluoro-
6-methylaniline (Table 1). Nevertheless, the actually observed urinary phenolic 
metabolite with its ppm value at -144.2 ppm could be identified as the C4 
hydroxylated product. This follows from the observation that i) chemical synthesis 
of the ortho hydroxylated product demonstrated its ppm value to be -143.7 ppm and 
ii) the presence of the para-hydroxylated methylaniline could be demonstrated in the 
urine using a chemical assay for detection of 4-aminophenol metabolites (data not 
shown). 
Table 1 also summarizes the actual resonances of metabolites observed in the 
l^F NMR spectra from the in vitro microsomal incubations and from hydrolysed 
urine samples of exposed rats. Comparison of the calculated 19p NMR resonances of 
phenolic metabolites (Table 1) to the ones observed in the l^F NMR spectra (Figures 
1 and 2) resulted in identification of the ^V NMR resonances of the various phenolic 
compounds. The presence of these phenolic resonances in 19p NMR spectra of urine 
samples only after treatment of the urine with arylsulphatase/p-glucuronidase 
further confirmed that these resonances belong to phenolic metabolites excreted as 
their sulphated or glucuronidated derivatives. 
In vitro cytochrome P450-catalysed aromatic ring hydroxylation of 3-
fluoro(methyl)anilines 
The in vitro aromatic ring hydroxylation of the 3-fluoro(methyl)anilines was 
investigated in incubations with microsomes from isosafrole pretreated rats. From 
the incubations of 3-fluoro-2-methylaniline and 3-fluoroaniline with microsomes 
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Table 1 Identification of aromatic ring hydroxylated derivatives of 3-fluoromethylanilines. 
Chemical shift values presented are relative to CFCI3. Estimated values were based on the changes in 
1'F NMR chemical shifts observed upon introduction of a hydroxyl moiety in a series of fluorinated 
benzene [2] and aniline [1] derivatives [33]. 
substrate PP m PP m observed 
metabolite estimated in vivo and /or 
in vitro 
3-fluoro-2-mefhylaniline - -121.93 
3-fluoro-4-hydroxy-2-methylaniline -145.0 + 0.6 -144.1 
3-fluoro-5-hydroxy-2-methylaniline -120.1 ±1.2 nob 
3-fluoro-6-hydroxy-2-methylaniline -132.9 ± 1.7 -131.1 
3-fluoro-6-rriethy)anilinp - -121.53 
3-fluoro-2-hydroxy-6-methylaniline -144.6 ± 0.6 -143.7a 
3-fluoro-4-hydroxy-6-methylaniline -144.6 ± 0.6 -144.2C 
3-fluoro-5-hydroxy-6-methylaniline -119.7 ±1.2 no" 
3-fluoro-4-methylaniline - -121.5a 
3-fluoro-2-hydroxy-4-methylaniline -144.6 ± 0.6 -144.9a 
3-fluoro-5-hydroxy-4-methylaniline -119.7 ±1.2 no"5 
3-fluoro-6-hydroxy-4-methylaniline -132.5 ± 1.7 -131.63 
a
 Identified also on the basis of a synthesized or commercially available reference compound. 
" No resonance observed at this position in vivo and/or in vitro. 
c
 Identified also on the basis of a chemical assay for 4-hydroxylated aminobenzene derivatives and by 
the fact that the 1°F NMR resonance of the synthesized 3-fluoro-2-hydroxy-6-methylaniline/ predicted 
to be at a similar value, was at -143.7 ppm. 
from rats pretreated with different inducers ((vide infra) and [1]) it was observed 
that incubations with microsomes derived from isosafrole pretreated rats showed 
the highest rate of conversion. Figure 1 presents the 19p NMR spectra of the 3-
fluoromethylaniline model compounds with microsomes from isosafrole pretreated 
rats. The 19p NMR spectrum of the incubation of 3-fluoroaniline with isosafrole 
microsomes was previously reported [1]. The amount of fluoride anions in the 
microsomal incubations equals the amount detected in the blank incubations 
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Figure 1 "V NMR spectra from incubations of (a) 3-fluoro-2-methylaniline, (b) 3-fluoro-6-
methylaniline and (c) 3-fluoro-4-methylaniline with microsomes from isosafrole pretreated rats. Peaks 
marked with an asterisk were also found in the blank incubations without NADPH. The resonance 
peak of the internal standard 4-fluorobenzoic acid is marked "IS". Chemical shifts are recorded 
relative to CFCI3. ^V NMR resonances of possible metabolites resulting from CH3 hydroxylation are 
masked by the relatively large resonance of the substrate. However, this is not of interest as the 
present study focuses on the regioselectivity of aromatic ring hydroxylation. 
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Figure 2 1°F NMR spectra from acid treated 24 h urine samples of rats exposed to (a) 3-
fluoro-2-methylaniline (b) 3-fluoro-6-methylaniline and (c) 3-fluoro-4-methylaniline. Chemical shifts 
are recorded relative to CFCI3. The bar in the spectrum indicates the ppm range where the C5 
hydroxylated metabolite can be expected (Table 1). Proton-coupled 19F NMR analysis of peaks 
observed in this region demonstrated that they contain three aromatic protons indicating that they 
can not be ascribed to C5 hydroxylated metabolites (data not shown). CHnOR presents metabolites 
resulting from CH3 hydroxylation with R=H and n=2 in case of a benzylalcohol and R=absent and 
n=l for a benzaldehyde (see text for further details). 
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without NADPH. From this it can be concluded that hydroxylation accompanied by 
defluorination is not observed. Hydroxylation accompanied by an NIH shift of the 
fluorine was also not observed. 
Table 2 presents the regioselectivity of the in vitro cytochrome P450 catalysed 
aromatic hydroxylation of the various model compounds as derived from the 19p 
NMR results. 
In vivo aromatic ring hydroxylation of 3-fluoro(methyl)anilines 
The regioselectivity of the aromatic hydroxylation of the 3-
fluoro(methyl)aniline derivatives upon their in vivo biotransformation was also 
determined. The regioselectivity of aromatic ring hydroxylation for the different 
substrates was derived from the 19p NMR spectra of the acid treated urine samples 
of rats exposed to the various model compounds. In Figure 2 the 19p NMR spectra of 
the acid treated urine samples of rats exposed to 3-fluoromethylanilines are shown. 
The 19p NMR spectrum of urine from a 3-fluoroaniline exposed rat was previously 
reported [1]. From these 19p NMR spectra it could be calculated that the 24 h 
recovery of the administered dose was 70-90% for all the model substrates. The 
amount of fluoride anions in the urine samples could be attributed to the fluoride 
anions originating from the food and /or drinking water, as a similar amount was 
observed in the 19p NMR spectra of control urine samples of unexposed rats. 
In addition to the resonances of the aromatic ring hydroxylated products the 
l^F NMR spectra presented in Figure 2 contain additional resonances (-121.9 ppm 
(Figure 2a), -121.5 ppm (Figure 2b) and -117.6 ppm (Figure 2c)). These resonances 
can be ascribed to metabolites resulting from hydroxylation of the methyl moiety of 
the 3-fluoromethylanilines. This follows from the fact that l H NMR and 19p NMR 
analysis of these metabolites, extracted into ethyl acetate after treatment of urine 
with arylsulphatase/p-glucuronidase, shows that they all still contain three aromatic 
protons, in addition to the fluorine substituent (data not shown). HPLC analysis of 
these samples show that these resonances can not be ascribed to the substrate (data 
not shown). Because metabolites resulting from hydroxylation of the amino moiety 
are generally not excreted into urine, it is most likely that these unidentified urinary 
metabolites result from a modification of the methyl group. Biotransformation of 
methylanilines to benzylalcohols and benzaldehydes, resulting from a modification 
of the methyl group, has been reported before [15,19,20]. Because the present study 
focuses on the regioselectivity of aromatic ring hydroxylation, the respective 
metabolites were not further identified at this stage. 
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Table 2 Regioselectivity of the in vitro and in vivo aromatic ring hydroxylation of 3-
fluoro(methyl)anilines. The in vitro data were obtained from incubations with MP-8 or microsomes 
from isosafrole pretreated rats (n=2). In vivo results were obtained from analysis of acid treated 24 h 
urine samples of exposed rats (n=2). Ring carbon atoms are numbered in such a way that the amino 
moiety is at CI. 
substrate 
ring carbon atom 
regioselectivity of aromatic ring hydroxylation 
observed^ 
in vitro in vivo 
cyt. P450 MP-8 
predicted"3 
3-fluoro-2-methylaniline 
C4 : C5: C6 94 : 0 : 6 
3-fluoro-6-methylaniline 
C2: C4: C5 0:100 :0 
3-fluoro-4-methylaniline 
C2: C5 : C6 25 :0 : 75 
3-fluoroaniline 
C2 : C4: C5: C6 5 : 8 4 : 0 : l l c 
71:0: 29 
0:100 :0 
30 : 0 : 70 
8:59 : 0: 33 
89 : 0 :11 
7:93 : 0 
20: 0 :80 
0: 75 :0 : 25c 
53 :10 :37 
25 : 70 : 5 
32 :11:57 
18 : 44 :5 : 33 
a
 % of total ring hydroxylated products. 
b % of total HOMO/HOMO-1 density on non-substituted ring carbon atoms. 
c
 Results taken from Cnubben et al. [1], 
Table 2 presents the calculated regioselectivity of the in vivo aromatic ring 
hydroxylation, as derived from the 19p NMR urine spectra. The data show that the 
cytochrome P450-catalysed regioselectivity of the ring hydroxylation observed in 
vivo resembles the regioselectivity observed in vitro (Table 2) (correlation=0.99, 
absolute mean deviation=4.8 + 4.1%). 
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Influence of chemical reactivity on the regioselectivity of aromatic hydroxylation 
Molecular orbital computer calculations were performed in order to find out 
to what extent electronic characteristics of the 3-fluoro(methyl)anilines can account 
for the regioselectivity of aromatic ring hydroxylation upon their biotransformation 
by the cytochromes P450. 
If aromatic ring hydroxylation proceeds by an initial attack of the 
cytochrome P450(FeO)3+ species on the 7t-electrons of the aromatic ring without the 
formation of epoxide intermediates, the regioselectivity may be directed by the 
HOMO/HOMO-1 density distribution in the parent substrate [2]. Table 2 presents 
the predicted regioselectivity of the aromatic ring hydroxylation of our model 
compounds calculated on the basis of the HOMO/HOMO-1 densities in the benzene 
ring according to the equation of Fukui et al. [31]. From the results presented in 
Table 2 it can be derived that the observed cytochrome P450-catalysed 
regioselectivity deviates with an absolute mean value of 18.6 ± 11.3% from the 
predicted regioselectivity. This deviation is much larger than the 6.5 ± 2.7% absolute 
mean deviation observed in a previous study for the fluorinated benzenes [2]. For 
comparison, in Figure 3A the regioselectivity of the in vivo aromatic ring 
hydroxylation for this series fluorinated benzenes is plotted against the percentage 
hydroxylation predicted on the basis of the molecular orbital calculations. Figure 3B 
presents these results for 3-fluoro-2-methylaniline, 3-fluoro-6-methylaniline and 3-
fluoroaniline, substrates with a hydrogen-substituted para C4 and ortho C2 and/or 
C6 position. The dotted line in Figures 3A and 3B presents the theoretical perfect 
correlation between the percentage of hydroxylation and the predicted value 
(slope=1.00, intercept=0.00). As can been seen from Figure 3A the data obtained with 
the fluorinated benzenes (slope=1.03, intercept=-1.21, correlation=0.96) almost match 
this theoretical line. The data obtained for the two fluorinated ortho methylanilines 
and 3-fluoroaniline, however, deviate from this theoretical line in a systematic 
manner. Non-substituted (i.e. hydrogen containing) C4 positions are hydroxylated to 
a significantly higher extent than predicted, whereas non-substituted C2 and C6 
positions are always below the theoretical line and are, thus, hydroxylated to a lower 
extent than their chemical reactivity would predict. 
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Chapter 4 
*H NMR Ti relaxation rate study on substrate orientation of 
fluoromethylanilines in the active sites of microsomal and purified 
cytochromes P4501A1 and 2B1 
J. Koerts, I.M.C.M. Rietjens, M.G. Boersma and J. Vervoort 
FEBS Letters 368,1995,279-284. 
Abstract 
The present study describes ^H NMR Ti relaxation rate studies on 
fluoromethylanilines bound to the active sites of microsomal and purified 
cytochromes P4501A1 and 2B1. From the data obtained, insights into the average 
orientation of the substrates with respect to the paramagnetic Fe^+ centre in the 
cytochromes P450 could be derived. Particular attention was paid to a possible extra 
relaxation pathway for methyl protons compared to the aromatic protons, due to the 
rotational motion of the CH3 around the a-C-CH3 bond. However, this effect 
appeared to be minimal and to result in at most a few percent underestimation of the 
actual distance of the methyl protons to the Fe^+ centre. Furthermore, the data 
obtained demonstrate that all aromatic protons are at about the same average 
distance from the paramagnetic centre. The results also demonstrate that the 
fluoromethylanilines are bound to the active sites of cytochromes P4501A1 and 2B1 
in a similar way. A time-averaged orientation of the substrate with the Fe3+ above 
the aromatic ring, with the rc-orbitals of the aromatic ring and those of the porphyrin 
rings in a parallel position, providing possibilities for energetically favourable n-n 
interaction defines the orientation which best fits the results of the present study. 
Possibilities for a flip-flop rotation around an axis in the plane of the aromatic ring 
can be included in this picture, as such rotations would still result in a similar 
average distance of all aromatic protons to the Fe3+ paramagnetic centre. The results 
obtained also indicate that possible differences in metabolic patterns resulting from 
conversion of the fluoromethylanilines by different cytochromes P450, especially 
P4501A1 and 2B1, are unlikely to be caused by a specific orientation of the substrate 
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imposed by the substrate binding site of the enzyme. 
Introduction 
Several studies in the literature describe Ti relaxation measurements 
investigating the manner of binding of substrates to the active sites of cytochromes 
P450 [1-5]. All of these studies report a stereoselective orientation of the substrate in 
the active site of the cytochrome P450, or even a link between the observed specific 
way of binding of the substrate and the regioselectivity of its hydroxylation by 
different P450 isozymes. However, some investigations have reported conflicting 
results. For example, the stereoselective orientation of 4-hydroxyacetanilide with 
respect to the Fe^+ centre in cytochromes P4501A1 and 2B1 was indicated to be 
different, but the actual difference reported appeared to be opposite in independent 
studies [2,3]. Using ^H NMR Ti relaxation rate measurements, the acetamino group 
was reported to be closer to the Fe^+ in P4502B1 than in P4501A1 [2], whereas in a 
study using ^N and l^C f j relaxation rate measurements the opposite was 
concluded, and the nitrogen atom of the acetamido group was reported to be closer 
to the Fe 3 + in cytochrome P4501A1 than in P4502B1 [3]. 
Furthermore, recent results with various halogenated benzene derivatives 
have provided evidence for the hypothesis that relatively small substrates become 
bound to the relatively aspecific and large active sites of the mammalian 
cytochromes P450 in such a way that the active site does not impose a stereoselective 
positioning of the substrate with respect to the (activated) metal centre. This 
conclusion follows from the observation that the regioselectivity of the aromatic 
hydroxylation of fluorobenzene derivatives and fluoroanilines did not vary 
significantly with change in the cytochrome P450 enzyme pattern catalysing the 
hydroxylation [6,7]. Instead, the regioselectivity of the aromatic hydroxylation of a 
series of fluorobenzenes and fluoroanilines could be explained and even predicted 
on the basis of the calculated reactivity of the various carbon centres for an 
electrophilic attack. Together, these results rather suggest an orientation of the 
aromatic substrate in the active site of the cytochromes P450 with all protons at equal 
average distances from the Fe 3 + centre, providing no distance limitations to 
hydroxylations at specific positions on the basis of a protein-imposed stereoselective 
orientation of the substrate in the active site of the cytochromes P450. 
The objective of the present study was to gain greater insights into this 
question related to the presence or absence of a stereoselective positioning of 
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relatively small substrates in the active sites of cytochromes P450. Cytochrome 
P4501A1 and cytochrome P4502B1 were used as the P450 enzymes for the study. 
Fluoromethylanilines were chosen as the model substrates. These substrates were 
chosen for several reasons. First, insight into factors that determine the 
regioselectivity of the cytochrome P450-catalysed conversion of methylanilines is of 
importance because N-hydroxylation pathways lead to bioactivation and mutagenic 
metabolites, whereas aliphatic side chain methyl and aromatic ring hydroxylations 
lead to products that can be excreted upon Phase II conjugation [8-12]. Second, the 
fluoromethylanilines are relatively small molecules. Third, the molecules contain an 
amino group that may be especially suitable for a possible specific orienting 
interaction with active site amino acids. Such an orienting interaction between a 
cytochrome P450 amino acid residue and an amino moiety of the substrate has for 
example been reported for cytochrome P450 debrisoquine 4-hydroxylase [13]. 
Fourth, the molecules contain a methyl substituent, which makes it possible to study 
whether the distances obtained for methyl protons, which have a possible additional 
relaxation pathway due to the rotation of the methyl group around the CJ-C-CH3 
bond [14], can actually be compared to distances obtained for aromatic protons 
which lack this additional relaxation pathway. In addition, preferential side-chain C-
hydroxylation of the methyl moiety over aromatic ring hydroxylation has been 
reported for para-methylanilines and toluene [15-17], while for orffeo-methylaniline 
the opposite is true [18]. Information on average proton distances for both the methyl 
and the aromatic protons may provide an answer to the question of whether the 
preferential site for hydroxylation originates from a closer proximity of the 
respective hydrogens to the active Fe3+ centre of the cytochromes P450. Finally, the 
substrates have a good water solubility making Ti NMR relaxation measurements 
under saturating substrate condition possible. 
Materials and Methods 
Chemicals 
4-Fluoro-2-methylaniline, 3-fluoro-4-methylaniline and 3-fluoro-2-
methylaniline were all obtained from Aldrich (Steinheim, Germany). 2-Fluoro-4-
methylaniline was purchased from Acros Chimica (Geel, Belgium). 
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Protein preparations 
Preparation of purified cytochromes P4501A1 and 2B1 as well as preparation 
of microsomes was carried out essentially as previously described [19,20]. The 
amount of cytochrome P450 was measured according to the method of Omura and 
Sato [21]. 
iHNMR TI relaxation rate measurements 
lH NMR T I relaxation rate measurements were performed on a Bruker CXP 
500 NMR spectrometer at 296.2 K. The longitudinal relaxation time (Ti) was 
determined by a 180°-90° inversion recovery method. Irradiation of the water signal 
was employed to reduce the disturbance by this resonance. The delay time (x) 
between the pulses for the samples containing purified or microsomal cytochromes 
P450 and for the samples containing only substrate was 0.1 and 0.2 sec respectively. 
About 12 x values were applied and 32 scans for each x value were recorded. 
Samples contained 0.1 M potassium phosphate pH 7.25 (containing 20% glycerol) or 
a solution of (microsomal) cytochrome P450 in this buffer (final concentration 1.26 
|iM cytochrome P450), or 0.4 M potassium phosphate pH 7.4 (containing 20% 
glycerol) or a solution of purified cytochrome P450 in this buffer (final concentration 
1.26 uM cytochrome P450), 0.1 mM EDTA, 5 mM substrate added from a 0.25 M 
stock solution in dimethyl sulfoxide and 1% D2O for locking the magnetic field. The 
total sample volume was 0.511 ml. Samples were made oxygen free by four cycles of 
evacuation and filling with argon. 
To correct for the diamagnetic contribution to the longitudinal relaxation 
time the Ti of a blank containing CO-dithionite-reduced cytochrome P450 was 
determined. 
The corrected Ti value (1/Ticorr = 1/Ti observed - 1/Tiblank) was used to 
calculate the distance (r) of the respective proton to the paramagnetic iron essentially 
as described by Novak and Vatsis [1], using the Solomon-Bloembergen equation, 
assuming the Fe3+ in both P4501A1 and 2B1 to be in the high spin conformation 
[1,22,23], and taking a xc value of 10~10 . This value for Xc for cytochromes P450 may 
actually vary between 10~10 and 10~H [24]. However, using a factor of 10~H would 
result in values that are 68% of those obtained with a value of 10"10. This changes the 
absolute values of the distances obtained by a constant factor, and does not influence 
relative differences obtained for protons in one substrate molecule bound to the 
active site of a specific cytochrome P450. 
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Calculation of optimised fluoromethylaniline geometry 
The optimised geometry for the various fluoromethylanilines was calculated 
on a Silicon Graphics Indigo^ using Insight (Biosym, CA, USA). The semi-empirical 
molecular orbital method was used, applying the AMI Hamiltonian from the 
AMP AC program. 
Results 
lH NMR T\ relaxation measurements on fluoromethylanilines bound to p-
naphtoflavone and phenoborbital induced microsomal cytochromes P450 
Previous ^H NMR relaxation rate studies on the interaction of 
benzo(a)pyrene with microsomal cytochromes P450 clearly demonstrated that 
differences in the orientation of a substrate in the active sites of cytochromes 
P4501A1 and 2B1 can be detected in studies with respectively P-naphtoflavone and 
phenobarbital induced microsomal preparations, respectively [5]. Thus, as a first 
approach, the binding of several fluoromethylanilines to cytochromes P450 was 
studied using p-naphtoflavone and phenobarbital induced microsomal preparations. 
The cytochrome P450 population in these microsomes contains 71% and 55% of 
cytochrome P4501A1 and cytochrome P4502B1, respectively [25]. 
Figure 1 presents the results of a ^H NMR Ti relation measurement for 3-
fluoro-2-methylaniline bound to phenobarbital induced microsomal cytochromes 
P450. A plot of the natural logarithm of the peak at infinite delay time (Moo) minus 
the peak area at the specific delay time t (Mx) against this delay time x gives a 
straight line with a slope of -1/Ti, from which the Ti relaxation time can be derived 
(Figure 2). Tables 1 and 2 present the Ti values thus obtained for the various 
substrate protons in the presence of microsomes from p-naphtoflavone and 
phenobarbital treated rats, respectively. Ti values for the CO-reduced blank samples 
are also listed. From these Ti and Ti CO-blank values the distances of the respective 
protons to the Fe3+ centre in the active site of the microsomal cytochromes P450 
were calculated, the results obtained are also being presented in Tables 1 and 2. The 
distances of the various aromatic protons to the Fe3+ cytochrome P450 metal centre 
do not vary significantly for the aromatic protons of the various 
fluoromethylanilines. Based on these results as well as the calculated optimal 
geometry of the fluoromethylaniline molecules, the expected distance for the methyl 
protons to the Fe3+ centre can be calculated. This was carried out assuming the Fe^+ 
centre to be at the measured distance away from the aromatic protons and, thus, 
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T ( S ) 
Figure 1 *H NMR spectra showing the inversion recovery sequence (180° - t -90° pulse 
sequence) of 3-fluoro-2-methylaniline in the presence of microsomal cytochrome P450 derived from 
phenobarbital pretreated rats. The water signal at 4.7 ppm is omitted. 
_A P\ 
- * - , — 0.5 x (S) 
ppm 
Figure 2 Plot showing In (Moo - Mt) plotted against t for the H4 proton of 3-fluoro-2-
methylaniline in the presence of microsomal cytochrome P450 derived from phenobarbital pretreated 
rats (Figure 1). The slope of this curve equals -1/Ti. 
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Table 1 T\ relaxation rates for protons of different fluoromethylanilines in a system 
containing microsomal cytochrome P450 from P-naphtoflavone pretreated rats 
1 A l [25] and in a CO-dithionite reduced P450 blank sample 
distances between the re* spective protons 
Materials and Methods section. 
substrate 
proton 
4-fluoro-2-methvlaniline 
H 3 
H 5 
H 6 
HCH3 
3-fluoro-2-methvlaniline 
H4 
H 5 
H 6 
HCH3 
2-fluoro-4-methvlaniline 
H 3 
H 5 + H 6 
HCH3 
3-fluoro-4-methvlaniline 
H 2 
H 5 + H 6 
HCH3 
Tl 
(s) 
0.834 ±0.034 
0.824 + 0.087 
0.759 ±0.013 
0.704 ±0.004 
0.646 ±0.065 
0.665 ±0.120 
0.616 ±0.074 
0.588 ±0.019 
0.689 + 0.109 
0.609 + 0.053 
0.564 ±0.047 
0.482 ±0.127 
0.423 ±0.001 
0.494 ±0.033 
containing 71% P450 
(Ti CO-blank). From these Ti values the 
and the paramagnetic iron were calculated as described in 
Ti CO-blank 
(s) 
1.187 ±0.062 
1.202 ±0.018 
1.086 ± 0.012 
0.848 ± 0.126 
0.908 ± 0.110 
0.927 ±0.098 
0.846 ±0.206 
0.727 ±0.058 
0.955 ± 0.038 
0.830 ±0.093 
0.704 ±0.084 
0.593 ±0.067 
0.561 ±0.028 
0.597 ±0.037 
r (Fe-H) 
(A) 
6.27 ±0.39 
6.20 ±0.06 
6.16 ±0.04 
6.69 ±0.62 
6.04 ±0.08 
6.09 ±0.70 
6.05 ±0.07 
6.23 ±0.21 
6.14 ±0.36 
6.06 ±0.15 
6.28 ±0.19 
6.18 ± 0.59 
5.78 ±0.08 
6.29 ±0.07 
r (Fe-Hmethyl) 
calculated (A) 
6.65 ± 0.06 
6.51 ± 0.02 
6.55 ± 0.05 
6.44 ±0.26 
averaged in time above the centre of the aromatic ring. Comparison of the distances 
thus calculated and those actually observed demonstrates that the observed values 
are generally 96.5 ± 2.2% (n=8) of those calculated. This implies that, although the Ti 
relaxation rate of the methyl protons in a fluoromethylaniline is generally faster than 
that of the aromatic protons, this effect is also observed in the blank and is 
independent of the presence of a paramagnetic centre. Thus, the distances obtained 
for the methyl protons can be well compared to those determined for the aromatic 
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protons. 
Furthermore, comparison of the results presented in Tables 1 and 2 indicates 
that there are no significant differences between the distances observed with the two 
microsomal cytochrome P450 preparations, suggesting that the average way of 
binding and, more precisely, the average distance of the protons of a given substrate 
to the paramagnetic Fe^+ in the active site of the various cytochromes P450 are 
comparable. 
Table 2 T i relaxation rates for protons of different fluoromethylanilines in a system 
containing microsomal cytochrome P450 from phenobarbital pretreated rats, containing 55% P450 2B1 
[25] and in a CO-dithionite reduced P450 blank sample (Ti CO-blank). From these Tj values the 
distances between the respective protons and the paramagneb 
Materials and Methods section. 
substrate 
proton 
4-fluoro-2-methvlaniline 
H 3 
H 5 
H 6 
HCH3 
3-fluoro-2-methvlaniline 
H4 
H 5 
H 6 
HCH3 
2-ftuoro-4-methvlaniline 
H 3 
H 5 + H 6 
HCH3 
3-fluoro-4-methylaniline 
H 2 
H 5 + H 6 
HCH3 
Tl 
(s) 
0.766 ±0.033 
0.718 ±0.035 
0.638 ±0.004 
0.651 ±0.014 
0.516 ± 0.106 
0.542 ± 0.164 
0.429 ± 0.064 
0.462 ±0.096 
0.706 ± 0.152 
0.646 ± 0.114 
0.581 + 0.025 
0.398 + 0.033 
0.395 ±0.007 
0.440 ± 0.064 
Tl CO blank 
(s) 
1.100 ±0.118 
1.033 ±0.093 
0.944 ±0.060 
0.838 ± 0.070 
0.958 ± 0.099 
0.893 ±0.087 
0.794 ±0.155 
0.743 ±0.030 
0.941 ± 0.061 
0.849 ± 0.081 
0.706 ± 0.052 
0.706 ±0.035 
0.691 ± 0.022 
0.664 ±0.010 
c iron were calculated as described in 
r (Fe-H) 
(A) 
6.16 ±0.26 
6.09 + 0.30 
5.91 ±0.10 
6.31+0.04 
5.38 + 0.25 
5.57 ±0.55 
5.22 ± 0.19 
5.46 + 0.34 
6.28 + 0.47 
6.23 ± 0.44 
6.44 + 0.07 
5.20 ± 0.12 
5.21 ± 0.06 
5.52 ± 0.31 
r (Fe-Hmethyl) 
calculated (A) 
6.50 ± 0.12 
5.89 + 0.16 
6.69 ±0.03 
5.72 ±0.01 
104 
Chapter 4 
lH NMR TI relaxation measurements on 4-fluoro-2-methylaniline and 2-fluoro-4-
methylaniline bound to purified cytochromes P4501A1 and 2B1 
To further support the observations obtained with the (i-naphtoflavone and 
phenobarbital induced microsomal cytochromes P450, a ^H NMR Ti relaxation rate 
study was performed with purified cytochromes P4501A1 and 2B1 using two of the 
fluoromethylanilines as the substrate. The results obtained are presented in Table 3. 
Comparison of the results obtained with those listed in Tables 1 and 2 for the 
microsomal cytochromes P450 demonstrates that the average distances obtained 
with the purified enzymes are generally somewhat (17.7 ± 3.6%) longer than those 
observed with the microsomal cytochromes P450, however, the overall effects 
observed are similar. No significant differences are observed in the distances 
between the aromatic protons and the Fe3+ in the active site of the two enzymes. 
Discussion 
The lH NMR Ti relaxation rate studies on fluoromethylanilines bound to the 
active sites of microsomal and purified cytochromes P4501A1 and 2B1 were used to 
investigate the presence or absence of a preferential orientation of the substrates in 
the active site of the cytochromes P450. Such a specific orientation would be reflected 
in different distances for the various protons in the substrates. An increased average 
distance of specific protons in the substrate molecule might result in an influence on 
the regioselectivity upon subsequent biotransformation to hydroxylated products. It 
should be mentioned that the actual orientation of the substrate bound to the Fe^+ 
resting state of the cytochrome P450 could be different from that of the substrate in 
the activated high-valent iron-oxo porphyrin form actually performing the 
hydroxylation step, as reported for thiocamphor bound to cytochrome P450cam [26]. 
However, an interaction between an active site amino acid and, for example the 
amino moiety of the substrate, could very well persist upon conversion of the Fe3+ 
form to the high-valent iron-oxo form of the enzyme and, thus, influence the 
regioselectivity of the hydroxylation by an effect on the actual distance of the 
possible reaction sites from the active metal centre. Such an influence of substrate 
orientation on the regioselectivity of the reaction imposed by the active site of the 
cytochrome P450 has been reported, for example, for amino-containing substrates 
converted by cytochrome P450 debrisoquine 4-hydroxylase [13], but have also been 
suggested for the conversion of, e.g., 4-hydroxyacetanilide by cytochrome P4501A1 
or 2B1 [2,3]. However, from the data obtained in the present study for the binding of 
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Table 3 T i relaxation rates for 4-fluoro-2-methylaniline and 2-fluoro-4-methylaniline in a 
system containing purified cytochrome P4501A1 or 2B1 and in a CO-dithionite reduced P450 blank 
sample (Ti CO-blank). From these Ti values the distances between the respective protons and the 
paramagnetic iron were calculated as described in Materials and Methods section. 
substrate 
proton 
Ti CO blank r(Fe-H) 
(s) (A) 
r (Fe-Hmethyl) 
calculated (A) 
4-fluoro-2-methylaniline / cytochrome P4501A1 
H3 1.638 ±0.057 2.004±0.034 
H5 1.649 + 0.026 2.089 + 0.078 
H6 1.42410.058 1.98710.389 
HCH3 1.08410.051 1.24310.007 
4-fluoro-2-methylaniline / cytochrome P4502B1 
H3 2.03310.155 2.85810.226 
H5 2.07710.176 2.92610.264 
H6 1.54910.436 2.694 + 0.426 
HCH3 1.19710.137 1.46510.036 
2-fluoro-4-methylaniline / cytochrome P4501A1 
H3 1.19110.150 1.448 + 0.090 
H5 + H6 1.08910.133 1.30510.093 
HCH3 0.89610.103 1.008 + 0.108 
2-fluoro-4-methylaniline / cytochrome P4502B1 
H3 1.71810.011 2.11810.030 
H5 + H6 1.46810.039 1.81410.030 
HCH3 1.12210.038 1.22010.075 
7.6110.25 
7.4410.27 
6.9110.57 
7.5410.23 
7.31 + 0.81 
7.33 + 0.74 
6.5510.47 
7.2210.40 
7.2510.19 
7.2310.23 
7.4810.42 
7.6310.04 
7.3810.18 
7.7710.39 
7.7010.35 
7.4510.42 
7.6210.01 
7.8710.17 
fluoromethylanilines to the active site of microsomal and purified cytochromes 
P4501A1 and 2B1, it follows that all aromatic protons are at about the same average 
distance from the paramagnetic centre. The results also demonstrate that the 
fluoromethylanilines are bound to the active sites of cytochromes P4501A1 and 2B1 
in a similar way. Thus the binding characteristics of the relatively small 
fluoromethylanilines to the active sites of cytochrome P4501A1 and 2B1 provide no 
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indications for a stereoselective orientation that may influence the regioselectivity of 
the oxidation. 
Special attention was paid to the average distance obtained from the Ti 
relaxation measurements for the methyl protons in the fluoromethylanilines. This 
was done for two reasons, first, the existence of an extra relaxation pathway for 
methyl protons compared to aromatic protons, due to a rotational motion of the CH3 
around the CT-C-CH3 bond, might hamper the comparison of distances obtained for 
aromatic protons to those determined for methyl protons. Second, preferential side-
chain C-hydroxylation of the methyl moiety over aromatic ring hydroxylation has 
been reported for para-methylanilines. Information on average proton distances for 
both the methyl and the aromatic protons provides an answer to the question of 
whether this preferential side chain C-hydroxylation originates from a closer 
proximity of the methyl than of the aromatic protons to the active Fe3+ centre of the 
cytochromes P450. Clearly, the results of the present study provide support for the 
methyl protons having higher Ti relaxation rates than the aromatic protons, but the 
same effect is observed in the Ti relaxation rates of the CO-reduced blanks, resulting 
in calculated average distances for the methyl protons that can be reliably compared 
to distances obtained for aromatic protons. The actual distances observed indicate 
that the methyl protons are not closer to the Fe3+ paramagnetic centre than the 
aromatic protons, providing no basis for the easier hydroxylation of the para-
methylanilines at the methyl group than in the aromatic ring. 
Taken together, the results obtained support a time-averaged orientation of 
the substrate in the active site in which the location of the Fe3+ is above the aromatic 
ring, with the 7C-orbitals of the aromatic ring and the rc-orbitals of the porphyrin rings 
in a parallel position providing possibilities for energetically favourable Jt-Jt 
interaction. Possibilities for a flip-flop rotation around an axis in the plane of the 
aromatic ring can be included in this picture, as such rotations would still result in a 
similar average distance of all aromatic protons to the Fe^+ paramagnetic centre. 
Furthermore, the results obtained in the present study support the 
conclusion that possible differences in metabolic patterns resulting from conversion 
of the fluoromethylanilines by different cytochromes P450, especially P4501A1 and 
2B1, and also the preferential sites for hydroxylation of the various sites in fluoro-
methylanilines, are unlikely to be defined by a specific orientation of the substrate, 
imposed by the substrate binding site of the cytochromes P450. This conclusion 
supports previous conclusions from studies on regioselectivity of aromatic 
hydroxylation, from which it emerged that chemical reactivity instead of 
stereoselective binding imposed by the amino acids of the active site of the 
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cytochromes P450 is the major determinant in setting the outcomes of the 
regioselectivity of the hydroxylation of relatively small benzene derivatives by 
cytochromes P450 [6,7]. 
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Abstract 
The mechanism of aromatic hydroxylation of aniline and phenol derivatives 
in a H2O2 driven microperoxidase-8 (MP-8)-catalyzed reaction was investigated. It 
was shown that the reaction was not inhibited by the addition of scavengers of 
superoxide anion or hydroxyl radicals, which demonstrates that the reaction 
mechanism differs from that of the aromatic hydroxylation catalyzed by a 
horseradish peroxidase/dihydroxyfumarate system. Additional experiments with 
l^O labelled H2^^02 demonstrated that the oxygen incorporated into aniline to give 
4-aminophenol originates from H2O2. Furthermore, it was found that the addition of 
ascorbic acid efficiently blocks all peroxidase-type of reactions that can be catalyzed 
by the MP-8/H2O2 system, but does not inhibit the aromatic hydroxylation of 
aniline and phenol derivatives. Together, these observations exclude reaction 
mechanisms for the aromatic hydroxylation that proceed through peroxidase-type of 
mechanisms in which the oxygen incorporated into the substrate originates from O2 
or H2O. The mechanism instead seems to proceed by an initial attack of the high-
valent iron-oxo intermediate of MP-8 on the rc-electrons of the aromatic ring of the 
substrate leading to product formation by a cytochrome P450-type of o-O-addition 
or oxygen-rebound mechanism. This implies that MP-8, which has a histidyl and not 
a cysteinate fifth axial ligand, is able to react by a cytochrome P450-like oxygen-
transfer reaction mechanism. 
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Introduction 
Microperoxidase-8 (MP-8) is a heme octapeptide obtained by enzymatic 
hydrolysis of horse-heart cytochrome c [1-3]. It contains a heme cofactor that is a 
protoporphyrin IX with an iron centre that exists in the ferric resting state, and is 
able to react with hydrogen peroxide to form high-valent iron-oxo intermediates that 
could be analogous to compounds I and II of horseradish peroxidase [4,5]. The 
ability of MP-8 to catalyze peroxidase-type of reactions has been well documented 
[6-9]. In addition to the peroxidase behaviour of MP-8, it has been claimed that MP-8 
catalyzes cytochrome P450-like reactions such as the hydroxylation of aniline to give 
4-aminophenol [10] and N-demethylations as well as S-oxygenations [11]. However, 
a major difference between the heme cofactor of (micro)peroxidases and 
cytochromes P450 is the nature of the axial ligand. In classical peroxidases and in 
MP-8, the iron retains histidine as its fifth ligand, whereas in cytochromes P450 the 
fifth ligand is a cysteinate. In the present study, the actual reaction pathway involved 
in the MP-8-catalyzed aromatic hydroxylation was investigated in more detail. This 
was done especially because the formation of 4-aminophenol from aniline in itself 
does not prove that MP-8 can react as a cytochrome P450. 
Previously the hydroxylation of aromatic substrates was reported to be 
observed in a horseradish peroxidase/dihydroxyfumarate/oxygen system but not in 
a H202-driven horseradish peroxidase system [12,13]. The mechanism of this 
horseradish peroxidase-mediated hydroxylation has been demonstrated to be 
completely different from the reaction pathway for the peroxidase activity of the 
enzyme and also different from the reaction pathways for aromatic hydroxylation by 
cytochromes P450 [14]. For instance, the chemistry of high-valent iron-oxo 
compounds I and II is not involved in the horseradish peroxidase/ 
dihydroxyfumarate-mediated aromatic hydroxylations. Instead, the aromatic 
hydroxylation has been reported to proceed through the involvement of superoxide 
anion radicals [14,15]. 
Possible mechanisms for the aromatic hydroxylation that do include a role 
for the high-valent iron-oxo compounds I and II are depicted in Figure 1. The first 
pathway presented is analogous to the so-called oxygen-rebound mechanism 
suggested for cytochrome P450-mediated reactions [16] and proceeds through an 
initial one-electron oxidation of the substrate by compound I to give compound II 
and a substrate radical which easily loses a proton (step A, Figure 1). A so-called 
oxygen-rebound of compound II to the one-electron-oxidized substrate molecule 
(step B, Figure 1) provides a pathway leading to formation of a monooxygenated 
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step F + 0 2 or + H20 
step A 
Por*(FeO) Por(FeO) 
+ H+ 
step D 
PorFe 
step B 
Por>(FeO) H 
3 + 
K- PorFe 
step E 
step C 
Figure 1 Schematic presentation of possible pathways for P450- and peroxidase-type of 
aromatic hydroxylation mechanisms by high-valent iron-oxo compound I (the exact nature and 
electron distribution in the high-valent iron-oxo species presented in this figure still requires 
unequivocal identification). Aniline is taken as an example, similar pathways can be presented for the 
aromatic hydroxylation of a phenol derivative. Steps A-C represent the so-called P450-type oxygen-
rebound mechanism, whereas steps D and E represent the so-called a-O-addition mechanism. 
Peroxidase-type of mechanisms are initiated by initial one-electron oxidation (step A) followed by 
oxygen incorporation through a reaction of the substrate radical with O2 or H2O (step F) [11]. See text 
for further details 
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product, which, upon keto-enol tautomerism (step C, Figure 1), gives rise to the 4-
aminophenol. This pathway presents the so-called oxygen-rebound-type of P450 
mechanism (steps A-C, Figure 1). In contrast, one-electron oxidation of a second 
substrate molecule by compound II would present the mechanism of a classical 
peroxidase reaction, in which dimerization or disproportionation of the two 
substrate radicals results in formation of the peroxidase-type products. 
Another possible P450-type of reaction pathway depicted in Figure 1 is the 
so-called a-O-addition mechanism proceeding by an initial addition of compound I 
to the reactive n-electrons of the aromatic substrate (step D, Figure 1). 
Rearrangement within the a-O-adduct can give rise to the hydroxylated product 
(step E, Figure 1) [16,17]. 
Finally, peroxidase-type of reaction mechanisms can be considered. In these 
peroxidase-type mechanisms, the oxygen atom incorporated in the aromatic 
substrate is not derived from H2O2, but originates from O2 or H2O. They would 
proceed through an initial one electron oxidation of the substrate by compound I 
(step A, Figure 1) followed by reactions of the substrate radicals with O2 or 
H2O/OH- [11] (step F, Figure 1). 
In the present study, it was investigated whether the MP-8/H202-catalyzed 
aromatic hydroxylation proceeds by a peroxidase- or P450-type of reaction 
mechanism. 
Materials and Methods 
Chemicals 
Microperoxidase (MP-8) was prepared by the proteolytic digestion of horse-
heart cytochrome c essentially as described by Aron et al. [3] and concentrations 
were determined by the pyridine chromogen method [3]. Based on HPLC analysis, 
the purity of the MP-8 preparation used in this study is estimated at over 96%. 
Horseradish peroxidase, catalase and superoxide dismutase (SOD) were purchased 
from Boehringer (Mannheim, Germany). Aniline, 4-aminophenol, 2-aminophenol, 3-
fluoroaniline and 2-fluorophenol were obtained from Janssen (Beerse, Belgium). 
Hydroquinone was from Aldrich (Steinheim, Germany), phenol from Merck 
(Darmstadt, Germany), and 2,2'-biphenol and 4,4'-biphenol from Sigma (St. Louis, 
MO). L-Ascorbic acid was obtained from Merck. All substrates were of 98-99% 
purity. Hydrogen peroxide (30%) was from Merck and was diluted in water to 
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obtain the required 50 mM stock solution. All other reagents used were analytical 
grade. H2^02 (2%) was obtained from Icon (Sunnit, New Jersey, USA). 
Incubation conditions 
A typical reaction mixture (total volume of 1.0 ml) contained the following 
(final concentrations): 3.0 mM ascorbic acid, 10 mM aniline (at 10 mM concentration 
of aniline the initial velocity of reaction approaches Vmax/ and is thus optimum for 
the product formation) or 1 mM 2-fluorophenol, 7.5 uM MP-8 or 5 uM horseradish 
peroxidase in 0.1 M potassium phosphate pH 7.6. The reaction mixture was 
preincubated at 37 °C for 2 min. The reaction was started by the addition of 
hydrogen peroxide (2.5 mM final concentration). The reaction was carried out for 1 
min at 37 °C, and either injected directly onto the column or stopped by freezing the 
samples into liquid nitrogen until analysis was performed. 
Aniline and phenol derivatives were added as 1% (v/v) of a 100 times 
concentrated stock solution in dimethyl sulfoxide to give the final concentration 
required. These optimized reaction conditions were chosen on the basis of 
experiments described hereafter (see Results section, Figure 2). 
Chemical determination of the concentration of 4-aminophenol 
For the chemical determination of 4-aminophenol, the reaction was 
terminated by adding 0.8 ml of the reaction mixture to 0.24 ml of 20% (w/v) of 
trichloroacetic acid. After centrifugation for 5 min at 13000 rpm, the supernatant was 
used for the determination of the concentration of 4-aminophenol following the 
procedure previously described [18]. It is important to note that the presence of 
ascorbic acid in the reaction mixture retarded the normal time of colour 
development. For this reason, the absorbance at 630 nm (the e value at 630 nm is 30.5 
mM'lcm'l) was measured after 4 h instead of 1 h incubation at room temperature. A 
calibration curve of 4-aminophenol in the presence of ascorbic acid demonstrated 
that the absorption coefficient of the indophenol was not affected by the addition of 
ascorbic acid. 
19F NMR analysis 
The volume of the reaction mixture was increased to 2.0 ml for samples for 
NMR analysis, and at the end of the incubation 325 U of catalase were added to 
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prevent H2C>2-driven product degradation during the overnight 19p NMR 
measurement. The final NMR sample consisted of 1.60 ml reaction mixture to which 
100 ul of 2 H 2 0 was added for locking the magnetic field and 10 ul 8.4 mM 4-
fluorobenzoic acid was added as internal standard. The samples were made oxygen-
free by four cycles of evacuation and filling with argon. 
l^F NMR analysis was performed on a Bruker AMX 300 spectrometer as 
previously described [19]. Quantification of the fluorinated compounds in the 
samples was performed by comparing the integrals of their 19p NMR resonances of 
4-fluorobenzoic acid used as an internal standard. 
High Performance Liquid Chromatography (HPLC) 
50 ul of sample was injected into a HPLC system equipped with a reverse-
phase Lichrosorb 5RP8 column (100 mm x 3 mm). Ultraviolet detection was 
performed with a Waters 996 diode array detector. Products were identified and 
quantified using commercially available standards (e.g. 4-aminophenol, 2-
aminophenol, 2-2'-biphenol, 4-4'-biphenol, and hydroquinone). Elution was carried 
out at 1.0 ml/min starting with 100% water, maintaining 100% water for 1 min, 
followed by a linear gradient to give 27.7% of methanol in water in 10 min. 
Analysis by Gas Chromatography-Mass Spectrometry (GC-MS) 
For reaction mixtures analysed by GC-MS, the sample volume was increased 
to 10 ml, the MP-8 concentration was increased to 83.8 mM, and in some cases 
H2I802 instead of H2O2 was used. At the end of the incubations, 2600 U of catalase 
were added to prevent possible H202-driven product formation upon further 
processing of the sample. The reaction mixture was extracted four times with 1.0 ml 
of ethyl acetate. The collected ethyl acetate fractions were concentrated by 
evaporation to about 50 ul and the sample thus obtained was used for GC-MS (the 
yield of the ethyl acetate extraction step was more than 98%). 
Of this preparation, a 2-ul or 5 ul-sample was injected into the GC-MS 
system. The gas chromatograph (Hewlett Packard 5890) was equipped with a 30 m x 
250 um capillary DB17 column. The carrier gas was helium at a flow of about 20 
ml/min. A temperature gradient from 70 °C to 200 °C for 13 min was used. The 
column was connected to a Hewlett Packard 5970 mass spectrometer. 
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Results 
Definition of reaction conditions 
Figure 2 shows part of the results of experiments that were performed to 
define appropriate conditions for MP-8-catalyzed aromatic hydroxylation. Aniline 
was used as the model substrate to study product formation as a function of time, 
concentration of H2O2, concentration of MP-8, and pH. The 4-aminophenol 
formation increases linearly with increasing concentration of MP-8 up to at least 100 
mM of MP-8 (data not shown). The dependence of 4-aminophenol formation on the 
concentration of H2O2 is presented in Figure 2a. Initially, the rate of the reaction 
increases with increasing concentration of hydrogen peroxide following saturation 
kinetics. At higher H2O2 concentrations the extent of product formation declines, 
most likely due to the rapid destruction of MP-8 and/or the reaction product by 
H2O2. Additional results (data not shown) demonstrate that the product formation 
is not linear in time. Following a non-linear increase in the first minute, product 
formation is no longer observed, due to inactivation of the mini-catalyst by an as yet 
unidentified mechanism. Similar peroxide-dependent inactivation has been reported 
for other heme-based enzymes [20,21]. 
Figure 2b shows the effect of varying pH on MP-8/H202-catalyzed aniline 4-
hydroxylation. The optimum pH for aniline hydroxylation by MP-8/H2O2 in the 
presence of ascorbic acid is rather broad, in the range pH 7.6-9.5 (Figure 2b). No 
significant difference was observed using different buffers at overlapping pH values. 
At pH values below 6.2, activity was no longer observed. It is interesting to note that 
the rate versus pH profile is consistent with that reported for aniline hydroxylation 
by a cytochrome P450/cumene hydroperoxide system [22]. 
Based on these results, the standard reaction conditions for further 
experiments on the mechanism of the MP-8-catalyzed aromatic hydroxylation were 
chosen (final concentration): 7.5 uM MP-8, 2.5 mM H2O2, 0.1 M potassium 
phosphate pH 7.6, and 1 min incubation time. 
Effect of radical scavengers on MP-8 lH202-mediated aromatic hydroxylation 
To investigate a possible role of superoxide anions (O2 "*) and/or hydroxyl 
(OH*) radicals in the mechanism of MP-8-mediated aromatic hydroxylation, the 
effect of various radical scavengers on the 4-hydroxylation of aniline by MP-8 was 
investigated. The scavengers used were superoxide dismutase, mannitol, ethanol, 
formate, and Tris. All are reported to be effective, at the concentrations used in our 
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Figure 2 Dependence of 4-hydroxyaniline formation on (a) the concentration of H2O2 (10 
mM aniline, 7.5 nM MP-8, 2 mM ascorbic acid, 1 min incubation time, 0.1 M potassium phosphate, pH 
7.6), (b) pH (10 mM aniline, 2.5 mM H2O2, 7.5 jiM MP8, 2 mM ascorbic acid, 1 min incubation time). 
The following buffers (0.1 M final concentration) were used: (x) sodium acetate; (A) potassium 
phosphate; (O) tricin; (+) potassium carbonate. 
experiments, in the inhibition of aromatic hydroxylation by a horseradish peroxidase 
/dihydroxyfumarate system [14,15,23]. The rate constants reported for the reaction 
between the scavengers (mannitol, formate, ethanol) and hydroxyl radicals are in the 
order of 10^ M"l s ' l , indicating that the reaction is almost diffusion limited [15,24]. 
In addition, Mn2+ was used, because Mn2+ was also reported to be capable of 
inhibiting the horseradish peroxidase/dihydroxyfumarate-catalyzed reaction [13,15]. 
The results obtained from these experiments (Table 1) clearly show that none of the 
scavengers tested affects the MP-8/H202-catalyzed aniline hydroxylation either in 
the presence and or in the absence of ascorbic acid. These results indicate that the 
reaction mechanism of the MP-8/H202-catalyzed aromatic hydroxylation is 
different from that of the horseradish peroxidase /dihydroxyfumarate-catalyzed 
reaction and also that the MP-8/H202-catalyzed aromatic hydroxylation is unlikely 
to proceed through formation of O2 "* and/or OH* radicals. 
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The increased amount of 4-aminophenol observed in incubations with ascorbic acid 
as compared to the incubations without ascorbic acid most likely has to be ascribed 
to inhibition by ascorbic acid of the autoxidation of the 4-aminophenol. 
Table 1 The effect of radical scavengers on MP-8/H2O2-
to 4-aminophenol. 
Incubation conditions 
(final concentration of 
MP-8 + ascorbic acid + 
+ M n 2 + 
+ SOD 
+ Mannitol 
+ Ethanol 
+ Formate 
+ Tris 
MP-8 + H2O2 
+ M n 2 + 
+ SOD 
+ Mannitol 
+ Ethanol 
+ Formate 
+ Tris 
scavenger) 
H2O2 
(0.10 mM) 
(0.01 mg/ml) 
(10mM;100mM) 
(10mM;100mM) 
(10 m M ; 100 mM) 
(50 m M ; 100 mM) 
(0.10 mM) 
(0.01 mg/ml) 
(10 m M ; 100 mM) 
(10 m M ; 100 mM) 
(10 m M ; 100 mM) 
(50 m M ; 100 mM) 
catalyzed hydroxylation of aniline 
4-Aminophenol formed 
jiM/min 
54.0 
54.0 
53.5 
52.4; 54.1 
55.2; 56.0 
52.7; 55.6 
55.5; 54.8 
14.5 
14.8 
15.6 
14.5; 15.6 
15.0; 13.8 
15.0; 14.2 
15.5; 14.4 
% 
100 
100 
99.0 
97.0; 100 
102; 104 
97.6; 103 
103; 100 
100 
102 
108 
100;108 
103; 95.2 
103; 97.9 
107; 99.3 
Origin of the oxygen in 4-aminophenol formed from aniline by MP-8 IHJOJ 
Figure 3 shows the mass spectrum of molecular ion region of 4-aminophenol 
observed in an incubation of aniline with MP-8 in either the presence of unlabelled 
H2O2 (Figure 3a) or l ^ o labelled H2^^02 (Figure 3b). Comparison of the two mass 
spectra demonstrates that the mass of the 4-aminophenol is at m / z 109 for the 
incubation with unlabelled H2O2, but increases to m / z 111 when H 2 ^ 0 2 is used. 
The mass spectrum in Figure 3b no longer contains a peak at m / z 109. This proves 
that the oxygen atom incorporated in aniline to give 4-aminophenol originates 
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fully from H2O2. 
In addition, experiments carried out in the absence of molecular oxygen 
further confirmed that the oxygen did not arise from O2, as product formation was 
not inhibited under anaerobic conditions (data not shown). 
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Figure 3 The mass spectra of the molecular ion region of 4-aminophenol obtained from the 
extraction of incubations of aniline with MP-8 in the presence of (a) unlabelled H2O2 or (b) 18<> 
labeUed H21802-
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Effect of ascorbic acid on MP-8/H202-catalyzed peroxidase activity 
Ascorbic acid may inhibit peroxidase reactions by chemically reducing the 
initial substrate radical formed in step A Figure 1, back to the parent substrate 
[25,26]. Therefore, further experiments were performed in order to investigate 
whether ascorbic acid also inhibits peroxidase-type of conversions by MP-8/H2O2. 
For this purpose, the effect of ascorbic acid on model peroxidase-type of reactions 
was first investigated. When ascorbic acid was present in the incubation mixture in 
assays with o-dianisidine, acetaminophen and guaiacol, which are standard 
substrates for the measurement of peroxidase activity [3,8,26], formation of the 
peroxidative products was completely inhibited (data not shown). This capacity of 
ascorbic acid to inhibit peroxidase type of product formation was confirmed in 
incubations with horseradish peroxidase and H2O2. Thus, ascorbic acid is able to 
effectively block peroxidase-type of conversions by H202-driven MP-8 and H2O2-
driven horseradish peroxidase systems. 
These results were further confirmed by additional experiments. First, Figure 
4 shows HPLC chromatograms that demonstrate the effect of ascorbic acid on MP-
8/H202-catalyzed conversion of phenol. In the absence of ascorbic acid (Figure 4a), 
formation of dimeric products was observed which could be identified as 4,4'-
diphenol and 2,2'-diphenol on the basis of added reference compounds. This 
conversion presents a classical peroxidative-type of conversion which could be 
confirmed by the observation that incubation of horseradish peroxidase with H2O2 
and phenol, also in the absence of ascorbic acid, gave rise to an identical HPLC 
pattern and, thus, similar product formation. When ascorbic acid was present in the 
incubations formation of the peroxidative products was no longer observed (Figure 
4b). In contrast, formation of the product resulting from monooxygenation of 
phenol, i.e. hydroquinone, is observed in the presence of ascorbic acid (Figure 4b). 
Table 2 summarizes similar results obtained with aniline and 2-fluorophenol as the 
model substrates. It is clear from Table 2 that, in contrast to MP-8, HRP does not 
catalyze aromatic hydroxylation in the presence or in the absence of ascorbic acid. 
This difference between HRP and MP-8, HRP being unable but MP-8 being able to 
catalyze oxygen incorporation in an aromatic substrate, can most likely be best 
explained by a barrier between the substrate and the high-valent iron-oxo species of 
HRP [20,21]. There are very likely quite different steric constraints in getting to the 
oxygen of the activated iron porphyrin of MP-8 and HRP. The iron complex of MP-8 
is much more accessible than that of HRP and this could in fact explain the lower 
reactivity of HRP. 
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Figure 4 Conversion of phenol by MP-8/H2O2 in (a) the absence and (b) the presence of 
ascorbic acid. The dimerization products were identified on the basis of commercially available 4,4'-
diphenol and 2/2'-diphenol. The peaks of the polymerization products were ascribed on the basis of 
the fact that incubation of phenol with horseradish peroxidase/H202 gave rise to similar complex 
polymeric metabolite patterns as presented in Figure a. The hydroquinone in Figure b was identified 
on the basis of comparison of the UV spectrum and retention time to that of a commercially available 
reference compound. 
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Table 2 Effect of ascorbic acid on MP-8/H2O2 and horseradish peroxidase/H2O2-
mediated conversion of aniline and 2-fluorophenol. Product patterns were analyzed by HPLC. 
Incubation condition Hydroxylated Polymerization 
product formed products3 
uM/min 
aniline + MP-8 + H2O2 14.5 
aniline + MP-8 + H2O2 + ascorbic acid 54.0 
aniline + HRP + H2O2 0 
aniline + HRP + H2O2 + ascorbic acid 0 
2-fluorophenol + MP-8 + H2O2 0 
2-fluorophenol + MP-8 + H2O2 + ascorbic acid 14.8 
2-fluorophenol + HRP + H2O2 0 
2-fluorophenol + HRP + H2O2 + ascorbic acid 0 
a) Polymerization products could not be quantified due to the fact that not all of them were 
characterized. They were identified as polymerization products on the basis of their higher retention 
times compared to the parent compound on reverse-phase HPLC, their formation in a horseradish 
peroxidase/H2C>2 system, and their disappearance in patterns of incubations in the presence of 
ascorbic acid (for an example see Figure 4). 
Effect of ascorbic acid on MP-SIHjOl-catalysed aromatic hydroxylation 
Although ascorbic acid effectively blocked peroxidase-catalyzed 
dimerization of phenol, aniline and 2-fluorophenol (Figure 4, Table 2), incubation of 
these model substrates with MP-8/H2O2 in the presence of ascorbic acid still results 
in the formation of the hydroxylated reaction products. Figure 4b and Figures 5-7 
show this for phenol, aniline, 2-fluorophenol, and 3-fluoroaniline, respectively. 
Figure 5 shows the HPLC chromatogram of the incubation of aniline in the presence 
of MP-8/H2O2 and ascorbic acid. Formation of two hydroxylated products is clearly 
observed which were identified as 4- and 2-aminophenol on the basis of 
commercially available reference compounds. The ratio between the formation of 4-
and 2-aminophenol was 0.85 : 0.15, which is similar to what has been reported for 
cytochrome P450-mediated conversions of aniline [27]. 
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Discussion 
In the present study, the mechanism of MP-8/H202-catalyzed aromatic 
hydroxylation was investigated. The results obtained provide conclusive evidence 
that the MP-8/H202-dependent hydroxylation of the model substrates proceeds by 
a reaction mechanism that differs from the reaction pathway proposed for the 
hydroxylation reaction of aromatic compounds mediated by a horseradish 
peroxidase/dihydroxyfumarate system. This conclusion is derived from the 
following observations of the present study. First, the MP-8-catalyzed hydroxylation 
requires H2O2 while H2O2 is unable to support horseradish peroxidase-mediated 
hydroxylation. Second, the radical scavengers (Table 1) had no effect on the MP-8-
catalyzed hydroxylation reaction, whereas they are known to inhibit, at the 
concentrations used in our investigations, the horseradish peroxidase/ 
dihydroxyfumarate-catalyzed hydroxylation [14,15] and are known to be extremely 
effective hydroxyl and superoxide anion radical scavengers [15]. Third, manganese, 
a powerful inhibitor of peroxidase hydroxylation [13,15,23], shows no effect on the 
MP-8/H202-catalyzed hydroxylation. 
In additional experiments, ascorbic acid was demonstrated to fully inhibit 
horseradish peroxidase-catalyzed-type of conversions of model compounds like 
guaiacol, o-dianisidine, and also of aniline and phenol. Such an inhibitory effect of 
ascorbic acid on peroxidase reactions is in accordance with results reported by Potter 
et al. [26], who used ascorbic acid to prevent the polymerization reaction of 
acetaminophen catalyzed by horseradish peroxidase, and also with studies reported 
by Subrahmanyam and O'Brien [25] who reported inhibition of horseradish 
peroxidase/H202-mediated oxidation of phenol to reactive DNA binding products 
by ascorbic acid. Thus, the results with ascorbic acid are an indication that the 
aromatic hydroxylation might not result from peroxidase-type reaction chemistry. 
Experiments with l^O-labelled H2^^02 further support this conclusion, because all 
oxygen incorporation into aniline to give 4-aminophenol was demonstrated to 
originate from H2^^02- In addition, the H2^^02 experiment excludes that the 
reactive entity formed from H2^^02 and MP-8 exchanges its oxygen with H2O or O2 
on the time scale of the experiments. Together, the results of the present study 
strongly support a mechanism of aromatic hydroxylation by MP-8/H2O2 through a 
P450-type of oxygen-transfer mechanism and not through a peroxidase-type reaction 
chemistry. 
This result of the present study implies that the nature of the axial ligand of 
the heme cofactor, which is histidyl in MP-8 but a cysteinate in the cytochromes 
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P450, does not play a dominant role in setting the type of reaction chemistry 
possible. Although MP-8 has a histidyl axial ligand, the results of the present study 
clearly show that the catalyst is able to support aromatic hydroxylations by a 
cytochrome P450 oxygen-transfer mechanism rather than a peroxidase-type reaction 
chemistry in which oxygen incorporated in the structural substrate originates from 
O2 or H2O [11]. This conclusion would be in agreement with conclusions from other 
studies in which the hypothesis is put forward that a barrier between the substrate 
and the oxygen of the high-valent iron-oxo species of HRP is responsible for the fact 
that horseradish peroxidase and other classical peroxidases differ from the 
monooxygenases in that they do not incorporate the oxygen of their high-valent 
iron-oxo intermediate into the product [20,21,29]. Another possibility would be that 
the type of ligand is not decisive for the type of reaction chemistry that can occur, 
but influences the ratio between the possible different reaction pathways. Thus, a 
histidyl ligand may favour peroxidase-type reaction chemistry over P450-type of 
oxygen transfer chemistry, whereas a cysteinate ligand may favour the latter. 
Clearly, further studies are required to solve this problem to a further extent. 
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Chapter 6 
The occurrence of the NIH shift upon the cytochrome P450-catalysed 
in vivo and in vitro aromatic ring hydroxylation of fluorobenzenes 
J. Koerts, A.E.M.F. Soffers, A. de Jager and I.M.C.M. Rietjens 
Chemical Research in Toxicology, submitted. 
Abstract 
The in vivo cytochrome P450-catalysed aromatic hydroxylation of a series of 
fluorobenzenes was investigated with special emphasis on the importance of the 
fluorine NIH shift. The results obtained demonstrate a minor role for the NIH shift 
in the metabolism of the fluorobenzenes to phenolic metabolites in control male 
Wistar rats. These results are different from data reported in the literature for their 
chlorinated analogues for which significant involvement of the NIH shift has been 
reported [Kohli et al. (1976) Can. J. Biochem. 54, 203-208; Chu et al. (1984) J. Toxicol. 
Environ. Health 13, 777-786; Schwartz et al. (1987) J. Toxicol. Environ. Health 22,341-
350]. Additional experiments presented in this paper provide an explanation for this 
discrepancy. Assuming that NIH shifted metabolites are likely to originate from 
arene oxide intermediates the actual in vivo occurrence of the NIH shifted 
metabolites will be -at least in part- dependent on i) the ease of arene oxide 
rearrangement to give the ring-opened intermediate preceding the NIH shifted 
phenol and ii) the ease and relative rate of the reaction of the arene oxide in 
competing biotransformation pathways such as GSH conjugation. 
Results of the present study show that the formation of NIH shifted phenolic 
metabolites from fluorine substituted benzenes is hampered relative to the 
corresponding chlorinated analogues. Calculations indicate that the reduced 
tendency of fluorine substituted benzenes to undergo an NIH shift can -at least in 
part- be ascribed to i) the reduced chance of fluorine rather than chlorine arene oxide 
intermediates on ring opening generating NIH shifted phenolic metabolites and ii) 
the provision of an alternate pathway by the more efficient GSH conjugation of 
fluorine over chlorine containing arene oxides. 
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Introduction 
During mammalian metabolism aromatic compounds can be converted to 
ring hydroxylated metabolites which can subsequently be conjugated and excreted 
from the body. Upon hydroxylation at an aromatic position the substituent 
originally present at this aromatic carbon atom might shift to the carbon atom 
adjacent to the site of hydroxylation. This phenomenon is believed to proceed via 
arene oxides and/or keto intermediates, and has been termed the NIH shift (Figure 
1) [1-4]. The NIH type of migration has not only been reported for substituents like 
deuterium and tritium, but also for halo- and alkyl substituents [1-3]. The extent to 
which a substituent actually shifts upon aromatic hydroxylation is known to be 
dependent both on the nature of the substituent itself and also on the nature of other 
substituents that may be present in the molecule [2]. For example, the percentage of 
migration of a deuterium or tritium is generally higher than that of a chlorine 
substituent. Similarly, the deuterium shift observed upon C4 hydroxylation of 4-
deuteromethoxybenzene is significantly higher than the deuterium shift reported for 
the C4 hydroxylation of 4-deuteroaminobenzene, revealing the effect of a para 
substituent [2,5,6]. 
O OH 
(FeO)3* 
Fe3+ 
Figure 1 Schematic presentation of the reaction pathway proposed for the cytochrome P450-
catalysed formation of NIH shifted phenolic metabolites through arene oxide intermediates. The 
pathway presented is that for the reaction which predominates at physiological pH where ring 
opening of the arene oxide intermediate to the carbonium ion is suggested to be the rate-limiting step 
in the formation of NIH shifted phenolic metabolites [1-4], 
Generally, the importance of the NIH shift of halogen substituents in the 
course of aromatic hydroxylation is less well documented than the NIH shift of 
deuterium or tritium substituents. Studies on the conversion of 4-halogenated 
phenylalanines to 4-hydroxylated metabolites by the enzyme phenylalanine 
hydroxylase report migration of chlorine and bromine substituents, resulting in 
formation of 3-substituted tyrosines in contrast to fluorine or iodine substituents 
which were preferentially lost from the molecule [7,8]. For cytochrome P450-
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catalysed hydroxylation of halogenated aromatic compounds evidence of the NIH 
shift has been presented primarily for substrates containing chlorine or bromine 
substituents [2;9-14]. The migration of fluorine or iodine substituents is far less well 
documented. Based on in vitro studies of the cytochrome P450-catalysed 4-
hydroxylation of 4-fluoroaniline, 4-fluoroacetanilide and 4-iodoanisole it has even 
been reported that, by analogy to the phenyl alanine hydroxylase reaction, an iodine 
or fluorine substituent is preferentially lost from the molecule rather than giving rise 
to an NIH shift [15-18]. However, the inability of a fluorine substituent to give rise to 
an NIH shift in a cytochrome P450-catalysed conversion has only been reported for 
4-fluoroaniline and 4-fluoroacetanilide so far [15,16]. Since, the involvement of the 
NIH shift is also dependent on other substituents present in the aromatic ring [2], it 
is uncertain whether the results obtained for the 4-fluorinated aniline derivatives are 
indicative of a general inability of a fluorine substituent to undergo the 
rearrangement. This uncertainty becomes even stronger if one takes into account the 
mechanism suggested for the cytochrome P450-catalysed C4 hydroxylation and 
subsequent dehalogenation of 4-fluorinated anilines and phenols. The presence of a 
substituent at CI with electron donating capacities increases the possibilities to 
eliminate the fluorine as a fluoride anion [19,20]. Thus, the fact that the cytochrome 
P450-catalysed hydroxylation of 4-fluoroaniline and 4-fluoroacetanilide is 
preferentially accompanied by fluoride anion elimination instead of by an NIH shift, 
may be ascribed to the electron donating character of the amino or acetamido 
substituent opposite the fluorine, instead of to the inability of the fluorine to 
rearrange to the adjacent carbon atom. 
Based on these considerations, the aim of the present study was to 
investigate the possible (in)ability of a fluorine substituent to give rise to an NIH 
shift in cytochrome P450-catalysed conversions to a greater extent when a series of 
compounds without substituents that would favour fluoride anion elimination was 
used. The following model compounds were used, 1,4-difluorobenzene, 1,2,3-
trifluorobenzene, 1,2,4-trifluorobenzene, 1,2,3,4-tetrafluorobenzene and 1,2,3,5-
tetrafluorobenzene. This series of fluorinated benzenes was chosen because their 
chlorinated analogues have been reported to be converted to NIH shifted phenolic 
metabolites to a significant extent upon their in vivo and/or in vitro conversion [9-14]. 
A second reason to use these fluorinated benzenes is that, in contrast to an amino, 
acetamido or phenolic moiety, the additional fluorine substituents in the molecule 
are unable to support an efficient fluoride anion elimination [21]. 
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Materials and Methods 
Chemicals 
1,4-Difluorobenzene, 1,2,3-trifluorobenzene, 1,2,4-trifluorobenzene, 1,2,3,4-
tetrafluorobenzene, 1,2,3,5-tetrafluorobenzene, 1,3,5-trifluorobenzene, 2,3-difluoro-
phenol, 2,4-difluorophenol, 2,6-difluorophenol, 2,3,6-trifluorophenol, 2,3,5-trifluoro-
phenol, 2,3,4-trifluorophenol, 3,4,5-trifluorophenol and 2,3,5,6-tetrafluorophenol 
were obtained from Fluorochem (Derbyshire, United Kingdom). 
2,5-Difluorophenol and 3,4-difluorophenol were obtained from Aldrich 
Chemie (Steinheim, Germany). 4-Fluorophenol was purchased from Acros Chimica 
(Beerse, Belgium). 
In vivo exposure of rats 
Male Wistar rats (300-400 g) were exposed to 200 umol of the desired 
fluorobenzene, administered in olive oil by oral injection. After dosing, 0-24 h urine 
samples were collected. 
For glutathione (GSH) depletion the rats (230 g) were pretreated with 
buthionine sulfoximine (Aldrich Chemie, Steinheim, Germany) as follows [22]. Rats 
were exposed to 4 mmol buthionine sulfoximine/kg i.p. and 2 mmol buthionine 
sulfoximine/kg i.v. (administered in 0.9% NaCl) at 6 h and 1 h respectively before 
oral dosage of 200 umol of 1,4-difluorobenzene. After dosing of 1,4-difluorobenzene, 
0-16 h urine samples were collected. In contrast to the 0-24 h urine for non-depleted 
rats, the 0-16 h urine was taken because a previous study showed that liver tissue 
GSH levels of mice were restored between 10 and 24 h after administration of 
buthionine sulfoximine [22]. For comparison, the 0-16 h urine of a control rat 
exposed to 1,4-difluorobenzene was collected as well. 
Analysis of urine samples 
Urine samples were analysed by 19p NMR after 1:1 dilution in 0.2 M 
potassium phosphate pH 7.6. Enzymatic hydrolysis was carried out as described 
previously [23] using arylsulphatase/p-glucuronidase from Helix pomatia 
(Boehringer Mannheim, Germany). Samples were routinely made oxygen-free by 
four cycles of evacuation and filling with argon to prevent autoxidation of the 
phenol derivatives. 
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Preparation of microsomes 
Microsomes were prepared from the perfused livers of male Wistar rats (300-
400 g) either untreated or treated with isosafrole as described before [16]. 
Cytochrome P450 content of the microsomes was measured as described by 
Omura and Sato [24]. 
Microsomal incubations 
Cytochrome P450 dependent conversion was studied in vitro in microsomal 
incubations containing (final concentrations) 0.1 M potassium phosphate pH 7.6, 2 
mM microsomal cytochrome P450,1 mM of the benzene added as 1% (v/v) of a 0.1 
M cold stock solution in acetone, 1 mM ascorbic acid to prevent autoxidation of the 
hydroxylated reaction products and 1.0 mM NADPH. The reaction was started by 
the addition of the benzene and NADPH. The total reaction volume was 20 ml and 
the reaction was carried out at 37 °C for 10 min in a closed reaction vessel to prevent 
evaporation of the substrate. The reaction was terminated by the addition of 1 ml 12 
N HC1 and 5 ml ethyl acetate. Upon mixing and centrifugation (10 min 3000 rpm) the 
ethyl acetate layer was collected and 1.6 ml of the ethyl acetate extract was analysed 
by 19p NMR as described hereafter. 
Purification of phenol hydroxylase from Trichosporon cutaneum 
Phenol hydroxylase was isolated from the yeast Trichosporon cutaneum 
essentially as described by Sejlitz and Neujahr [25]. The final preparation had a 
specific activity of 5 U/mg protein. 
Incubations with isolated phenol hydroxylase 
Phenol hydroxylase incubations were carried out in closed reaction vessels to 
prevent evaporation of the fluorophenol and contained (final concentrations) 50 mM 
potassium phosphate pH 7.6, 1 mM (poly)fluorophenol, added from 100 times 
concentrated stock solution in dimethyl sulfoxide, 0.1 mM phenol hydroxylase, 0.1 
mM EDTA, 10 mM flavin adenine dinucleotide (FAD) and 1 mM ascorbic acid to 
prevent autoxidation of the (poly)fluorocatechols formed. The incubations were 
started by the addition of 0.17 mM (final concentration) NADPH. Reactions were 
carried out at 25 °C for 15 min and terminated by freezing the samples in liquid 
nitrogen. 
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19FNMR measurements 
l^F NMR measurements were performed on a Bruker AMX 300 spectrometer 
as previously described [23]. Between 1500 and 100,000 scans were recorded, 
depending on the concentrations of the fluorine containing compounds and the 
signal to noise ratio required. The urinary sample volume was 1.71 ml containing 100 
ul 2H20 for locking the magnetic field and 10 ul of a 8.4 mM 4-fluorobenzoic acid 
solution, added as internal standard. 
The ethyl acetate extracts from the microsomal incubations were analysed 
using a coaxial insert containing a known amount of the internal standard dissolved 
in 2H20, instead of adding ^H20 and the internal standard to the 1.6 ml ethyl 
acetate extract in the NMR tube. Chemical shifts are reported relative to CFCI3. 
Concentrations of the various metabolites could be calculated by comparison of the 
integrals of the 19p NMR resonances of the metabolites to the integral of the l^F 
NMR resonance of the internal standard, 4-fluorobenzoic acid. 
Proton-coupled, proton-decoupled and HOMO-decoupling 19p NMR of 
urine samples were acquired on a Bruker DPX 400 NMR spectrometer at 303 K. 
Spectra were recorded using 5 us pulses. About 1000 scans were recorded for each 
spectrum. 
Molecular orbital calculations 
Semi-empirical molecular orbital calculations were performed on a Silicon 
Graphics Indigo^ using InsightH (Biosyn, San Diego, CA, USA). The PM3 
Hamiltonian from the MOP AC program was used. All calculations were carried out 
with PRECISE criteria and for all calculations the self-consistent field (SCF) was 
achieved. Geometries were optimised for all bond lengths, bond angles and torsion 
angles using BFGS criteria. The outcomes of the semi-empirical calculations on 
molecules in vacuum are related to the electronic characteristics of the substrates in 
the active site of cytochromes P450 or GSH S-transferases. Due to solvation effects 
and a different dielectric constant, the intrinsic properties of the compounds might 
be influenced upon binding to the active site. However, it is assumed that this 
phenomenon will not influence the relative differences of parameters between a 
series of closely related compounds or between similar centres within one molecule, 
to a significant extent. Electrophilic reactivity of the halogenated arene oxides was 
characterised by the calculated energy of their LUMO [26]. Heats of formation 
calculated for formation of the ring-opened intermediate from the arene oxide 
precursor of the benzene derivatives (Figure 1), i.e. AHF values, were calculated as 
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follows. The heat of formation of the arene oxides as well as of the ring-opened 
intermediates were calculated. The heat of formation of an arene oxide was then 
substracted from the heat of formation of the ring-opened intermediate leading to a 
AHF value. The relative AHF values, i.e. AAHF, were obtained by setting the lowest 
AHF value to zero. The AAHF values, calculated from the computer program in kcal 
per mole were converted to eV to provide values in the same unit as used for the 
E(LUMO). 
Frontier electron densities for electrophilic attack on the rc-electrons of the aromatic 
ring were calculated according to the equation of Fukui et al. [27]. In this equation 
the contribution of the HOMO (highest occupied molecular orbital) and the HOMO-
1 (highest occupied molecular orbital below the HOMO) are both taken into account. 
Results 
In vivo conversion offluorobenzenes to phenolic metabolites 
Figure 2 presents the l^F NMR spectra of the arylsulphatase/p-
glucuronidase treated 0-24 h urine from rats exposed to a) 1,4-difluorobenzene, b) 
1,2,3-trifluorobenzene, c) 1,2,4-trifluorobenzene, d) 1,2,3,4-tetrafluorobenzene and e) 
1,2,3,5-tetrafluorobenzene. l^F NMR resonances of the fluorophenols were identified 
on the basis of i) added reference compounds, ii) literature data [28], iii) analysis of 
proton-coupled and proton-decoupled 19p NMR spectra and/or iv) incubation of 
fluorophenols with purified phenol hydroxylase from the yeast Trichosporon 
cutaneum, an enzyme known to catalyse hydroxylation of phenols at the position 
ortho with respect to the hydroxyl moiety [25] (see figure legend for further details). 
Table 1 presents the 19p NMR ppm values of the identified phenolic metabolites 
together with the quantified phenolic metabolite patterns as obtained from the l^F 
NMR spectra of the 0-24 h urine samples (n=2) (Figure 2). Urinary recoveries (0-24 h) 
were between 65 and 75% of the dose administered and phenolic metabolites 
resulting from hydroxylation at a non-halogenated position make up a major part 
(36 to 75%) of the total amount of fluorinated metabolites (Figure 2 and Table 1). 
Phenolic metabolites resulting from hydroxylation accompanied by an NIH shift of a 
fluorine substituent are generally observed if at all to a very limited extent (< 1.2% of 
the total amount of fluorinated metabolites, and < 3.3% of all identified phenolic 
metabolites) (Table 1). Hydroxylation accompanied by defluorination was also 
observed to only a limited extent (generally < 1.9% of all identified metabolites, and 
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Figure 2 " F NMR spectra of the arylsulphatase/P-glucuronidase treated 0-24 h urine from 
male Wistar rats exposed to (a) 1,4-difluorobenzene, (b) 1,2,3-trifluorobenzene, (c) 1,2,4-
trifluorobenzene, (d) 1,2,3,4-tetrafluorobenzene and (e) 1,2,3,5-tetrafluorobenzene. 19F NMR 
resonances were identified on the basis of i) added reference compounds, ii) literature data [28], iii) 
analysis of proton-coupled and proton-decoupled 19F NMR spectra or iv) incubation of fluorophenols 
with purified phenol hydroxylase from the yeast Trichosporon cutaneum, an enzyme known to catalyse 
hydroxylation of phenols at the position ortho with respect to the hydroxyl moiety [25]. In Figure 2a 
the arrow labelled 1) marks the resonance position of 4-fluorophenol, the metabolite that would result 
from hydroxylation accompanied by dehalogenation. In Figure 2b the arrows mark the resonance 
positions of 1) 2,3,6-trifluorophenol (the third resonance of this phenol at -164.0 ppm is masked by 
one of the resonances of 2,3,4-trifluorophenol), 2) 2,3-difluorophenol and 3) 2,6-difluorophenol, 
metabolites that (would) result from hydroxylation accompanied by an NIH shift or dehalogenation. 
In Figure 2c the arrows mark 1) 2,4,6-trifluorophenol, 2) 2,3,4-trifluorophenol, 3) 2,4-difluorophenol, 
4) 2,3,5-trifluoro-4-hydroxyphenol and 5) 2,3,5-trifluoro-6-hydroxyphenol, metabolites that would 
result from hydroxylation accompanied by an NIH shift or dehalogenation. Both resonance positions 
of 2,5-difluorophenol (-122.3 and -147.2 ppm) are masked by peaks from unidentified metabolites that 
do not belong to phenolic metabolites. In Figure 2d the arrows mark the resonance positions of 1) 
2,3,4,6-tetrafluorophenol and 2) 2,3,6-trifluorophenol, metabolites that would result from 
hydroxylation accompanied by an NIH shift or dehalogenation. In Figure 2e the arrows labelled 1) 
marks 2,3,4,5-tetrafluorophenol, the metabolite that would result from hydroxylation accompanied by 
an NIH shift. The resonance marked "IS" is from the internal standard 4-fluorobenzoic acid. 
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Table 1 Phenolic metabolite pattern of rats exposed to different fluorobenzenes as 
determined in the urine by *"F NMR (n=2). Chemical shifts of the phenols were determined in urine 
1:1 diluted in 0.2 M potassium phosphate pH 7.6. Chemical shifts are reported relative to CFCI3. NIH 
shifted and defluorinated metabolites are indicated with (NIH) and (-F) respectively. 
fluorobenzene 
possible metabolite 
1.4-difluorobenzene 
2,5-difluorophenol 
2,4-difluorophenol (NIH) 
4-fluorophenol (-P) 
2,5-difluoro-6-dihydroxyphenol 
2,5-difluoro-4-dihydroxyphenol 
total 
chemical shift 
(ppm) 
-122.3; -147.2 
-126.1; -137.3 
-129.1 
-144.7" 
-144.7" 
% of total 
fluorine 
containing 
metabolites 
72.6 ±0.4 
0.6 ±0.2 
<0.1 
2.1 ±0.4° 
2.1 ± 0.4fl 
75.4 ± 1.0 
%of 
identified 
phenolic 
metabolites 
96.5 
0.7 
<0.1 
2.7° 
2.7fl 
100 
1.2.3-trifluorobenzene 
2,3,4-trifluorophenol 
3,4,5-trifluorophenol 
2,3,6-trifluorophenol (NIH) 
2,3-difluorophenol (-F") 
2,6-difluorophenol (-F") 
2,3,4-trifluoro-6-hydroxyphenol 
total 
-152.5 ; 
-139.6; 
-144.3; 
-142.8; 
-138.9 
-153.6; 
-161.9; 
-177.6 
-148.4; 
-166.9 
-162.0; 
-164.5 
-164.0 
-176.0 
26.0 ± 1.1 
10.3 ±0.4 
<0.1 
0.4 ±0.1 
<0.1 
1.5 ± 0.1 
38.4 ± 1.7 
67.7 
26.8 
<0.3 
1.0 
<0.3 
3.9 
100 
a
 The resonance is due to one of the two possible dihydroxylated products. 
" The presence of 2,5-difluorophenol could not be determined because its resonance positions were 
masked by resonances from unidentified metabolites. 
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Table 1 -continued-
fluorobenzene 
possible metabolite 
1.2.4-trifluorobenzene 
2,3,6-trifluorophenol 
2,4/5-trifluorophenol 
2,3,5-trifluorophenol 
2,3,4-trifluorophenol (NIH) 
2,4,6-trifluorophenol (NIH) 
3,4-difluorophenol (-F") 
2,5-difluorophenol (-F") 
2,4-difluorophenol (-F) 
2,3,5-trifluoro-4-hydroxyphenol 
2,3,5-trifluoro-6-hydroxyphenol 
total 
1.2.3.4-tetrafluorobenzene 
2,3,4,5-tetrafluorophenol 
2,3,4,6-tetrafluorophenol (NIH) 
2,3,4-trifluorophenol (-F") 
2,3,6-trifluorophenol (-F-) 
total 
1.2.3.5-tetrafluorobenzene 
2,3,4,6-tetrafluorophenol 
2,3,4,5-tetrafluorophenol (NIH) 
2,3,5,6-tetrafluorophenol (NIH) 
3,4,5-trifluorophenol (-F") 
2,3,5-trifluorophenol (-F-) 
2,4,6-trifluorophenol (-F") 
total 
chemical shift 
(ppm) 
-144.3; -148.4; -164.0 
-139.4; -143.6; -146.9 
-121.9;-141.6;-172.7 
-152.5; -161.9; -164.5 
-123.0; -136.6 
-140.9; -154.2 
-122.3; -147.2 
-126.1; -137.3 
-144.4; -162.2; -169.7 
-146.0; -153.1; -171.5 
-147.5; -163.8; -169.3; -179.2 
-144.5;-159.8;-162.6;-171.4 
-152.5;-161.9;-164.5 
-144.3; -148.4; -164.0 
-144.5; -159.8; -162.6; -171.4 
-147.5;-163.8;-169.3;-179.2 
-149.3; -170.6 
-139.6; -177.6 
-121.9;-141.6;-172.7 
-123.0; -136.6 
% of total 
fluorine 
containing 
metabolites 
10.2 ±0.1 
20.1 ± 1.3 
8.6 ±0.0 
<0.1 
<0.1 
1.8 ±0.4 
_b 
<0.1 
<0.1 
<0.1 
41.2 ±1.8 
49.0 ±0.4 
<0.1 
1.6 ±0.0 
<0.1 
50.8 ± 0.4 
29.2 ± 1.8 
<0.1 
1.1 ± 0.1 
3.0 ±0.1 
1.7 ±0.1 
1.2 ±0.1 
36.3 ±2.2 
%of 
identified 
phenolic 
metabolites 
24.8 
48.8 
20.9 
<0.2 
<0.2 
4.4 
_b 
<0.2 
<0.2 
<0.2 
100 
96.5 
<0.2 
3.1 
<0.2 
100 
80.4 
<0.3 
3.0 
8.3 
4.7 
3.3 
100 
141 
Chapter 6 
< 4.6% of all identified phenolic metabolites). Only for 1,2,3,5-tetrafluorobenzene was 
formation of small amounts of defluorinated phenolic metabolites observed; 5.9% of 
the total amount of fluorinated metabolites, and 16.3% of all identified phenolic 
metabolites. 
I ^ F NMR analysis of the parent fluorobenzenes demonstrated that the presence of 
NIH shifted or dehalogenated metabolites was not the result of other fluorobenzene 
or fluorophenol impurities in the parent compounds (data not shown). 
The unidentified resonances in Figure 2 do not represent phenolic metabolites but 
they most likely belong to mercapturic acid metabolites or other sulphur containing 
metabolites. This follows from the fact that i) their resonance positions did not 
change upon enzyme treatment of the urine and ii) these type of derivatives are well 
known to be formed upon in vivo metabolism of halogenated benzenes [29-31]. 
However, as the objective of the present paper was the investigation of the 
occurrence of the NIH shift upon the formation of phenolic metabolites, these 
resonances were not further identified at this stage. 
Altogether, the data presented in Figure 2 and Table 1 clearly indicate the 
absence of a significant amount of NIH shifted phenolic metabolites formed from the 
fluorobenzenes. 
In vitro conversion of fluorobenzenes to phenolic metabolites 
In addition to the in vivo studies the possible formation of NIH shifted 
phenolic fluorobenzene metabolites was also investigated in in vitro microsomal 
studies. Only 1,4-difluorobenzene gave detectable levels of conversion in the 
microsomal incubations. The lower reactivity of the tri- and tetrafluorobenzenes 
toward microsomal conversion can be explained by the decreased nucleophilicity of 
these substrates, reducing the rate of reaction between the activated cytochrome 
P450(FeO)3+ and their 7t-systems [32]. 
Figure 3 presents the 1°F NMR spectrum of a microsomal incubation with 
1,4-difluorobenzene. The results from incubations with microsomes from isosafrole 
pretreated rats are presented because they show a higher rate of conversion than the 
control microsomes, but results with control microsomes were comparable. In 
contrast to the results obtained in vivo, formation of a significant amount of the NIH 
shifted 2,4-difluorophenol can be observed, amounting to 26.8 ± 1.4% (n=4) of the 
total amount of phenolic metabolites (Figure 3). In vivo this percentage amounted to 
less than 1% of the total amount of phenolic metabolites (Table 1). 
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Figure 3 l"p NMR spectra of the ethyl acetate extract of a microsomal incubation with 1,4-
difluorobenzene. The resonance marked "IS" is from the internal standard 4-fluorobenzoic acid. The 
resonances marked with an asterisk were also present in samples from blank incubations carried out 
in the absence of NADPH. 
The effect ofGSH on the extent of the fluorine NIH shift for the in vitro metabolism 
of 1,4-difluorobenzene 
The observed discrepancy between the relative importance of the fluorine 
NIH shift in vivo and in vitro was further investigated by performing an in vitro 
microsomal incubation in the presence of liver cytosol, containing glutathione S-
transferases, and GSH. The rationale behind this experiment was that a possible 
efficient GSH conjugation of the arene oxide intermediates could explain the minor 
role of NIH shifted phenolic metabolites upon in vivo metabolism [2,3]. In 
microsomal incubations such reaction pathways are absent giving rise to possibilities 
for the conversion of the arene oxides to NIH shifted phenolic metabolites. Thus, in 
vitro microsomal incubations in the presence of GSH and cytosol were performed. 
l^F NMR analysis from such microsomal incubations of 1,4-difluorobenzene in the 
presence of 1 mM GSH and liver cytosol fraction (l^F NMR spectrum not shown) 
showed that the amount of the NIH shifted 2,4-difluorophenol amounted to 19.9 ± 
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1.6% (n=6) of the total amount of phenolic metabolites. Compared to the microsomal 
incubations of 1,4-difluorobenzene without GSH and cytosol, which amounted to 
26.8 ± 1.4% (n=4), this implies a relative reduction in the percentage of NIH shifted 
phenolic metabolites by around 26%. 
The effect of GSH on the extent of the fluorine NIH shift for the in vivo metabolism 
of 1,4-difluorobenzene 
The possible influence of GSH conjugation on the formation of NIH shifted 
phenolic metabolites was further investigated by studying the metabolism of 1,4-
difluorobenzene in GSH-depleted rats. The 19p NMR spectra of the 
arylsulphatase/p-glucuronidase treated urine samples of GSH-depleted rats exposed 
to 1,4-difluorobenzene were compared to the l^F NMR urine spectra of non-
depleted rats exposed to 1,4-difluorobenzene. The results show that for the GSH-
depleted rats the amount of the NIH shifted phenolic metabolite 2,4-difluorophenol 
was 2.8 ± 0.1% of the total phenolic metabolites while this amount was 1.0 ± 0.0% for 
the non-depleted rats, indicating an almost 3-fold increase in the absolute amount of 
NIH shifted phenolic metabolites due to the partial GSH depletion. 
Calculated reactivity for an NIH shift and GSH conjugation 
Finally, computer calculations were performed to investigate possible 
reasons underlying the reduced probability of forming NIH shifted phenolic 
metabolites from fluorobenzenes compared to chlorobenzenes [9-11]. At 
physiological pH, the formation of NIH shifted phenolic metabolites is postulated as 
proceeding by the pathway presented in Figure 1 [1-4]. In this reaction pathway 
formation of the carbonium ion, i.e. the ring-opened intermediate, from the arene 
oxide intermediate, is believed to be the rate-limiting step [2,3]. Table 2 presents the 
calculated relative heats of formation of the ring-opened intermediates from the 
arene oxide precursors. Results in Table 2 show that the heat of formation for the 
ring opening of the arene oxide intermediate for fluorine derivatives is in all cases 
energetically more costly than it is for the chlorine analogues. 
Table 2 also presents the E(LUMO) values of the various arene oxides. This 
parameter has been demonstrated to be representative of the relative rate and ease of 
the reaction of the arene oxide with GS" [33,34]. The computational results indicate 
that rates of GS" conjugation are predicted to be faster for fluorine than for chlorine 
substituted arene oxides. 
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Table 2 Relative heat of formation of the ring-opened intermediate from the 
precursor and the E(LUMO) 
benzenes. 
arene oxide 
1,4-dihalobenzene 
1,2-arene oxide 
1,2,3-trihalobenzene 
3,4-arene oxide 
1,2,4- trihalobenzene 
2,3-arene oxide 
1,2,4-trihalobenzene 
3,4-arene oxide 
1,2,4-trihalobenzene 
4,5-arene oxide 
1,2,4-trihalobenzene 
1,6-arene oxide 
1,2,3,4-tetrahalobenzene 
4,5-arene oxide 
1,2,3,5-tetrahalobenzene 
3,4-arene oxide 
1,2,3,5-tetrahalobenzene 
4,5-arene oxide 
value of this arene oxide for a 
AAHF for formation of 
the ring-opened 
intermediate from the 
series fluorine or chlorine 
E(LUMO) arene 
(eV) 
arene oxide precursor 
(eV) 
nature of haloeen substiruent 
F 
0.62 
0.69 
0.66 
0.49 
0.75 
0.43 
0.56 
0.73 
0.88 
CI 
0.35 
0.11 
0.25 
0.43 
0.40 
0.00 
0.02 
0.31 
0.48 
F 
-0.84 
-1.15 
-1.13 
-1.15 
-1.17 
-1.15 
-1.47 
-1.45 
-1.47 
arene oxide 
containing 
oxide 
CI 
-0.66 
-0.85 
-0.89 
-0.88 
-0.86 
-0.88 
-1.03 
-1.07 
-1.05 
Finally, a difference in the chances for attack by the (FeO)3+ species on a chlorinated 
respectively a fluorinated aromatic carbon centre might be another reason 
underlying the greater tendency of a chlorine than a fluorine to give an NIH shift. To 
investigate this at least to some extent parameters that may influence the chance on 
such an (FeO)3+ attack were calculated. In a previous study it was shown that the 
cytochrome P450-catalysed regioselectivity of aromatic ring hydroxylation of a series 
of fluorobenzenes was predicted well by the frontier orbital density 
(HOMO/HOMO-1 density) on an aromatic carbon centre indicating this to be a 
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parameter of influence [28]. In addition, in theory, reactivity of a carbon centre might 
also be influenced by its Coulombic interactions with the (FeO)3+ species on the 
chances for (FeO)3+ attack. Therefore, the frontier orbital and net charge density on 
the ring carbon atoms of the tested series of fluorobenzenes and their chlorinated 
analogues were calculated (Table 3). The results in Table 3 show that a chlorinated 
carbon centre is less positively, even negatively, charged than a fluorinated carbon 
centre. Taking into account the negative partial charge of the oxygen in a cysteinate-
coordinated Por+Fe(IV)0 species [35], these data indicate that Coulombic 
interactions can be expected to favour an iron-oxene attack on a fluorinated over a 
chlorinated aromatic carbon atom. Table 3 presents also the frontier orbital density 
on the carbon centres of a series of halobenzenes. From these data it can be 
concluded that not only the Coulombic factor, but also the frontier orbital parameter 
favour an iron-oxene attack on a fluorinated over a chlorinated carbon centre. 
Discussion 
In the present study the importance of the fluorine NIH shift for the 
cytochrome P450-catalysed aromatic ring hydroxylation of fluorobenzenes was 
investigated. The fluorobenzenes studied were the analogues of chlorobenzenes for 
which literature data report the formation of significant amounts (4-79% of the total 
amount of phenolic metabolites) of NIH shifted phenolic metabolites both in vivo 
and in vitro [9-14]. The results obtained in the present study for the in vivo 
cytochrome P450-catalysed aromatic hydroxylation of the fluorobenzenes show an 
extent of formation of NIH shifted phenolic metabolites that is significantly lower 
(0.3-3.3% of the total phenolic metabolites) than reported in the literature for their 
chlorinated analogues [9-11]. In contrast to the in vivo results, in vitro conversion of 
1,4-difluorobenzene resulted in significant formation of the NIH shifted 2,4-
difluorophenol (26.8% of the total amount of phenolic metabolites), which 
demonstrates the inherent ability of a fluorine atom to migrate. 
Formation of NIH shifted phenolic metabolites is believed to proceed 
through arene oxide intermediates which rearrange to NIH shifted phenolic 
products via a ring-opened intermediate (Figure 1). Ring opening of the arene oxide 
has been reported as the rate-limiting step in the reaction [1-4]. However, it is also 
known that arene oxide intermediates, besides reacting in a rearrangement reaction 
to phenolic metabolites, are reactive electrophiles and can add to protein and DNA 
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Table 3 The frontier orbital density (HOMO/HOMO-1) and net charge on the ring carbon 
atoms of a series fluorine and chlorine containing benzenes. 
benzene 
1,4-difluoro-
HOMO/HOMO-1 
net charge 
1,4-dichloro-
HOMO/HOMO-1 
net charge 
1,2,3-trifluoro-
HOMO/HOMO-1 
net charge 
1,2,3-trichloro-
HOMO/HOMO-1 
net charge 
1,2,4-trifluoro-
HOMO/HOMO-1 
net charge 
1,2,4-trichloro-
HOMO/HOMO-1 
net charge 
1,2,3,4-tetrafluoro-
HOMO/HOMO-1 
net charge 
1,2,3,4-tetrachloro-
HOMO/HOMO-1 
net charge 
1,2,3,5-tetrafluoro-
HOMO/HOMO-1 
net charge 
1,2,3,5-tetrachloro-
HOMO/HOMO-1 
net charge 
CI 
0.50 
0.05 
0.32 
-0.13 
0.29 
0.07 
0.18 
-0.13 
0.49 
0.03 
0.30 
-0.14 
0.39 
0.05 
0.22 
-0.13 
0.22 
0.09 
0.13 
-0.12 
C2 
0.20 
-0.11 
0.13 
-0.09 
0.36 
0.01 
0.23 
-0.15 
0.30 
0.07 
0.18 
-0.13 
0.25 
0.04 
0.16 
-0.14 
0.47 
0.09 
0.28 
-0.15 
C3 
0.20 
-0.11 
0.13 
-0.09 
0.29 
0.07 
0.18 
-0.13 
0.14 
-0.14 
0.09 
-0.10 
0.25 
0.04 
0.16 
-0.14 
0.22 
0.09 
0.13 
-0.12 
C4 
0.50 
0.05 
0.32 
-0.13 
0.30 
-0.12 
0.18 
-0.09 
0.41 
0.08 
0.14 
-0.12 
0.39 
0.05 
0.22 
-0.13 
0.25 
-0.16 
0.15 
-0.10 
C5 
0.20 
-0.11 
0.13 
-0.09 
0.28 
-0.06 
0.15 
-0.08 
0.31 
-0.12 
0.19 
-0.09 
0.23 
-0.10 
0.13 
-0.08 
0.35 
0.11 
0.19 
-0.11 
C6 
0.20 
-0.11 
0.13 
-0.09 
0.30 
-0.12 
0.18 
-0.09 
0.13 
-0.08 
0.08 
-0.08 
0.22 
-0.10 
0.13 
-0.08 
0.25 
-0.16 
0.15 
-0.10 
[29,36], and/or undergo conjugation with GSH, resulting in mercapturic acids and 
other sulphur containing metabolites as final products [1,2,29-31]. Based on these 
facts, it can be anticipated that the in vivo formation of NIH shifted phenolic 
metabolites will be dependent on i) the chances for attack of the activated high-
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valent iron-oxo form of cytochrome P450 on the halogenated aromatic carbon centre, 
but also on ii) the ease of ring opening of the arene oxide intermediates preceding 
the formation of the NIH shifted phenol and /or iii) the ease and relative rate of the 
reaction of the arene oxide in competing alternative biotransformation pathways 
such as GSH conjugation. Additional experiments in the present study were 
performed to investigate whether these considerations could explain the relatively 
low extent of formation of NIH shifted phenolic metabolites for fluorobenzenes 
compared to chlorobenzenes. For these studies 1,4-difluorobenzene was used as 
model compound and microsomal studies were performed in addition to the in vivo 
experiments. First, it was demonstrated that microsomal incubations of 1,4-
difluorobenzene in contrast to the results observed for its in vivo metabolism, result 
in significant formation (26.8 ± 1.4% of the total amount of phenolic metabolites) of 
the shifted phenolic 2,4-difluorophenol. In the presence of GSH and liver cytosol a 
significantly (P< 0.02) lower extent of formation of the shifted phenolic metabolite 
2,4-difluorophenol (19.9 ± 1.6% of the total amount of phenolic products) was 
observed. This result clearly points at GSH conjugation as a competing pathway for 
the route leading to formation of NIH shifted phenolic metabolites. This was further 
investigated in an in vivo experiment in which the formation of NIH shifted phenols 
in GSH-depleted rats was determined. From this experiment it appeared that the 
metabolic pattern of 1,4-difluorobenzene in GSH-depleted rats shows an almost 3-
fold significantly (P< 0.01) higher level of the NIH shifted metabolite 2,4-
difluorophenol (2.8 ± 0.1% of all phenolic metabolites) compared to non-depleted 
rats (1.0 ± 0.0% of all phenolic metabolites). Upon interpreting these in vivo results it 
should be kept in mind that treatment of experimental animals with buthionine 
sulfoximine generally does not result in a full depletion of liver GSH levels; in 
studies with mice it was demonstrated that a reduction by about 50% could be 
reached. Furthermore, GSH levels were fully restored within 24 h [22]. Thus, it can 
be anticipated that in our in vivo metabolism study GSH depletion and, thus, also the 
influence of GSH depletion on formation of NIH shifted metabolites from 1,4-
difluorobenzene can only partly reflect the theoretical maximum effect of full GSH 
depletion. 
Together, t h e results of the in vitro GSH/glutathione S-transferase addition and in 
vivo GSH depletion experiment show that GSH conjugation is a competing pathway 
for the formation of NIH shifted phenolic metabolites. 
In additional investigations, molecular orbital calculations were performed 
to further study possible mechanisms underlying the observed difference in the in 
vivo formation of NIH shifted phenolic metabolites for fluorobenzenes compared to 
148 
Chapter 6 
chlorobenzenes. The relative heats of formation calculated for the process of ring 
opening of the arene oxide precursors (Figure 1) shows that for fluorobenzenes the 
heats of formation were always higher than for the chlorinated analogues (Table 2). 
This indicates that the chances for ring opening of the arene oxides to NIH shifted 
phenolic metabolites are higher for chlorine than fluorine substituted benzene 
analogues. Furthermore, calculation of the E(LUMO) of these arene oxides, 
indicative of their relative ease of GSH conjugation [32,33], show that E(LUMO) 
values for fluorinated arene oxides are generally lower than for the chlorinated 
analogues suggesting higher rates of GS" conjugation for fluorine than chlorine 
containing arene oxide analogues. 
Finally, a difference in the chances for attack by the (FeO)3+ species on a chlorinated 
respectively a fluorinated aromatic carbon centre might be another reason 
underlying the greater tendency of a chlorine than a fluorine to give an NIH shift. 
Experimental support for this came previously from the fact that the site of 
cytochrome P450-catalysed aromatic hydroxylation of a series of polyfluorobenzenes 
could be even predicted with 6% accuracy and a correlation of 0.96 on the basis of 
frontier orbital, not Coulombic, parameters [28]. In addition, in theory, reactivity of a 
carbon centre might also be influenced by its Coulombic interactions with the 
(FeO)3+ species on the chances for (FeO)3+ attack. Therefore, the frontier orbital and 
net charge density on the ring carbon atoms of the tested series of fluorobenzenes 
and their chlorinated analogues were calculated. The results of these calculations 
show that a chlorinated carbon centre is less positively, even negatively, charged 
than a fluorinated carbon centre. Taking into account the negative partial charge of 
the oxygen in a cysteinate-coordinated Por+Fe(IV)0 species [35], these data indicate 
that Coulombic interactions can be expected to favour an iron-oxene attack on a 
fluorinated over a chlorinated aromatic carbon atom. Furthermore, based on 
previous results [28] and the fact that the reaction is a radical-type interaction, and 
radical-type reactions are usually frontier-orbital controlled, the frontier orbital 
density was calculated as well [26]. Results of the calculated frontier orbital densities 
in the aromatic ring show that not only the Coulombic factor, but also the frontier 
orbital parameter favour an iron-oxene attack on a fluorinated over a chlorinated 
carbon centre. Thus, these data argue strongly against the hypothesis that differences 
in the charge for an iron-oxene attack on a chlorinated and fluorinated aromatic 
carbon centre are the reason underlying the higher tendency of a chlorine than a 
fluorine to give NIH shifted metabolites. 
Altogether, results of the present study show that the formation of NIH 
shifted phenolic metabolites from fluorine substituted benzenes is hampered as 
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compared to their chlorinated analogues. Calculations indicate that the reduced 
tendency of fluorine substituted benzenes to undergo an NIH shift can-at least in 
part- be ascribed to i) the reduced chance of fluorine rather than chlorine arene oxide 
intermediates on ring opening generating NIH shifted phenolic metabolites and ii) 
the provision of an alternate pathway by the more efficient GSH conjugation of 
fluorine over chlorine containing arene oxides. 
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Metabolism of the insecticide Teflubenzuron in rats 
J. Koerts, A.E.M.F. Soffers, J.-W. de Kraker, N.H.P. Cnubben and I.M.C.M. Rietjens 
Xenobiotica, submitted. 
Abstract 
The metabolic fate of the insecticide teflubenzuron, orally dosed to male 
Wistar rats, was investigated. Particular attention was paid to the metabolic fate of 
the benzoate and aniline moiety after hydrolysis of the urea bridge. The 0-48 h 
urinary and faecal metabolite patterns and recoveries showed that for a dose range 
of 4-53 umol (1.5-20 mg) teflubenzuron 90% of the dose was excreted in the faeces 
mainly in unmodified form, approximately 4.6% was absorbed from the lumen and 
excreted in the urine and 5.4% was retained in the body. Metabolites excreted in the 
urine could be identified as benzoate and aniline derivatives originating from the 
two aromatic rings of teflubenzuron liberated from the parent molecule by 
hydrolysis of the urea bridge. The amount of urinary benzoate-type metabolites was 
about eight times the amount of aniline-type metabolites, indicating significant 
differences in efficiency of urinary excretion of the benzoate moiety as compared to 
the aniline ring. To further investigate the possible reason underlying this difference 
in urinary excretion efficiency between the two aromatic derivatives formed from 
teflubenzuron, dose-recovery studies of these aniline- and benzoate-type metabolites 
were performed. These studies confirmed the discrepancy observed between the 
urinary recovery of the benzoate and the aniline moiety of teflubenzuron. Additional 
results of the present study indicate that the discrepancy can be explained by the fact 
that the benzoate derivative is excreted mainly in its unmetabolized form whereas 
the aniline derivative needs additional Phase I and II modifications before it can be 
excreted from the body. Furthermore, conversion of the halogenated aniline 
derivative in Phase I metabolism might result in a reactive benzoquinone-type 
primary metabolite that can be withheld in the body due to a reaction with cellular 
macromolecules. 
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Introduction 
In the past twenty years the development of fluorinated agrochemicals has 
increased considerably and an even further increase in fluorinated agrochemicals is 
foreseen for the years ahead [1]. Replacement of an atom by a fluorine can change 
the properties of a chemical and affect its metabolism, chemical reactivity and 
lipophilicity [1-3]. 
An example of such a series of fluorinated agrochemicals consists of the 
benzoylphenyl urea insect growth regulants which act by inhibiting the enzyme 
responsible for the chitin synthesis in larves [4]. Diflubenzuron which is the active 
component in the product named Dimilin (Figure 1), which was introduced in 1975 
and used as larvicide for fruit, cotton and soybeans, was the first benzoylphenyl urea 
insect growth regulant commercialized. Teflubenzuron, the active component in the 
insecticide commercialized as Nomolt (Figure 1), was introduced in 1984, and is 
another benzoylphenyl urea larvicide used for the protection of fruit and vegetables. 
Upon development of an agrochemical it is important to investigate the 
metabolic fate and disposition of the compound in target [4,5] but also in non-target 
organisms [4,6-9]. Non-target organisms, including man, are exposed to these 
chemicals upon the manufacture of these compounds but also when these chemicals 
are released into the environment or are present as a residue in food following crop 
treatment. 
Previous studies on the bioavailability and metabolism of diflubenzuron in 
various non-target species, i.e. rat, sheep, cattle, swine and chicken, showed that 
upon a 4-10 mg/kg (13-32 umol/kg) oral dose of diflubenzuron more than 50% of 
the dose was excreted unchanged in the faeces [7-10]. The remainder of the dose was 
absorbed from the gastro-intestinal tract. Part of the diflubenzuron absorbed was 
metabolized to conjugated aromatic ring hydroxylated diflubenzuron derivatives 
and excreted in the bile. The remainder of the dose absorbed was excreted in the 
urine mainly as derivatives from products resulting from hydrolysis of the urea 
bridge, which were identified especially as 2,6-difluorobenzoic acid derived 
metabolites. However, there were relatively many unidentified metabolites in the 
urine pattern and especially a lot of uncertainty remained about the recovery and 
metabolic fate of the aniline moiety which must also have been formed upon the 
hydrolytic splitting of the parent compound. Metabolites of this second scission 
product 4-chlorophenylurea, containing the aniline ring, could not be detected in the 
urine or bile although unidentified metabolites observed in the urine were taken as 
154 
Chapter 7 
^y v fy-c4-c-
\ = / I I ii 
Diflubenzuron p ° ° 
^VF ¥ fy-c4-c-
\=< U 11 Teflubenzuron ^ p O O 
* 
H 
1 
"
N
^O~ C I 
? R w c l 
•N^Q^F 
\ 
y Hydrolytic cleavage of s <•
 v 
^ ffee urea bridge \ 
/ 
1) f V—c—OH 
w y 
F 
+ 
i V<C1 H , N _ l" N ~i i F 
^ d 
/ 
2) / V - C—NH2 
F 
+ 
N=/C1 H
^\j-F 
\ , 
Figure 1 The molecular structure of the insecticides diflubenzuron and teflubenzuron and 
the proposed scission products formed by hydrolytic cleavage of the phenylurea bridge of 
teflubenzuron, pathway 1 being the major route [4' 
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being suggestive of further metabolism of the 4-chlorophenylurea moiety [8]. 
Altogether, the metabolic fate of benzoylphenylurea insecticides is not well 
described and especially the fate of the aniline part of the insecticide upon 
hydrolysis of the urea bridge has not been well investigated. Therefore, the aim of 
the present study was to investigate the differences in the recovery and metabolic 
fate of the two aromatic scission products of the benzoylphenyl urea insecticides 
formed upon hydrolysis of the urea bridge. To do so the benzoylphenyl urea 
larvicide teflubenzuron was taken as the model compound because the presence of 
fluorine substituents in both the benzoate but also the aniline moiety (Figure 1) 
provides a way to actually detect the metabolic fate of both parts of the molecule, 
since the fluorine containing metabolites can be identified and quantified by the use 
of 1 9F NMR. 
Materials and Methods 
Chemicals 
Teflubenzuron, the active compound in Nomolt (purchased from Shell BV, 
The Netherlands), was obtained by extracting Nomolt with chloroform in an 1:2 (v:v) 
ratio. The chloroform phase was evaporated and white powder was obtained which 
was dissolved in dimethyl sulfoxide. (3,5-Dichloro-2,4-difluorophenyl)urea and 3,5-
dichloro-2,4-difluoroaniline were a generous gift from Shell Forschung 
(Schwabenheim, Germany). 2,6-Difluorobenzamide was purchased from Aldrich 
Chemie (Steinheim, Germany) and 2,6-difluorobenzoic acid was obtained from 
Fluorochem Limited (Derbyshire, United Kingdom). Synthesis of 2,6-
difluorobenzoylglycine from 2,6-difluorobenzoic acid was performed according to 
Vogel, 1989 [11]. Synthesis of 2-amino-3,5-difluoro-4,6-dichlorophenylsulphate was 
carried out according to a method for synthesis of O-aminophenyl sulphates 
described by Boyland et al. [12]. 
In vivo metabolism 
Male Wistar rats (350-400 g) were exposed to 1-53 amol (as indicated) of 
teflubenzuron, 2,6-difluorobenzoic acid, 2,6-difluorobenzamide, 3,5-dichloro-2,4-
difluoroaniline or (3,5-dichloro-2,4-difluorophenyl)urea, all administered in olive oil 
with 20% dimethyl sulfoxide by oral injection. After dosing, 0-24 h, 24-48 h urine and 
0-48 h faeces samples were collected. 
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For 19p NMR measurement, urine samples were either diluted once in 0.2 M 
potassium phosphate pH 7.6 or, when necessary, concentrated by freeze-drying and 
subsequent dissolving in 0.1 M potassium phosphate pH 7.6. 
Faeces samples were homogenized by extensive (o/n) stirring in 25 ml ethyl 
acetate using a magnetic stirrer. The homogenate obtained was filtered over glass 
mineral wool and the residue was washed 3 times with 25 ml ethyl acetate. The ethyl 
acetate filtrate was evaporated to dryness. The residue was dissolved in 4 ml ethyl 
acetate and analysed by 19p NMR. 
Acid and enzyme hydrolysis of urine samples 
In order to identify phenolic metabolites excreted in the urine in their N-
acetylated, glucuronidated or sulphated form, urine samples were treated with acid, 
with P-glucuronidase (from Escherichia coli K12 (Boehringer, Mannheim, Germany)) 
or with arylsulphatase/ P-glucuronidase (from Helix pomatia (Boehringer, Mannheim, 
Germany)). Enzyme treatments were carried out essentially as described before by 
Vervoort and Rietjens [13]. 
For acid hydrolysis of the urine samples 1.0 ml urine sample was incubated 
with 0.1 ml 37% (12 N) HC1 for 1 hour in a boiling water bath. After acid hydrolysis 
the mixture was neutralised with 6 N NaOH and the sample was diluted once in 0.2 
M potassium phosphate pH 7.6 for analysis by 1°F NMR. 
Microsomal preparations 
Preparation of microsomes was carried out essentially as described 
previously [13]. Microsomes were obtained from perfused livers of male Wistar rats 
(300-400 g) which were exposed to 150 mg/kg body weight of the cytochrome P450 
inducer isosafrole (Janssen Chimica, Beerse, Belgium) by i.p. injection daily for three 
days using a stock solution of 100 mg/ml in olive oil. The amount of cytochrome 
P450 in the microsomes was measured according to the method described by Omura 
and Sato [14]. 
In vitro microsomal incubations 
In vitro microsomal incubations contained (final concentrations): 0.1 M 
potassium phosphate pH 7.6, 0-5 mM 3,5-dichloro-2,4-difluoroaniline, added from a 
100 times concentrated stock solution in dimethyl sulfoxide and 2 \iM microsomal 
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cytochrome P450. Microsomes from isosafrole pretreated rats were used to allow 
comparison of the results to those of microsomal metabolism of aniline derivatives 
reported in a previous study [15], which also demonstrated that these microsomes 
are most effective in metabolism of aniline derivatives [15,16]. The total sample 
volume was 1 ml. The reaction was started by the addition of NADPH (1 mM final 
concentration) and the incubation mixture was incubated at 37 °C for 10 min. The 
reaction was stopped by the addition of 0.3 ml 20% (w/v) trichloroacetic acid after 
which the mixture was centrifuged for 3 min at 13,000 rpm. 
Chemical assay for the detection of4-hydroxy-3,5-dichloro-2-fluoroaniline 
4-Hydroxy-3,5-dichloro-2-fluoroaniline present in the urine and microsomal 
incubations was determined using the method of Brodie and Axelrod [17] for 
chemical determination of 4-aminophenol derivatives. Arylsulphatase/p-
glucuronidase treated urine samples were extracted with ethyl acetate. To 40 ul of 
this ethyl acetate fraction, 760 ul demi water and 240 ul trichloroacetic acid (20% 
w/v) were added. To 800 ul of this mixture 80 ul phenol reagent (5% w / v phenol in 
2.5 M NaOH) and 160 ul 2.5 M Na2C03 were added. The absorbance at 630 nm was 
measured after 1 h at room temperature. Ethyl acetate extract from non-enzyme 
treated urine was used as a blank. 
For the in vitro microsomal incubations 100 ul phenol reagent and 200 ul 
Na2C03 were added to 1 ml of the trichloroacetic acid mixture. A microsomal 
incubation with water instead of substrate was used as blank. 
The E630 value of the 4-hydroxy-3,5-dichloro-2-fluoroaniline derived 
indophenol is not known. Therefore, based on a previous study on the cytochrome 
P450-catalysed 4-hydroxylation of halogenated aniline derivatives in which the 6630 
values of various halogenated aminophenol-derived indophenols were determined 
[15], the E630 of the 4-hydroxy-3,5-dichloro-2-fluoroaniline-derived indophenol 
could be set to 20 mM'l cm'l. 
Data analysis 
The apparent Michaelis-Menten constant K m (mM) and the apparent 
maximum reaction rate kCat (nmol 4-hydroxy-3,5-dichloro-2-fluoroaniline/min/ 
nmol cytochrome P450) for the in vitro microsomal cytochrome P450-catalysed 4-
hydroxylation of 3,5-dichloro-2,4-difluoroaniline were calculated by fitting the 
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obtained data of the in vitro incubations to the Michaelis-Menten equation v=Vmax • 
[S]/(Km + [S]). Fitting the experimental data to the Michaelis-Menten equation 
resulted in correlation coefficients > 0.97. 
1&F NMR measurements 
l^F NMR measurements were performed on a Bruker AMX 300 NMR 
spectrometer at 280 K. Proton-decoupling was achieved with the Waltz-16 pulse 
sequence at -20dB from 50W. 
Samples contained 100 ul ^H20 for locking the magnetic field and 10 ul 8.4 
mM 4-fluorobenzoic acid added as an internal standard. The total sample volume 
was 1.71 ml. Enzyme and acid treated urine samples were made anaerobic by 
evacuating and filling with argon four times before analysis. This was done to 
prevent autoxidation of the phenolic metabolites. Quantification of the different 
metabolites was done by comparison of the integral of the 19p NMR resonance of the 
added internal standard 4-fluorobenzoic acid to the integrals of the l^p NMR peaks 
of the metabolites. The ethyl acetate extract of the faeces was analysed with a coaxial 
insert containing 4-fluorobenzoic acid dissolved in ^-HzO. The total sample volume 
was 1.6 ml. Chemical shifts are reported relative to CFCI3. 
Molecular orbital calculations 
Semi-empirical molecular orbital calculations were performed on a Silicon 
Graphics Iris 4D/85 computer with the AMI (Austin Method 1) Hamiltonian from 
the AMP AC program (Quantum Chemistry Program Exchange, program no. 506, 
Indiana University, Bloomington, IN, USA). Calculations were carried out with 
PRECISE criteria and self-consistent field was achieved for all calculations. 
Geometries were optimised for all bond lengths, bond angles and torsion angles 
using the Fletcher-Powell criteria. 
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Results 
Urine and faeces metabolic patterns of 2,6-difluorobenzoic acid, 2,6-
difluorobenzamide, 3,5-dichloro-2,4-difluoroaniline, (3,5-dichloro-2,4-difluoro-
phenyl)urea and teflubenzuron 
The in vivo metabolism of 2,6-difluorobenzoic acid, 2,6-difluorobenzamide, 
3,5-dichloro-2,4-difluoroaniline and (3,5-dichloro-2,4-difluorophenyl)urea was 
investigated in order to identify the metabolites from teflubenzuron that result from 
hydrolysis of the phenylurea bridge (Figure 1) and subsequent metabolism of the 
scission products. 
2,6-Difluorobenzoic acid 
Figure 2a shows the l^F NMR spectrum of the 0-24 h urine of a rat exposed 
to 10 umol of 2,6-difluorobenzoic acid. Metabolites were identified on the basis of 
commercially available 2,6-difluorobenzoic acid and its synthesized glycine 
conjugate. The 19p NMR spectrum shows that urinary excretion of 2,6-
difluorobenzoic acid occurs mainly (96%) in the form of the unmodified parent 
compound 2,6-difluorobenzoic acid and to a minor extent (4%) as 2,6-
difluorobenzoylglycine. The amount of F" observed could be fully accounted for by 
the F" present in blank urine samples from unexposed rats. The total urinary 
recovery was 86%. 
The 19p NMR spectra of the ethyl acetate extracts of the 0-48 h faeces of the 
2,6-difluorobenzoic acid exposed rat show no resonance peaks (detection limit 1 uM 
for an o /n run) (19p NMR spectrum not shown). 
2,6-Difluorobenzamide 
Figure 2b shows the 19p NMR spectrum of the 0-24 h urine of a rat exposed 
to 10 umol of 2,6-difluorobenzamide. Metabolites were identified on the basis of 
commercially available or synthesized reference compounds. The 19p NMR 
spectrum shows that urinary excretion of 2,6-difluorobenzamide mainly occurs in 
the form of 2,6-difluorobenzoic acid (94%) while a minor extent was excreted as 2,6-
difluorobenzoylglycine (4%) and unmodified 2,6-difluorobenzamide (2%). The 
amount of F" observed could be fully accounted for by the F" present in blank urine 
samples from unexposed rats. The 24 h urinary recovery was 100%. 
The l^F NMR spectra of the ethyl acetate extracts of the 0-48 h faeces of the 
2,6-difluorobenzamide exposed rat show no metabolite or substrate resonances 
(detection limit 1 uM for an o /n run) (19p NMR spectra not shown). 
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3,5-Dichloro-2,4-difluoroaniline 
Figure 2c shows the 19p NMR spectrum of the 0-24 h urine of a rat exposed 
to 10 (imol of 3,5-dichloro-2/4-difluoroaniline. l^F NMR resonances of conjugated 
metabolites, i.e. sulphated, glucuronidated or acetylated products, were identified on 
the basis of the shift of their 19p NMR resonance in the spectrum upon 
arylsulphatase and/or P-glucuronidase, or acid treatment of the urine. The aromatic 
ring hydroxylated product 2-amino-3,5-difluoro-4,6-dichlorophenylsulphate was 
identified on the basis of its synthesized reference compound. Identification of 4-
hydroxy-3,5-dichloro-2-fluoroaniline, formed from its N-acetylated, sulphated 
and/or glucuronidated conjugate upon acid, arylsulphatase and/or P-glucuronidase 
treatment of the urine, was achieved on the basis of the chemical assay for detection 
of 4-aminophenol derivatives. The amount of 4-hydroxy-3,5-dichloro-2-fluoroaniline 
detected by this chemical assay correlated with the amount of the metabolite giving 
rise to the 19p NMR resonance at -136.5 ppm which could thus be identified. This 
latter result was supported by the following observation. In a previous study it was 
demonstrated that the introduction of a hydroxyl group meta with respect to a 
fluorine in a fluorinated benzene derivatives results in a l °p NMR chemical shift of 
1.8 ± 1.2 ppm [16]. Based on this result, the 1 9F NMR chemical shift of 4-hydroxy-3,5-
dichloro-2-fluoroaniline was predicted to be -136.3 ± 1.2 ppm clearly supporting the 
identification of the 19p NMR resonance value at -136.5 ppm as 4-hydroxy-3,5-
dichloro-2-fluoroaniline. 
The results in Figure 2c show that the urinary excretion of 3,5-dichloro-2,4-
difluoroaniline is mainly in the form of the N-acetylated, sulphated and /o r 
glucuronidated conjugates of its ortho and para-hydroxylated metabolites. Only one 
of the metabolite peaks in the 19p NMR spectrum could not be further identified. 
However, its presence in the urine spectrum of 3,5-dichloro-2,4-difluoroaniline 
exposed rats clearly identifies this metabolite as derived from the aniline moiety of 
teflubenzuron. The total 24 h urinary recovery was 59.5% of the administered dose. 
The 19p NMR spectra of the ethyl acetate extracts of the 0-48 h collected 
faeces reveal the presence of some parent aniline compound excreted in the faeces to 
about 2% of the dose administered (l^F NMR spectrum not shown). 
(3,5-Dichloro-2,4-difluorophenyl)urea 
Figure 2d shows the 19p NMR spectrum of the 0-24 h urine of a rat exposed 
to 10 umol (3,5-dichloro-2,4-difluorophenyl)urea. Metabolites were identified in a 
similar way as described for 3,5-dichloro-2,4-difluoroaniline. The results in Figure 2d 
demonstrate that (3,5-dichloro-2,4-difluorophenyl)urea is excreted in the urine as the 
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Figure 2 The ^ F NMR spectra of the 0-24 h urine samples of rats exposed to (a) 2,6-
difluorobenzoic acid, (b) 2,6-difluorobenzamide, (c) 3^-dichloro-2,4-difluoroaniline, (d) (3,5-dichloro-
2,4-difluorophenyl)urea and (e) teflubenzuron. The resonance peak marked with an "a" in Figure 2e 
belongs to a metabolite derived from biotransformation of 3,5-dichloro-2,4-difluoroaniline, which is 
one of the scission products of teflubenzuron after hydrolysis of the urea bridge. The fluorine 
resonances in the spectra a-d are not similar in size due to the different volumes of the 0-24 h urine 
samples produced by the rats. The resonance peak marked IS is from the internal standard 4-
fluorobenzoic acid. Chemical shifts values are reported relative to CFCI3. 
163 
Chapter 7 
sulphated and glucuronidated conjugates of (4-hydroxy-3,5-dichloro-2-fluoro-
phenyl)urea. The total 24 h urinary recovery was 54.5% of the administered dose. 
The 19p NMR spectra of the ethyl acetate extracts of the 0-48 h faeces sample 
reveal the presence of some parent compound excreted in the faeces to about 6% of 
the dose administered (l^F NMR spectrum not shown). 
Teflubenzuron 
Figure 2e shows the l^F NMR spectrum of the 0-24 h urine of a rat exposed 
to 53 umol (20 mg) teflubenzuron. Based on the in vivo urinary metabolic patterns of 
2,6-difluorobenzoic acid, 2,6-difluorobenzamide, 3,5-dichloro-2,4-difluoroaniline and 
(3,5-dichloro-2,4-difluorophenyl)urea (Figures 2a-d), metabolites resulting from 
hydrolysis of the urea bridge of teflubenzuron and further metabolism of the 
aromatic scission products could be identified. The metabolic profiles thus identified 
shows that the benzoate part of teflubenzuron is mainly excreted as 2,6-
difluorobenzoic acid, and, to a minor extent, as 2,6-difluorobenzoylglycine and 2,6-
difluorobenzamide. The aniline ring of teflubenzuron was excreted as the sulphated 
and glucuronidated conjugates of (4-hydroxy-3,5-dichloro-2-fluorophenyl)urea and 
6-hydroxy-3,5-dichloro-2,4-difluoroaniline, the sulphated conjugate of 4-hydroxy-
3,5-dichloro-2-fluoroaniline and the glucuronidated conjugate of 4-hydroxy-3,5-
dichloro-2-fluoroacetamido. In addition to all these identified metabolites, the 19p 
NMR spectrum of the urine of the teflubenzuron exposed rats shows several 
unidentified resonance peaks, one of which has the same chemical shift value as the 
unidentified resonance peak observed in the urine of rats exposed to 3,5-dichloro-
2,4-difluoroaniline indicating that this metabolite can also be ascribed to a metabolite 
derived from the aniline part of teflubenzuron. The percentage of unidentified peaks 
amounts to only 12.3% of the total metabolic pattern. 
Although a similar amount of benzoate and aniline metabolites should 
originate from the hydrolytic cleavage of teflubenzuron, the amount of benzoate 
derived metabolites thus identified in the urine made up 91.3% of the total identified 
metabolic pattern whereas the amount of aniline derivatives was 8.7%, indicating 
that the amount of benzoate derived metabolites was eight times the amount of 
aniline derived metabolites. Thus, the 12.3% of unidentified minor metabolites will 
not alter the conclusion that there is a remarkable difference in urinary recovery of 
the two aromatic moieties derived from teflubenzuron. The 24-48 h urine sample of 
the rat exposed to 53 umol was also analysed in order to investigate whether due to 
retarded excretion the remainder of the aniline moiety was excreted in the 24-48 h 
urine. However, the amount of metabolites in this 24-48 h urine was only 1.5% of the 
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amount excreted in the 0-24 h urine. Altogether, these data show that part of the 
aniline moiety is withheld in the body. Since total recovery in 0-24 h urine, 24-48 h 
urine and 0-48 h faeces amounted to 4.5%, 0.1% and 90% respectively, approximately 
5.4% of the dose of teflubenzuron could not be accounted for. Taking into account 
that recovery of the dose of teflubenzuron administered as benzoate and aniline 
derived urinary metabolites amounts to 7.5% and 0.9% respectively, indicates that a 
significant amount of the dose withheld in the body in the first 48 h might indeed 
have to be ascribed to aniline moiety containing metabolites. 
The l^F NMR spectra of the ethyl acetate extracts of the 0-48 h faeces sample 
of the teflubenzuron exposed rats showed mainly (91%) unchanged teflubenzuron. 
Scission products of teflubenzuron or metabolites derived from them were not 
observed. The recovery of teflubenzuron in the faeces was about 90% of the dose. 
Dose-recovery studies of teflubenzuron, 2,6-difluorobenzoic acid, 2,6-difluoro-
benzamide, 3,5-dichloro-2,4-difluoroaniline and (3,5-dichloro-2,4-difluoro-
phenyl)urea 
To investigate whether the amount of teflubenzuron administered and of the 
scission products derived from it would affect the extent of absorption and excretion 
via urinary and faecal excretion routes dose-recovery studies of teflubenzuron and 
its possible scission products were performed. Analysis of the 0-48 h urinary samples 
showed that over the whole dose-range tested, i.e. 4-53 umol for teflubenzuron and 
1-10 umol for the scission products, for all these compounds their urinary recoveries 
did not vary significantly. For the scission products this dose range of 1-10 umol was 
chosen because the results obtained from the dose-recovery study of teflubenzuron 
showed that about 0.5-4.0 umol of teflubenzuron was absorbed from the gastro-
intestinal tract and excreted in the 0-24 h urine indicating that the range of 1-10 umol 
of aromatic scission products would be in the range to be actually expected to be 
formed in the rats exposed to 4-53 umol of teflubenzuron. 
At all dose-levels of teflubenzuron about 4.5% of the dose of teflubenzuron is 
excreted in the 0-24 h urine mainly as metabolites derived from the scission products 
resulting from hydrolysis of the urea bridge of teflubenzuron, while about 90% of 
the dose is excreted in the faeces mainly as unmodified teflubenzuron. Furthermore, 
the urinary recovery of the aniline moiety was only about 12% of the excreted 
benzoate moiety at the whole 4-53 umol dose range. 
The dose-recovery studies of the benzoate and aniline scission products of 
teflubenzuron (Figure 3) show that, for a dose range of 1-10 umol, the 0-24 h urinary 
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recovery of 2,6-difluorobenzoic acid and of 2,6-difluorbenzamide was always 
significantly (P<0.001) higher and about twice the recovery observed for similar 
doses of 3,5-dichloro-2,4-difluoroaniline or (3,5-dichloro-2,4-difluorophenyl)urea. 
This two-fold difference thus explains only part of the eight-fold difference in 
recovery of the benzoate and aniline moiety in case of their formation from 
teflubenzuron. This discrepancy might be due to the fact that at the doses tested the 
rate-limiting Phase I metabolism of the aniline-type scission products is still 
operating at almost saturating aniline derivative concentrations, whereas upon their 
formation in situ by hydrolysis of teflubenzuron their steady-state concentration for 
Phase I metabolism is below Vmax conditions. Because dose-recovery studies at 
lower doses of the aniline derivatives were not feasible due to the detection limit of 
the 19p NMR urine analysis, further experiments were performed to actually 
determine the kinetic values for this Phase I aromatic hydroxylation of the aniline 
derivatives. 
In vitro microsomal incubations 
Figure 4 presents the Michaelis-Menten plot for the microsomal cytochrome 
P450-catalysed 4-hydroxylation of 3,5-dichloro-2,4-difluoroaniline. The K m and kcat 
value derived from these data were 0.58 ± 0.06 mM and 0.24 ± 0.01 nmol/min/nmol 
P450 respectively. 
Molecular orbital computer calculations 
Since the microsomal conversion of (3,5-dichloro-2,4-difluorophenyl)urea 
could not be followed by the sensitive chemical assay available for the aniline 
derivative, support for its equally low k c a t value was derived from theoretical 
studies. Molecular orbital computer calculations on 3,5-dichloro-2,4-difluoroaniline 
and (3,5-dichloro-2,4-difluorophenyl)urea were performed to find theoretical 
support for the low rate of Phase I aromatic hydroxylation of these teflubenzuron-
derived splitting products. 
The energy of the HOMO (Highest Occupied Molecular Orbital) of 3,5-
dichloro-2,4-difluoroaniline and (3,5-dichloro-2,4-difluorophenyl)urea is -9.0 and -9.3 
eV respectively, indicative of a kCat for (3,5-dichloro-2,4-difluorophenyl)urea that 
can not be higher than that obtained for the aniline derivative [15] since the lower 
E(HOMO) indicates an even lower reactivity of this compound for an electrophilic 
attack by the activated (FeO)3+ species of cytochromes P450. 
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Discussion 
The aim of the present study was to investigate the biotransformation of the 
insecticide teflubenzuron in rats. Particular attention was focused on the metabolic 
fate of the aniline part of teflubenzuron because in previous studies on the 
biotransformation of diflubenzuron, which is an analogue of teflubenzuron, a lot of 
uncertainty remained about the recovery and metabolic fate of the aniline derivative 
formed after hydrolysis of the urea bridge [4,7-10]. 
Male Wistar rats were orally exposed to different dose levels of 
teflubenzuron and urine samples as well as faecal extracts were analysed by 19p 
NMR. The 19p NMR spectra of urine samples of rats orally exposed to teflubenzuron 
(Figure 2e) mainly showed metabolites derived from products resulting from 
hydrolysis of the urea bridge. Analysis of faecal extracts of teflubenzuron exposed 
rats revealed the presence of mainly unmodified teflubenzuron. Within 48 h almost 
the total dose of teflubenzuron was recovered, partly as metabolites in the urine 
(4.6% of the dose administered) and mainly in unmodified form in the faeces extract 
(90% of the dose administered). Independent of the dose of teflubenzuron, the 
amount of urinary aniline derived metabolites observed amounted to only 12% of 
the amount of benzoate derived metabolites, in spite of the fact that hydrolytic 
cleavage of the urea bridge in teflubenzuron will generate equal amounts of 
benzoate and aniline derivatives. This observation of inefficient excretion of 
especially the aniline part of teflubenzuron, formed upon hydrolytic cleavage of the 
urea bridge in the benzoylphenyl urea agrochemical, is in agreement with the 
qualitative results described previously for diflubenzuron [4,7-10]. 
Further experiments described in the present study were performed to find a 
rationale for this significant difference between the urinary recovery of the benzoate-
and aniline-type scission products. 
First, it was investigated to what extent the observed discrepancy might be 
ascribed to a difference in excretion efficiency of the benzoate and aniline derivatives 
themselves. Dose-recovery studies were performed for the four possible scission 
products, i.e. 2,6-difluorobenzoic acid, 2,6-difluorobenzamide, 3,5-dichloro-2,4-
difluoroaniline and (3,5-dichloro-2,4-difluorophenyl)urea. The results obtained 
showed a difference in the excretion efficiency between the benzoate-type 
derivatives on the one hand, which were, at all dose levels investigated, almost fully 
excreted within the first 24 h following administration and the aniline-type 
derivatives on the other hand, which were excreted, also independent of the dose, to 
about 50% of the dose administered. Based on these data, excretion efficiencies of the 
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aniline-type compounds is demonstrated to be at least two-fold lower than that of 
the benzoates. However, the difference observed in the excretion efficiency of the 
benzoate- and aniline-type compounds when compounds are formed in situ from 
teflubenzuron is eight-fold. This discrepancy between the excretion efficiency of the 
benzoate- and aniline-type compounds of teflubenzuron compared to the 
experiments when the compounds were dosed as such might be explained on the 
basis of the following additional observations of the present study. 
First, is of importance to notice that the benzoate moiety is almost exclusively 
excreted in its unmodified form, suggesting that after hydrolysis no further 
metabolism is required to obtain efficient excretion of the 2,6-difluorobenzoate or the 
2,6-difluorobenzamide. In contrast, the metabolites derived from the aniline part of 
teflubenzuron, i.e. from 3,5-dichloro-2,4-difluoroaniline or from (3,5-dichloro-2,4-
difluorophenyl)urea require further metabolism in both Phase I and II metabolism 
before they can be excreted from the body. Especially the aromatic hydroxylation of 
such aniline derivatives catalysed by cytochromes P450 to give the aminophenol 
metabolites suitable for Phase II conjugation and formation of the products that can 
be efficiently excreted, could be a relatively slow reaction. It is likely that the rate of 
this cytochrome P450-catalysed aromatic ring hydroxylation is relatively low 
because cytochrome P450-catalysed aromatic hydroxylation is often the rate-limiting 
step in biotransformation and generally much slower than Phase II conjugation 
reactions [15,18]. 
If the rate of cytochrome P450 conversion of the aniline derivative would 
indeed be the rate-limiting factor for excretion of the aniline-type derivatives, the 
actual concentrations of the aniline derivatives in relation to especially the K m for 
the reaction might be a factor influencing the actual efficiency of the conversion to a 
large extent. Especially when the concentration is around or below the Km values, 
variation in the actual concentration of the compound will affect the efficiency of its 
conversion and excretion. This may then be the explanation for the fact that upon 
direct administration of 1-10 umol of the aniline derivatives their excretion is more 
efficient, than when a similar dose is formed over a long time interval upon the 
hydrolytic cleavage of teflubenzuron. The latter might result in a lower time 
averaged concentration of the compound. 
Comparison of the actual K m and V m a x values determined for the 
cytochrome P450-catalysed C4-hydroxylation of 3,5-dichloro-2,4-difluoroaniline in 
the present study, to estimate the concentrations expected in the liver, supports this 
hypothesis. Assuming a liver volume of 5-10 ml, and full absorption and transport of 
a 1-10 umol aniline dose from the gastro-intestinal tract to the liver, a maximum 
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concentration of 3,5-dichloro-2,4-difluoroaniline in the liver of about 0.1-2.0 mM can 
be foreseen. This is around the K m value for the cytochrome P450-catalysed 
oxidative C4-dehalogenation determined to be 0.58 ± 0.06 mM. When in the 
teflubenzuron exposed animals the same amount of aniline is liberated from the 
parent compound over a time interval that is for example four times longer than the 
time interval required for the efficient uptake of the single dose, this will result in 
lower liver concentrations that will be below the K m resulting in lower rates of 
conversion. Such an effect could explain that in the teflubenzuron exposed rats the 
efficiency for excretion of the aniline-type metabolites is eight-fold lower than for the 
benzoate-type of metabolites whereas in the direct exposure experiments this 
difference is only two-fold. 
Although this difference in excretion efficiency of the benzoate and aniline-
type compounds can explain the observed difference in their urinary recovery, one 
can not neglect the fact that even upon a single dose of the aniline derivative about 
50% of the dose can not be recovered in the 0-48 h urine or faeces. This means that 
part of the aniline derivative remains in the body. An explanation for this 
observation might be related to the mechanism by which the cytochrome P450-
catalysed oxidative dehalogenation of these halogenated anilines to 4-aminophenol 
derivatives occur. This oxidative dehalogenation represents the first step required 
for formation of the 4-hydroxylated urinary metabolites observed. Figure 5 presents 
the reaction pathway suggested for this reaction. The primary product formed in 
such a cytochrome P450-catalysed oxidative dehalogenation of a C4-halogenated 
aniline derivative is the reactive benzoquinoneimine and not its two-electron 
reduced aminophenol form [19,20]. Swift binding of this reactive 
benzoquinoneimine to tissue macromolecules instead of its chemical and /or 
enzymatic reduction to the non-toxic aminophenol, might cause the compound to be 
withheld in the body. The possibility of such a mechanism causing covalent binding 
of the aniline part of teflubenzuron to tissue macromolecules seems to be supported 
by several other observations. First, about 5.4% of the dose of teflubenzuron could 
not be recovered in urine or faeces. At least part of this 5.4% was expected to be 
excreted in the form of urinary aniline-type of metabolites since the urinary recovery 
in the form of benzoate-type metabolites was 7.5% compared to only 0.9% in the 
form of aniline-type of metabolites. Furthermore, the amount of the fluorine in the 24 
h urine of (3,5-dichloro-2,4-difluorophenyl)urea exposed rats was above the amount 
that could be accounted by the fluorine originating from food and/or drinking water 
and from the amount of dehalogenated products observed. This observation 
suggests that part of the aniline moiety is dehalogenated but not excreted from the 
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of 4-halogenated anilines [19], 
body. Finally, the absence of full excretion of the urea agrochemical from the body 
would be in line with the results obtained in a study with rats orally exposed to 5 
mg/kg diflubenzuron for which 4% of the dose was eventually recovered in the 
carcass [8]. Finally, the observation of the present study that the 24-48 h urine 
recovery of teflubenzuron was significantly below the 0-24 h recovery to some extent 
argues against the slow cytochrome P450-catalysed conversion of the aniline moiety 
as the main reason for its relatively low recovery. Slow metabolism of a circulating 
amount of 3,5-dichloro-2,4-difluoroaniline would imply that even after 24 h 
metabolism and excretion would continue at a level comparable to that observed in 
0-24 h. Since this is not what is observed the explanation for low aniline recovery 
due to covalent interaction of a reactive metabolite derived from it with tissue 
macromolecules provides the best explanation for this phenomenon. Altogether, the 
mechanism depicted in Figure 5 might provide the best explanation for the low 
recovery of the C4-halogenated aniline part of the molecules, both in case of 
teflubenzuron, but also in case of diflubenzuron, where the C4 position in the aniline 
moiety is chlorinated. Clearly, such a process resulting in formation of a reactive 
benzoquinone-type metabolite may be of importance also from a toxicological point 
of view, especially when taking into account that diflubenzuron was reported to 
elicit hepatocellular changes in mice [21]. 
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Summary and Conclusions 
The amount of newly developed chemicals such as agrochemicals, drugs and 
food additives in our modern society is ever increasing. The industrial production, 
use and also the release in the environment of these chemicals expose organisms to 
these xenobiotics. Due to the often hydrophobic character of these xenobiotics they 
can be easily absorbed and accumulated in the body. However, organisms defend 
themselves against these agents by converting them enzymatically to more 
hydrophilic easily excretable products. Sometimes these biotransformation reactions 
can lead to reactive intermediates which cause cell damage, toxicity, malignancy 
and/or ultimately carcinogenicity. This indicates why a lot of toxicological screening 
and safety tests have to be performed during the development of these agents. 
However, modern society still requires new compounds with better 
properties. As it is unfeasible to test the biological activity and toxic effects of all 
newly developed chemicals in experimental animals, many in vitro systems have 
been developed in which these chemicals can be quickly tested for various biological 
and/or toxicological effects. To diminish the use of experimental test systems the 
QSAR concept has been developed, describing so-called Quantitative Structure-
Activity Relationships. This QSAR approach should make it possible to predict the 
biological effect, the biotransformation pattern and/or the toxicity of a chemical 
based on its physical and chemical characteristics. In this respect the application of 
MO (Molecular Orbital) computer calculations to describe at least some of these 
chemical characteristics appears to become more and more useful. 
The present thesis focuses on the use of these computer calculated MO 
parameters for the prediction of biotransformation characteristics of benzene 
derivatives. Benzene derivatives play an important role as precursors for the 
synthesis of many xenobiotics and industrially relevant chemicals. The cytochrome 
P450-catalysed biotransformation of various substituted benzenes was studied and 
the results were evaluated to determine whether (MO-based) computer calculated 
chemical parameters of benzenes could explain the results obtained. Where results 
could not be described well by the chemical reactivity of the substrate itself, 
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additional experimental work was performed to investigate to which factors and/or 
interactions the observed deviations could be ascribed. This information can then be 
used to adopt and improve the predictive model. 
Biotransformation of xenobiotics by higher organisms is an enzymatic 
process in which cytochromes P450 play a major role. This system is able to handle 
an enormous amount of very structurally different chemicals. The cytochrome P450 
enzymes differ in their substrate specificity, metabolic activity and their extent of 
contribution to the production of toxic metabolites. As outlined in the introduction 
of this thesis (Chapter 1), there are several factors which control the cytochrome P450-
catalysed biotransformation. These factors include for example, electron donation to 
cytochrome P450, the accessibility of the active (FeO)3+ species in the active site of 
the enzyme, the interaction between the substrate and the active site and the 
chemical reactivity of the substrate itself. In cases where the latter factor controls the 
outcomes of the cytochrome P450-catalysed biotransformation, one could describe a 
QSARs for the reaction. Based on these QSARs the cytochrome P450-catalysed 
biotransformation of other chemicals might be predicted. Furthermore, these QSARs 
might give more insight in the mechanistic background of the biotransformation 
reaction for which it has been developed. 
An example of this approach is described in Chapter 2 of this thesis. In this 
chapter in vivo cytochrome P450-catalysed aromatic ring hydroxylation of various 
substituted benzene derivatives was determined using 19p NMR. Previous reported 
results on the regioselectivity of cytochrome P450-catalysed aromatic ring 
hydroxylation of a series (poly)fluorobenzenes [1] demonstrated a clear QSAR 
(correlation 0.96) relating the site of hydroxylation of the site of the reactive HOMO 
Jt-electrons in the benzene substrate. Thus, in Chapter 2 the same parameter was 
tested for its ability to predict the regioselectivity of aromatic hydroxylation of a 
series C4-substituted fluorobenzenes. It turned out that the MO-QSAR approach 
could well predict the regioselectivity of the series of 4-X-substituted fluorobenzenes 
when X was a H, F, CI, and CN group. However, this approach of predicting the 
regioselectivity of aromatic hydroxylation ran into problems when the para 
substituent was a bromine or iodine. The extent to which the hydroxylation adjacent 
to a bromine and iodine substituent was reduced, correlated qualitatively with the 
size of the substituents as given by their Van der Waals radius, i.e. the larger the 
substituent the greater the deviation between the predicted and observed 
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hydroxylation at the adjacent aromatic carbon centre. Additional experiments 
showed that the observed deviations could not be ascribed to a stereoselective 
orientation of these substrates in the active sites of cytochromes P450. These results 
led to the hypothesis that bromine and iodine substituents sterically hamper the 
electrophilic attack of the cytochrome P450 high-valent iron-oxo species on the 
carbon atoms adjacent to the substituted carbon centres. This hypothesis was 
supported by calculating the steric effects of bromine and iodine substituents, thus 
defining a steric correction factor for prediction of the aromatic ring hydroxylation at 
sites ortho with respect to a bromine or iodine substituent. In a second series of 
regioselectivity experiments using a series of tri-substituted benzenes containing 
fluorine, chlorine, bromine, iodine and cyano substituents, these steric correction 
factors were validated. Without using the steric correction factors for bromine and 
iodine substituents no correlation between the predicted and observed 
regioselectivity was obtained. However, upon application of the correction factors a 
correlation factor of 0.91 was obtained for prediction and actually observed 
regioselectivity of cytochrome P450-catalysed aromatic hydroxylation of the series 
tri-substituted benzenes. These results show that the QSAR which was initially 
developed for a series of (poly)fluorobenzenes was still valid for other substituted 
benzenes taking into account the steric hindrance by relatively large substituents 
such as bromine and iodine. Furthermore, from a mechanistic point of view these 
MO-QSARs suggest that the cytochrome P450-catalysed aromatic ring hydroxylation 
of at least the benzene derivatives tested proceeds by an initial attack of the iron-oxo 
species on the ring carbon atom, without the formation of arene oxide intermediates 
as a major route [2,3]. 
The question remains why going from a chlorine to a bromine substituent, 
steric hindrance is observed rather abrupt. A possible explanation might be found in 
the observation that when two molecules approach each other the potential energy 
goes through a minimum and thereafter increases rapidly with decreasing distance. 
Surprisingly, it was found that steric hindrance by the cyano group was not 
observed although this group is definitely larger than a bromine. However, with 
respect to steric hindrance of the electrophilic attack of the (FeO)3+ species, only the 
atom closest to the aromatic ring might have to be taken into account. Steric 
hindrance of this atom, a carbon, is not expected since a carbon, has a size similar to 
that of a chlorine. 
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More complicated substituents than H, F, CI, Br, I and CN were investigated 
in Chapter 3 where the regioselectivity of aromatic ring hydroxylation of 3-
fluoro(methyl)anilines was investigated. Little is known about the cytochrome P450-
catalysed biotransformation of such methylanilines. Results from the in vivo and in 
vitro cytochrome P450-catalysed regioselectivity of aromatic hydroxylation showed 
that the frontier orbital density distribution in the aromatic ring could only 
qualitatively predict the observed regioselectivity. Again, as for the bromine and 
iodine substituents the observed regioselectivity of aromatic ring hydroxylation for 
the various amino and methyl substituted substrates showed systematic deviations 
from the predicted regioselectivity, i.e. hydroxylation at the ring carbon C4 para with 
respect to the amino moiety was always higher than predicted while hydroxylation 
at the carbon atoms ortho with respect to the amino group (C2 and C6) was lower 
than expected. Further research was performed to investigate why for this series of 
amino and/or methyl substituted benzene derivatives the intrinsic chemical 
reactivity did not predict the observed regioselectivity of aromatic hydroxylation 
quantitatively. Three different experimental approaches were used to investigate 
possible reasons underlying the systematic deviations between predicted and 
observed regioselectivity for the cytochrome P450-catalysed aromatic hydroxylation 
of amino-containing benzenes. These results are discussed in some more detail 
hereafter. 
1. As a first approach, incubations of 3-fluoro-2-methylaniline with different 
microsomal preparations containing various cytochrome P450 enzyme patterns as 
well as with purified cytochrome P4502B1 were performed. The regioselectivity for 
aromatic hydroxylation of 3-fluoro-2-methylaniline observed in all these incubations 
were similar. This result indicates that cytochromes P450 with different active sites 
give similar regioselectivities and, thus, in case of 3-fluoro-2-methylaniline similar 
deviations for predicted values. This suggests that the observed discrepancy 
between predicted and observed aromatic hydroxylation patterns can not be 
ascribed to a stereoselective orientation of the 3-fluoro(methyl)anilines imposed by 
the active sites of the cytochromes P450 catalysing its conversion. 
2. Further support for this conclusion was obtained from ^H NMR Ti relaxation 
studies on fluoromethylanilines. These studies are described in Chapter 4. It appears 
that the orientation of the tested fluoromethylanilines in the active sites of 
cytochromes P4501A1 and 2B1 is similar. Based on the observation that all aromatic 
protons are at about the same average distance from the catalytic Fe^+ centre, these 
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results are most compatible with a time-averaged orientation of the substrates with 
the Fe^+ above the aromatic ring and the Jt-orbitals of the aromatic ring and those of 
the porphyrin rings in a parallel position. This latter aspect would provide 
possibilities for energetically favourable n-n interactions. Possibilities for a flip-flop 
rotation around an axis in the plane of the aromatic ring of the substrate can be 
included in this picture, as such rotations would still result in a similar average 
distance of all aromatic protons to the Fe^+ centre. Altogether, the data strongly 
suggest that, independent of the cytochrome P450 enzyme these substrates can rotate 
freely in the active site and are not hindered and/or specifically orientated by 
interactions with specific amino acid residues of the active site. 
3. Finally, the possible influence of the active site on the cytochrome P450-catalysed 
aromatic hydroxylation was tested by using microperoxidase-8 as a model system 
for cytochrome P450-catalysed aromatic ring hydroxylation. Microperoxidase-8 is a 
so-called mini-enzyme prepared by proteolytic digestion of horse-heart cytochrome 
c. MP-8 contains a heme covalently attached to a peptide chain of only eight amino 
acids and thus it lacks an active site. MP-8 is well known to perform peroxidase-like 
reactions. However, experimental evidence has been obtained described in Chapter 5 
of this thesis that the MP-8-catalysed aromatic ring hydroxylation of aniline and 
phenol derivatives in a H202-driven system proceeds by a cytochrome P450-like 
oxygen-transfer mechanism. This could be concluded from the fact that l^O 
incorporation from H2^^02 into the 4-aminophenol formed from aniline was 100%. 
Thus, the H202-driven MP-8 system was used as a model to study regioselectivity of 
oxygen-transfer in a heme-based catalyst without an active site. 
The results of such experiments demonstrated that the MP-8-catalysed 
aromatic ring hydroxylation of 3-fluoro(methyl)anilines (Chapter 3) results in similar 
regioselectivities of aromatic ring hydroxylation as those observed for cytochrome 
P450-catalysis. As a specific substrate binding site in MP-8 can be excluded, these 
results, together with those obtained from different microsomal preparations 
(Chapter 3) and the ^H NMR Tl relaxation measurements (Chapter 4), clearly 
eliminates the possibility that the regioselectivity of aromatic ring hydroxylation is 
predominantly dictated by a stereoselective orientation of the substrate in the active 
site of cytochromes P450. Thus for these relatively small and non-polar substrates 
specific interactions between molecular sides in the substrate and amino acid side 
chains present in the active site are not dictating a stereoselective orientation of these 
substrates. 
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Since the MP-8-catalysed reactions showed similar deviations between predicted and 
observed regioselectivity of aromatic hydroxylation of 3-fluoro(methyl)anilines, it 
was concluded that the deviations must result from an orientating interaction 
between the substrate and the high-valent iron-oxo species (FeO)3+ itself, resulting 
in a stereoselective orientation of the substrate towards the catalytically active 
species. This interaction can be expected to be quite similar for different cytochromes 
P450 and might also be comparable in the active MP-8 system. This implies that, in 
contrast to what was observed by ^H NMR for substrates bound to the Fe^+ resting 
state of the enzyme, the (FeO)3+ form of the protein would impose a preferential 
orientation of the amino-containing substrate in such a way that on the average C4 
(para to the amino) is closer to whereas C2/6 (ortho to the amino) are further away 
from the (FeO)3+ species. Support for a different substrate orientation in the Fe^+ 
resting state and the (FeO)3+ activated form respectively can be found in a study of 
Paulsen and Ornstein [4]. They showed that the orientation of camphor in the 
presence and absence of the high-valent iron-oxo species (FeO)3+ was different and 
that orientation in the presence of the catalytically active form of the enzyme 
((FeO)3+) was in accordance with the observed regioselectivity of oxidation. 
Altogether, results from all studies on the regioselectivity of aromatic 
hydroxylation of the various benzene derivatives show that the regioselectivity of 
the H, F, CI, Br, I, CN, CH3 and NH2 substituted benzene derivatives investigated is 
predominantly determined by their chemical reactivity. However, especially for 
amino-containing benzene derivatives interactions between the substrate and the 
high-valent iron-oxo species, resulting in a stereoselective orientation of the 
substrate, might also play a role. This means that the QSAR for aromatic ring 
hydroxylation in the case of amino-containing benzenes predicts only qualitatively 
the regioselectivity of aromatic ring hydroxylation for these series of substrates. 
An additional result obtained in all regioselectivity studies was the absence 
of formation of NIH shifted phenolic metabolites. The formation of such NIH shifted 
phenolic metabolites has been well documented especially for the biotransformation 
of chlorinated and brominated benzene derivatives. As the benzenes in our studies 
were mainly fluorinated, we decided to investigate whether there was a (chemical) 
reason for this discrepancy. 
In Chapter 6 the possibility of a cytochrome P450-catalysed fluorine NIH shift 
in a series of polyfluorobenzenes was investigated and compared with the 
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literature data of the chlorinated analogues. The in vivo biotransformation of a series 
polyfluorobenzenes showed that formation of NIH shifted metabolites was not a 
significant biotransformation route. As outlined above, this is in contrast to the 
results reported in the literature for the chlorinated analogues. However, in contrast 
to the in vivo data, in in vitro microsomal studies with 1,4-difluorobenzene formation 
of a significant amount of fluorine NIH shifted phenolic metabolite was observed. 
Unfortunately, the in vitro microsomal conversion of the other used 
polyfluorobenzenes could not be detected, possibly due to the fact that the HOMO 
energy of these substrates was too low for an efficient conversion by cytochromes 
P450 [5]. It is generally accepted that formation of NIH shifted metabolites proceeds 
via arene oxide intermediates and that these arene oxides, especially in vivo, but not 
in vitro in a microsomal system, might react in competing conjugation pathways 
such as GSH conjugation. Additional in vivo and in vitro experiments showed that 
indeed GSH conjugation was a competing pathway for the arene oxide 
intermediates, its presence or absence resulting in an influence on the amount of 
NIH shifted phenolic metabolites observed. 
Nevertheless, the results thus obtained also clearly illustrated and confirmed 
the reduced capacity for formation of NIH shifted phenolic metabolites for fluoro- as 
compared to chlorobenzenes. This differences between the NIH shift for fluorine and 
chlorine containing benzenes was further investigated and could be explained by 
MO computer calculations on the proposed reaction intermediates in the two 
biotransformation pathways. Epoxide ring opening, supposed to be the rate-limiting 
step in the formation of NIH shifted metabolites, appeared easier for chlorinated 
benzenes compared to their fluorinated analogues. Furthermore, these MO 
calculations in combination with a MO-QSAR for the rate of GS-conjugation of 
electrophilic model compounds [6] were indicative for higher rates of GSH 
conjugation for the fluorinated benzene arene oxides than the chlorinated analogues. 
The detoxifying pathway of GSH conjugation is very important for assessing the 
risks of these kind of substrates as arene oxides are known to react with protein and 
DNA provoking toxic and /or mutagenic/carcinogenic responses. 
Altogether, the results from this study show that MO calculations can not 
only explain and thus predict the regiospecificity of biotransformation in a molecule 
but also explain the relative rates, i.e. chances, on different biotransformation routes. 
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Finally, in addition to all studies on model benzene derivatives, the last 
chapter of this thesis (Chapter 7) describes studies on the biotransformation of a 
halogenated benzene derived compound that is used as an insecticide, i.e. 
teflubenzuron. This may provide some insight in the possibilities to use outcomes 
from studies on model compounds to obtain insights also in the biotransformation of 
other compounds. Teflubenzuron, which is used for the protection of fruit and 
vegetables against larves, contains two aromatic benzene-derived rings connected 
via an urea bridge. These aromatic rings are differently substituted and are a suitable 
starting point to evaluate the influence of various substituents on the metabolic fate 
of the chemical. Basically, they are an aniline and a benzoate derived moiety. Results 
of this study on the biotransformation of teflubenzuron demonstrate that upon an 
oral dose of the insecticide to male Wistar rats the metabolic fate of the two aromatic 
rings is significantly different. Though about 90% of the dose was excreted 
unchanged in the faeces, the remainder of the dose was absorbed from the gastro-
intestinal tract and -in part- excreted in the urine mainly after hydrolysis of the urea 
bridge. Interestingly, the urinary recovery of the benzoate moiety was about 8 times 
higher than that of the aniline moiety of teflubenzuron. Dose-recovery studies on the 
scission products of teflubenzuron confirmed these results as the urinary recovery of 
the metabolites from the benzoate moiety were nearly 100% while the recovery of 
the aniline derivatives was only about 50%. The benzoate moiety is excreted 
unchanged or after a Phase II reaction, while the aniline moiety has to undergo both 
a Phase I and II reaction before it can be excreted. The significant difference between 
the recovery of the benzoate and aniline moiety can be best explained by the 
formation of a cytochrome P450-catalysed reactive benzoquinoneimine from the C4 
halogenated aniline derivatives. Swift binding of these reactive benzoquinoneimines 
to tissue macromolecules might cause the compound to be withheld in the body. 
This is also important from a toxicological point of view as binding of these reactive 
benzoquinoneimines might provoke toxic and/or mutagenic /carcinogenic effects in 
the body. 
Altogether, the results described in this thesis show that QSARs are very 
useful in explaining the biotransformation pattern of relatively small and non-polar 
benzene derivatives. Their biotransformation pattern was demonstrated to be 
predominantly determined by the chemical reactivity of the benzenes and - although 
to a much lesser extent for bromine, iodine and amino containing derivatives- more 
than by steric factors (Br,I) and/or electronic dipole-dipole interactions with the 
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activated (FeO)3+ cofactor (NH2). However, the further extension of the presently 
developed QSARs to more complicated and especially to larger molecules might 
require the incorporation of computer techniques that take into account preferential 
stereoselective substrate orientations imposed by the active sites. Although the 
molecular modelling computer techniques to do these type of additional orientation 
analyses are available, such studies also require the availability of the enzyme crystal 
structures. Since such 3-D structures for cytochromes P450 are at present restricted to 
some bacterial cytochromes P450 and not available for mammalian cytochromes 
P450 the studies may have to await the elucidation of the mammalian cytochrome 
P450 structures. Nevertheless, the concept as such might be developed using either 
molecular modelling combined with quantum chemical calculations for the bacterial 
cytochrome P450 system as done recently by Zakharieva et al. [7] and Freutel et al. 
[8], or by performing similar studies for other biotransformation enzymes, such as 
for example the glutathione S-transferases for which several 3-D structures have 
been described. 
In general, QSARs can be used to predict the biological activity of non-tested 
chemicals but they can also give more insight in the mechanistic rules of 
biotransformation of molecules. This knowledge can be very helpful for example 
when the technical ability of cloning cytochromes P450, and thus producing these 
enzymes in large quantities, is increasing. Cytochromes P450 could then be used for 
the synthesis of chemical products (P450 biotechnology). Especially cytochromes 
P450 are suitable as they are able to convert many structural diverse substrates. The 
advantage of enzymatic synthesis compared to chemical synthesis is that it causes 
among others less waste problems. 
References 
1 Rietjens, I.M.C.M., Soffers, A.E.M.F., Veeger, C, and Vervoort, J. (1993) Regioselectivity of 
cytochrome P-450 catalyzed hydroxylation of fluorobenzenes predicted by calculated 
frontier orbital substrate characteristics. Biochemistry 32,4801-4812. 
2 Korzekwa, K.R., Swinney, D.C., and Trager, W.F. (1989) Isotopically labeled chlorobenzenes 
as probes for the mechanism of cytochrome P-450 catalyzed aromatic hydroxylation. 
Biochemistry 28,9019-9027. 
3 Rizk, P.N., and Hanzlik, R.P. (1995) Oxidative and non-oxidative metabolism of 4-
iodoanisole by rat liver microsomes. Xenobiotica 25,143-150. 
4 Paulsen, M.D., and Ornstein, R.L. (1993) Substrate mobility in thiocamphor-bound 
cytochrome P450cam: An explanation of the conflict between the observed product profile 
and the X-ray structure. Protein Engng. 6, 359-365. 
183 
Chapter 8 
Cnubben, N.H.P., Peelen, S., Borst, J.-W., Vervoort, J., Veeger, C, and Rietjens, I.M.C.M. 
(1994) Molecular orbital-based Quantitative Structure-Activity Relationship for the 
cytochrome P450-catalyzed 4-hydroxylation of halogenated anilines. Chem. Res. Toxicol. 7, 
590-598. 
Soffers, A.E.M.F., Ploemen, J.H.T.M., Moonen, M.J.H., Wobbes, Th., Van Ommen, B., 
Vervoort, J., Van Bladeren, P.J., and Rietjens, I.M.C.M. (1996) Regioselectivity and 
quantitative structure-activity relationships for the conjugation of a series 
fluoronitrobenzenes by purified glutathione S-transferase enzymes from rat and man. Chem. 
Res. Toxicol. 9,638-646. 
Zakharieva, O., Grodzicki, M., Trautwein, A.X., Veeger, C, and Rietjens, I.M.C.M. (1996) 
Molecular orbital study of the hydroxylation of benzene and monofluorobenzene catalysed 
by iron-oxo porphyrin n cation radical complexes. JBIC 1,192-204. 
Freutel, J.A., Collins, J.R., Camper, D.L., Loew, G.H., and Ortiz de Montellano, P.R. (1992) 
Calculated and experimental absolute stereochemistry of the styrene and (3-methylstyrene 
epoxides formed by cytochrome P450cam. /. Am. Chem. Soc. 114,6987-6993. 
184 
Abbreviations and Symbols 
Abbreviations and Symbols 
AcetylcoA 
AMI 
ATP 
C2 
CO 
CYP/cyp 
Cys 
DNA 
E 
EDTA 
E(HOMO) 
elec 
E(LUMO) 
EROD 
FAD 
GC-MS 
FeO(H) 
GSH 
H 
H r 
Ht 
AHF 
HPLC 
HOMO 
HRP 
IS 
JHF 
kcat 
kDa 
Km 
Ks 
LUMO 
3-MC 
MINDO/3 
MNDO 
MP-8 
mRNA 
MO 
MO-QSAR 
MT 
acetyl coenzyme A 
Austin method 1 
adenosine triphosphate 
frontier orbital density 
carbonmonoxide 
cytochrome P450 gene 
cysteine 
deoxyribonucleic acid 
energy 
ethylenediaminetetraacetate 
energy of the HOMO 
electrophile 
energy of the LUMO 
ethoxyresorufin O-dealkylation 
flavin adenine dinucleotide 
gaschromatography-mass spectrometry 
high-valent iron-oxo species 
glutathione 
Hamiltonian operator 
heat of formation of a reaction 
activation energy 
heat of formation 
high performance liquid chromatography 
highest occupied molecular orbital 
horseradish peroxidase 
internal standard 
coupling constant 
first-order rate constant of enzymatic conversion 
kilodalton 
Michaelis-Menten constant, substrate concentration at 1/2 
Vmax 
binding affinity constant 
lowest unoccupied molecular orbital 
3-methylcholanthrene 
modified intermediate neglect of differential overlap/3 
modified neglect of differential overlap 
microperoxidase-8 
messenger ribonucleic acid 
molecular orbital 
molecular orbital based quantitative structure-activity 
relationship 
nmr peak area at delay time t 
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NAD(P)H 
NIH 
NMR 
nucl 
o /n 
P450Cam 
P450BM3 
P450terp 
PAPS 
PCN 
PCA 
PLS 
ppm 
Q 
QSAR 
QSMR 
r 
R 
S 
SAM 
S.D. 
SO 
SOD 
SOMO 
t 
Tl 
UDP 
UDP-GA 
Vmax 
P 
p-NF 
e 
£x 
X 
Xc 
Y 
reduced nicotinamide adenine dinucleotide (phosphate) 
national institute of health, USA 
nuclear magnetic resonance 
nucleophile 
overnight 
cytochrome P450 camphor 
cytochrome P450 Bacillus megaterium 
cytochrome P450 terpineol 
3'-phosphoadenosine-5'-phosphosulfate 
pregnenolone 16a-carbonitrile 
principal components analysis 
partial least squares 
parts per million 
charge 
quantitative structure-activity relationship 
quantitative structure-metabolism relationship 
distance or correlation coefficient 
molar gas constant 
substrate 
S-adenosylmethionine 
standard deviation 
oxygenated substrate 
superoxide dismutase 
singly occupied molecular orbital 
time 
longitudinal relaxation time 
uridine diphosphate 
uridine-5'-diphospho-oc-D-glucuronicacid 
maximal enzymatic velocity 
resonance overlap integral 
P-naphtoflavone 
local dielectric constant 
extinction coefficient at wavelength x 
delay time 
correlation time 
electron wave function 
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Samenvatting 
(ook voor niet-ingewijden) 
De welvaart in de westerse samenleving is mede te danken aan de 
ontwikkeling van vele chemische verbindingen zoals gewasbeschermingsmiddelen 
(b.v. pesticiden en herbiciden), farmaceutische verbindingen, plastics en 
kunstmatige voedseladditieven. Deze niet van nature voorkomende verbindingen 
zijn voor organismen, zoals mens en dier, lichaamsvreemd en worden xenobiotica 
genoemd. Organismen worden aan deze verbindingen onder zeer verschillende 
omstandigheden blootgesteld, zoals tijdens de fabricage en het gebruik van 
xenobiotica, maar ook doordat zij als verontreinigingen in het milieu voorkomen. 
Veel xenobiotica zijn hydrofoob (vet oplosbaar) en kunnen dus makkelijk in 
het vetweefsel van het lichaam opgehoopt worden. Gelukkig zijn organismen in 
staat om zich te verdedigen tegen ophoping van deze chemicalien in het lichaam 
doordat enzymen ("kleine chemische fabriekjes") deze componenten kunnen 
omzetten in meer hydrofiele (water oplosbare) verbindingen die het lichaam kunnen 
verlaten via de urine en/of faeces. Het enzymatisch omzetten van verbindingen 
wordt biotransformatie genoemd. Deze biotransformatie reakties voor 
lichaamsvreemde stoffen kunnen ingedeeld worden in Fase I (transformatie) en II 
(conjugatie) reakties. In Fase I reakties wordt meestal een groep ingebracht of 
vrijgemaakt die het molecuul vatbaar maakt voor een Fase II reaktie waarin het 
gemodificeerde molecuul wordt gekoppeld aan een endogene (van nature in het 
lichaam aanwezige) component (b.v. glutathion). Meestal leiden deze 
biotransformatie reakties tot verbindingen die niet alleen beter wateroplosbaar zijn 
maar ook minder giftig zijn dan de uitgangsverbinding (detoxificatie). Echter, in 
sommige gevallen leiden deze reakties tot voor het lichaam giftige (toxische) 
verbindingen (bioactivatie) die schade kunnen aanrichten doordat zij reageren met 
eiwitten, DNA en/of andere celcomponenten en daardoor de normale functies van 
cellen verstoren. 
Een van de belangrijkste Fase I enzymen verantwoordelijk voor de 
biotransformatie van lichaamsvreemde stoffen is het cytochroom P450 dat in vele 
lichaamsdelen voorkomt, vooral in de lever. Het lichaamsvreemde molecuul wordt 
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op een bepaalde plaats in het enzym gebonden (actieve centrum) en aldaar omgezet. 
Bij deze omzetting wordt in het algemeen een zuurstof atoom van een geactiveerde 
ijzer-oxo porphyrine (heem) groep ((FeO)3+) in het substraat gezet. Bij de omzetting 
van lichaamsvreemde stoffen door dit enzym spelen diverse factoren een rol. De 
chemische reactiviteit van het substraat bepaalt voor een belangrijk deel de 
omzetting. Daarnaast kunnen interacties tussen specifieke chemische of sterische 
eigenschappen van het substraat en het actieve centrum resulteren in een specifieke 
orientatie van het substraat in het actieve centrum. Hierdoor is het mogelijk dat het 
substraat niet vrij draaibaar is en zullen bepaalde plaatsen in het molecuul beter 
bereikbaar zijn voor een aanval door het (FeO)3+ deeltje dan andere plaatsen. 
Het feit dat sommige verbindingen schade kunnen aanrichten in organismen 
betekent dat nieuw gesynthetiseerde chemicalien eerst goed getest moeten worden 
voordat zij op de markt kunnen komen. Daar het aantal nieuw ontwikkelde 
componenten groot is, is het onmogelijk om alle nieuw gesynthetiseerde 
verbindingen te testen in proefdieren op hun toxische eigenschappen. Een geld- en 
tijdbesparende methode die de laatste jaren is ontwikkeld om de reactiviteit van 
deze verbindingen te kunnen voorspellen is het beschrijven van QSAR's 
(Quantitatieve Structuur-Activiteits Relaties). Een QSAR beschrijft een correlatie 
tussen bijvoorbeeld de chemische, fysische of geometrische eigenschappen van een 
verbinding en zijn biologische activiteit. Deze eigenschappen van een verbinding 
worden tegenwoordig steeds meer bepaald met behulp van vaak snelle en 
eenvoudige computer programma's. Op basis van eenmaal opgestelde QSAR's 
kunnen voorspellingen gedaan worden voor de biologische activiteit van nog niet 
onderzochte verbindingen (Hoofdstuk 1). 
In dit proefschrift is onderzocht in hoeverre een QSAR voor de cytochroom 
P450 gekatalyseerde aromatische ring hydroxylering van fluorbenzenen (zie Figuur 
1) toepasbaar is op benzeen derivaten die substituenten bevatten die ingewikkelder 
zijn dan het relatieve kleine en inerte fluor atoom. Het blijkt dat de QSAR geldig kan 
zijn voor substituenten zoals CI, Br, I en CN, maar dat voor Br en I wel een correctie 
factor nodig is om de regioselectiviteit van aromatische ring hydroxylering 
quantitatief te kunnen voorspellen (Hoofdstuk 2). Deze substituenten zijn zo groot dat 
zij sterische hinder veroorzaken voor de aanval van het (FeO)3+ deeltje op de 
koolstof atomen in de aromatische ring naast het gesubstitueerde koolstof atoom. 
Geconcludeerd kon worden dat de QSAR die is opgesteld voor de regioselectiviteit 
van aromatische ring hydroxylering van fluorbenzenen ook kan worden gebruikt 
voor benzeen derivaten met een CI, Br, I, en CN groep, rekening houdend met 
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P450(FeO)3+ + [ jl 
5 ^ . J>3 
OFe 
3+ 
OH 
|l + P450(Fe)3+ 
OH 
3+ 
-»- I | + P450(Fe)3+ 
Figuur 1 De cytochroom P450 gekatalyseerde regioselectiviteit van aromatische ring 
hydroxylering van fluorbenzeen. 
sterische hindering van de Br en I atomen. Dit houdt in dat de cytochroom P450 
gekatalyseerde aromatische ring hydroxylering van deze onderzochte benzeen 
derivaten voornamelijk verloopt via een electrofiele aanval van het (FeO)3+ deeltje 
op de ring koolstof atomen (cr-additie). Dit a-adduct legt vervolgens direkt, of via 
een keto intermediair, om naar de fenol. Dit betekent dat areenoxide intermediairen 
geen belangrijke rol spelen in de route die leidt tot fenol vorming. Dit laatste is in 
tegenstelling tot wat vaak in de literatuur wordt aangenomen. 
Bij een serie benzeen verbindingen met een amino (NH2) en methyl (CH3) 
groep als substituenten in de aromatische ring (3-fluor(methyl)anilines), bleek dat de 
QSAR de regioselectiviteit van aromatische ring hydroxylering alleen qualitatief kon 
voorspellen (Hoofdstuk 3). De afwijkingen die gevonden werden tussen de 
voorspelde en gevonden regioselectiviteit kunnen worden toegeschreven aan een 
mogelijke interactie tussen het (FeO)3+ deeltje en de amino groep in het substraat 
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resulterend in een stereoselectieve orientatie van het substraat in het actieve centrum 
van het cytochroom P450. Deze stereoselectieve orientatie van het substraat zorgt 
ervoor dat niet alle ring koolstof atomen even goed bereikbaar zijn voor aanval van 
het (FeO)3+ deeltje. Deze hypothese werd ondersteund door resultaten van *H NMR 
Ti relaxatiemetingen die lieten zien dat een serie fluormethylanilines in de actieve 
centra van microsomaal en gezuiverd cytochroom P4501A1 en 2B1 vrij draaibaar 
waren ten opzichte van het Fe3+ centrum (Hoofdstuk 4). De invloed van het actieve 
centrum op de regioselectiviteit van aromatische ring hydroxylering werd verder 
onderzocht met behulp van het mini-heem enzym microperoxidase (MP-8), hetgeen 
bestaat uit een ijzer porphyrine gebonden aan slechts acht aminozuren en dus een 
actief centrum mist. Resultaten van experimenten toonden aan dat de MP-8 
gekatalyseerde aromatische ring hydroxylering verloopt via een cytochroom P450 
type van zuurstof overdracht en dus kon dit MP-8 gebruikt worden als model 
systeem voor de invloed van het actieve centrum op de cytochroom P450 
gekatalyseerde regioselectiviteit van aromatische hydroxylering (Hoofdstuk 5). 
Aangezien de MP-8 gekatalyseerde regioselectiviteit van aromatische ring 
hydroxylering van de 3-fluor(methyl)anilines vergelijkbaar is met die van de 
cytochroom P450 gekatalyseerde omzetting kan geconcludeerd worden dat de 
cytochroom P450 gekatalyseerde regioselectiviteit van aromatische ring 
hydroxylering van de 3-fluor(methyl)anilines niet het gevolg is van een 
stereoselectieve orientatie van de substraten in de actieve centra als gevolg van 
interacties tussen het substraat en de aminozuren in het actieve centrum. 
Tijdens de aromatische ring hydroxylering van benzeen derivaten is het 
mogelijk dat halogeen atomen (b.v. CI, Br, F) verschuiven naar het naast gelegen 
koolstof atoom (NIH shift). Deze NIH shift verloopt via areenoxide intermediairen 
(zie Figuur 2). Het blijkt dat tijdens de in vivo cytochroom P450 gekatalyseerde 
aromatische ring hydroxylering van polyfluorbenzenen fluor atomen nauwelijks 
shiften terwijl in vitro verschuiving van fluor atomen wel mogelijk is. Dit kan 
verklaard worden doordat in vivo GSH conjugatie van het areenoxide een efficient 
alternatief is voor areenoxide opening gekoppeld met een NIH shift (Hoofdstuk 6). 
Voor de chloor analogen van deze polyfluorbenzenen treedt zowel in vivo als in vitro 
aanzienlijk meer chloor NIH shift op. Uit computer berekeningen kon de volgende 
verklaring worden afgeleid voor de gevonden verschillen tussen de in vivo fluor en 
chloor shift in halogeen benzenen: voor fluorbenzenen is de areenoxide opening 
energetisch moeilijker dan voor de chloor analogen. Bovendien bleek ook nog dat de 
fluor areenoxiden sneller reageren in de alternatieve reactie route met glutathion 
dan de chloor analogen. 
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Figuur 2 Twee mogelijke metabole routes van areenoxiden. 
Het effect van verschillende substituenten in benzeen derivaten op de 
biotransformatie route werd nogmaals geillustreerd aan de hand van het insecticide 
teflubenzuron, dat is opgebouwd uit twee verschillend gesubstitueerde benzeen 
ringen verbonden door een ureum brug (Hoofdstuk 7). Ratten die oraal gedoseerd 
werden met deze verbinding namen slechts een klein percentage (10%) op uit het 
maag-darm kanaal, de rest werd ongemetaboliseerd uitgescheiden in de faeces. De 
ureum brug van het opgenomen teflubenzuron wordt gehydrolyseerd en de 
splitsingsprodukten, het benzoaat en aniline gedeelte, worden uitgescheiden in de 
urine. Het benzoaat deel wordt voornamelijk uitgescheiden als 2,6-
difluorbenzoezuur en het aniline gedeelte wordt uitgescheiden als metabolieten van 
3,5-dichloor-2,4-difluoraniline en (3,5-dichloor-2/4-difluorfenyl)ureum. Hoewel een 
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gelijke hoeveelheid product is te verwachten van het benzoaat en aniline deel, wordt 
ongeveer 8 keer zoveel benzoaat als aniline product gevonden. Dosis-recovery 
studies van de splitsingsprodukten van teflubenzuron bevestigden deze resultaten 
daar urine recovery van het benzoaat gedeelte bijna 100% was terwijl dat van de 
aniline derivaten slechts ongeveer 50%. Dit verschil in recovery kan het best worden 
toegeschreven aan het feit dat het aniline gedeelte een cytochroom P450-
gekatalyseerde dehalogenering op de C4 positie ondergaat waarbij mogelijk het zeer 
reactieve benzoquinonimine wordt gevormd. Dit benzoquinonimine kan binden aan 
celcomponenten en dus in het lichaam achterblijven. Dit laatste is vanuit 
toxicologisch oogpunt van belang omdat de vorming van een reactieve metaboliet in 
principe tot toxiciteit kan leiden. 
Het onderzoek dat is uitgevoerd toont aan dat voor de onderzochte benzeen 
derivaten de chemische reaktiviteit van het substraat de belangrijkste rol speelt in 
het bepalen van het biotransformatie patroon. De chemische reaktiviteit kan gebruikt 
worden voor het opstellen van QSAR's zodat voorspellingen gedaan kunnen worden 
voor het biotransformatie patroon van nog niet onderzochte verbindingen. De vraag 
is nu in hoeverre deze QSAR's gebruikt kunnen worden voor verbindingen die qua 
structuur niet gerelateerd zijn aan de in deze studies onderzochte relatieve kleine 
niet polaire benzeen derivaten. Te verwachten is dat bij verbindingen met 
substituenten die specifieke interacties aangaan met de actieve centra of die zo groot 
zijn dat zij niet vrij draaibaar zijn in de actieve centra, een stereoselectieve orientatie 
van het substraat de regio/stereoselectieve katalyse zal bepalen naast de chemische 
reaktiviteit van het substraat. De consequentie is dat bij het opstellen van QSAR's 
voor dit soort verbindingen additionele parameters in rekening moeten worden 
gebracht zoals de (berekende of gemeten) optimale orientatie van het substraat in het 
actieve centrum. 
Ook zijn QSARs van nut omdat zij meer inzicht kunnen geven in het 
mechanisme van reaches. Deze kennis kan mogelijk in de toekomst gebruikt worden 
om bijvoorbeeld een biotransformatie enzym als cytochroom P450 te gebruiken als 
biokatalysator. Deze mogelijkheid zal zeker steeds dichterbij komen als ook de 
techniek om enzymen te klonen verder ontwikkeld wordt en het dus ook 
economisch aantrekkelijker wordt om dit soort enzymen te gebruiken als 
katalysatoren bij de productie van chemische verbindingen. Via deze methode 
zullen minder afvalproducten ontstaan hetgeen uit milieuoogpunt zeer aantrekkelijk 
is. 
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